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Summary 
Actin is one of the most abundant proteins in eukaryotic cells and regulation of the 
microfilament system is crucial for a wide range of cellular functions including cell shape, cell 
motility, cell division and membrane dynamics. The aim of this thesis was (1) to gain a better 
understanding of the function of distinct actin binding domains in the regulation of the actin 
cytoskeleton and (2) to elucidate the role of actin variants. 
 WH2 domains (WH2, Wiskott-Aldrich syndrome protein homology 2) are ubiquitous 
multifunctional regulators of actin dynamics. The protein Spire contains four central WH2 
domains A-B-C-D with about 20 amino acids each and the cyclase-associated protein CAP2 
contains only one WH2 domain. Under certain conditions, they can (1) nucleate actin 
polymerization, (2) disintegrate actin filaments and (3) sequester actin monomers. Here, the 
influence of selected Drosophila melanogaster Spire-WH2 and Mus musculus CAP2-WH2 
domain constructs on actin dynamics was tested in vitro. To act as a filament nucleator, at 
least two WH2 domains are required, and nucleation of actin polymerization was only 
observed at substoichiometric concentrations of WH2 domains over actin. At higher 
concentrations, the sequestering activity of WH2 domains takes over. Preformed and purified 
SpireWH2-actin complexes act as extremely efficient nuclei for actin polymerization, even at 
superstoichiometric WH2 concentrations, under which free WH2 domains would sequester 
actin. All analyzed constructs, including these with only a single WH2 domain, sequester 
actin as well as they can disrupt filaments. This latter and most peculiar behavior of WH2 
domains was observed in fluorometric, viscometric and TIRF assays. The WH2 domains seem 
to have such a high affinity for actin that they can forcefully sequester monomers even from 
filaments and filament bundles, thus breaking the whole structures. Taken together, the data 
clearly show that SpireWH2-actin complexes are the intermediates that account for the 
observed nucleating activity, whereas free WH2 domains can disrupt filaments and filament 
bundles within seconds, again underlining the intrinsic versatility of this regulator of actin 
dynamics. These data have been confirmed by crystallography in collaboration with the 
groups of Prof. Dr. Tad Holak and Prof. Dr. Robert Huber (Martinsried, Germany). 
Besides the well-studied conventional actins many organisms harbor actin variants 
with unknown function. The model organism Dictyostelium discoideum comprises an 
actinome of a total of 41 actins, actin isoforms and actin-related proteins. Among them is 
filactin, a highly conserved actin with an elongated N-terminus. The 105 kDa protein has a 
distinct domain organization and homologs of this protein are present in other Dictyosteliidae 
and in some pathogenic Entamoebae. Here, the functions of filactin were studied in vivo and 
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in vitro. Immunofluorescence studies in D. discoideum localize endogenous and GFP-filactin 
in the cytoplasm at vesicle-like structures and in cortical regions of the cell. A most peculiar 
behavior is the stress-induced appearance of full length filactin in nuclear actin rods. To 
perform in vitro analyses recombinant filactin was expressed in Sf9 cells. Fluorescence 
studies with the filactin actin domain suggest that it interferes with actin polymerization by 
sequestering G-actin or even capping filaments. Gel filtration assays propose a tetrameric 
structure of full length filactin. Protein interaction studies suggest that filactin is involved in 
the ESCRT (endosomal sorting complexes required for transport) pathway which is 
responsible for multivesicular body formation. The data on filactin suggest that only the 
conventional actins are the backbone for the microfilamentous system whereas less related 
actin isoforms have highly specific and perhaps cytoskeleton-independent subcellular 
functions. 
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Zusammenfassung 
Aktin ist als Bestandteil des Zytoskeletts eines der häufigsten Proteine in allen 
eukaryontischen Zellen. Eine genaue Regulation des Mikrofilamentsystems ist essentiell für 
Zellform, Zellmigration, Zellteilung und Membrandynamik. Ziel dieser Arbeit war (1) die 
Funktion von ausgewählten Aktin Bindedomänen in der Regulation des Aktin Zytoskeletts zu 
untersuchen und (2) die Funktion von Aktinvarianten zu verstehen. 
 WH2 Domänen (WH2, Wiskott-Aldrich Syndrom Protein Homologie 2) sind kurze, 
konservierte Sequenzmotive (ca. 20 Aminosäuren), welche bevorzugt monomere 
Aktinmoleküle binden. Von besonderem Interesse waren Drosophila melanogaster Spire-WH2 
und Mus musculus CAP2-WH2 Konstrukte. Das Protein Spire enthält vier WH2 Domänen (A-
B-C-D) wohingegen CAP2 (Cyclase-assoziiertes Protein 2) nur eine WH2 Domäne besitzt. 
Diese WH2 Domänen können unter bestimmten Bedingungen (1) die Aktinpolymerisation 
stimulieren, (2) Aktinfilamente zerstückeln und (3) Aktinmonomere sequestrieren. Für die 
Nukleation der Aktinpolymerisation müssen mindestens zwei hintereinander angeordnete 
WH2 Domänen vorhanden sein und unterstöchiometrische Mengen an WH2 Domänen im 
Vergleich zur Aktinkonzentration vorliegen. Bei höheren WH2 Konzentrationen überwiegt die 
Sequestrierungsaktivität. Polymerisationsexperimente mit vorgefertigten SpireWH2-Aktin 
Komplexen bestätigen, dass diese Komplexe für die beobachtete Nukleation der 
Aktinpolymerisation verantwortlich sind. Im Gegensatz zu ungebundenen WH2 Domänen 
sind diese WH2-Aktin Komplexe selbst bei überstöchiometrischen WH2 Konzentrationen 
äußerst effiziente Nukleatoren. Alle untersuchten WH2 Konstrukte zeigen die bereits 
bekannte Bindung an G-Aktin, können aber auch vorgeformte Aktinfilamente sogar 
auseinanderreißen. Diese letztere und besonders auffällige Eigenschaft von WH2 Domänen 
wurde in fluorometrischen, viskometrischen und TIRF Experimenten nachgewiesen. 
Anscheinend ist die Affinität der WH2 Domänen zu Aktinmonomeren so stark, dass sie diese 
aus den Filamenten entfernen können und damit ganze Filamente und Filamentbündel 
zerstückeln. Für die Multifunktionalität der analysierten konservierten WH2 Domänen spricht 
zusammenfassend, dass sie neben der Aktinfilament Nukleation auch Filamente und 
Filamentbündel innerhalb von Sekunden fragmentieren können. Diese Daten wurden in 
Kollaboration mit den Gruppen Prof. Dr. Tad Holak und Prof. Dr. Robert Huber (Martinsried) 
durch kristallographische Versuchsansätze bestätigt. 
Neben den gut untersuchten konventionellen Aktinisoformen liegen oft auch 
Aktinvarianten vor, deren Funktion bisher unbekannt ist. Der Modellorganismus Dictyostelium 
discoideum besitzt mit seinen 41 Aktinen und Aktin-verwandten Proteinen ein umfangreiches 
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„Aktinom”. Dazu gehört auch das Protein Filaktin (105 KDa), eine besonders 
außergewöhnliche Aktinvariante, die neben der konservierten Aktin-ähnlichen Domäne 
zusätzlich einen verlängerten N-Terminus mit einer definierten Domänenstruktur besitzt. 
Homologe von Filaktin wurden bisher in Dictyosteliden und einigen pathogenen Entamoeben 
identifiziert. Im zweiten Teil dieser Arbeit wurden die Funktionen von Filaktin in vivo und in 
vitro analysiert. Immunfluoreszenz Experimente zeigen, dass Filaktin mit konventionellem 
Aktin kolokalisiert und zusätzlich im Zytoplasma an Vesikel-artigen Strukturen zu sehen ist. 
Ein besonderes Merkmal von Filaktin ist zudem, dass es Teil von Stress-induzierten, 
intranukleären, stäbchenförmigen Proteinaggregaten, sogenannten „nuclear rods” ist. Für 
umfassende in vitro Experimente wurden rekombinante Filaktin Konstrukte mithilfe von Sf9 
Insektenzellen exprimiert. Die Ergebnisse von fluorometrischen und viskometrischen 
Experimenten deuten darauf hin, dass die Aktin Domäne von Filaktin Aktinmonomere 
sequestrieren oder sogar Aktinfilamente verkappen kann. Gelfiltrationsexperimente ergaben 
zusätzlich, dass Filaktin wohl als Tetramer vorliegt. Außerdem verbinden Protein-
Interaktionsstudien Filaktin mit dem ESCRT Signalweg (Endosomal Sorting Complexes 
Required for Transport), der unter anderem bei der Entstehung von multivesikulären Körpern 
wichtig ist. Zusammengefasst besteht das Mikrofilamentsystem vermutlich hauptsächlich aus 
konventionellen Aktinen, wohingegen spezielle Aktinvarianten andere zusätzliche und sogar 
Zytoskelett-unabhängige Funktionen übernehmen können. 
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1. Introduction 
1.1 The actin cytoskeleton 
The three major components of the cytoskeleton in eukaryotic cells are (1) microfilaments, 
(2) microtubules and (3) intermediate filaments. The filaments provide the cell with 
structure, shape, internal transport tracks and enable cell movement as well as cell division. 
Actin constitutes the microfilament system and is a highly conserved and abundant protein, 
making up to 5 – 10 % of the total cell protein. It was initially isolated from frog muscle 
(Halliburton, 1887) and purified, named and described by Straub (Straub, 1942). Actin is a 
protein of about 42 kDa with a characteristic structure of four subdomains and an ATP 
binding cleft between the main-domains one and two. Actin is present in two forms, as (1) 
monomeric, globular actin (G-actin) and as (2) polymeric, filamentous actin (F-actin). The 
filaments consist of two helical, interlaced strands of monomeric actin subunits resulting in a 
right handed helix with a diameter of about 7-9 nm. De novo formation of actin filaments 
requires an actin ‘nucleus’ which is essentially an actin trimer. The formation of such a 
nucleus is kinetically unfavorable, but once it is formed, further monomers elongate the 
filament spontaneously (figure 1).  
 
 
Figure 1: The process of spontaneous actin polymerization. Spontaneous actin assembly is 
highly inefficient as the formation of actin dimers and trimeric ‘nuclei’ is kinetically unfavorable as 
represented by the calculated dissociation constants (Sept & McCammon, 2001). Once a nucleus is 
formed, addition of further actin molecules is accelerated by more than three orders of magnitude. 
Therefore, in vivo initiation of actin polymerization from free actin monomers requires nucleation 
factors that help to overcome this lag phase. 
 
 
In vitro, actin polymerization continues until almost all G-actin is consumed attaining 
the so-called steady state. In this situation, the system reaches a balance between actin 
assembly and disassembly, which occurs in an asymmetric way: ATP-loaded monomers are 
preferentially added at the ‘barbed’/plus end of the filament and ADP-actin monomers 
dissociate from the ‘pointed’/minus end. This happens since the minimal concentration of G-
actin required for addition of monomers (critical concentration) is lower at the plus end (ca. 
0.1 µM) than at the minus end (ca. 0.8 µM). The ATP-loaded actin which is incorporated into 
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the filament releases the phosphate a short time after addition and remains as ADP-actin in 
the filament. Therefore, filaments are polar not only because of the structural asymmetry of 
monomers they are built of but also because the growing plus end is marked by newly added 
ATP-actin, whereas the minus end consists of ADP-actin subunits.  
In vivo, the average actin concentration is about 100 µM and due to intracellular Mg2+ 
and K+ concentrations the entire actin would polymerize spontaneously. However, all steps in 
actin dynamics are regulated by actin binding proteins. The nucleation of filaments is 
triggered by proteins like the ARP2/3 complex, formins or WH2 domain containing nucleators 
like Spire, which will be discussed below. Profilin or β-thymosins control the pool of available, 
non-filamentous actin by sequestering G-actin. Furthermore, profilin also ensures the 
efficient exchange of ADP for ATP in the actin molecule. ADP-actin stretches within filaments 
are preferred targets for severing or disassembling proteins, like gelsolin, severin or cofilin. 
Finally, there are proteins that can ‘cap’ the plus or the minus end of a filament, thereby 
inhibiting polymerization or protecting the filament from depolymerization. Tropomodulin 
capping the minus end thus stabilizes F-actin and CapZ by binding to the plus end of the 
filament prevents further elongation. 
The number of actin genes among eukaryotes is highly variable. Saccharomyces 
cerevisiae possesses only one gene that encodes conventional actin, Arabidopsis thaliana 
contains 10, and M. musculus has 35 genes that code for actin proteins (Joseph et al, 2008; 
McKinney & Meagher, 1998). In humans, actins are classified based on cell type and 
location: there are specific actins in cardiac, skeletal or smooth muscle tissues or only 
present in the cytoplasm (McHugh et al, 1991; Vandekerckhove & Weber, 1978). It is still 
unknown why almost identical isoforms are so different in their localization and furthermore, 
what the functions of other, yet uncharacterized actin isoforms are. 
There are many diseases associated with defective actin dynamics in the cell, 
including muscular, neurological, immunological, vascular diseases and even cancer (Cleuren 
& Boonstra, 2012). A dysfunction of actin protein can lead to nemaline myopathies in 
mammals. The intranuclear rod myopathy (IRM) is in the majority of cases a result of a 
Val163Leu mutation in ACTA1, the actin gene expressed in skeletal muscle (Domazetovska et 
al, 2007; Kaimaktchiev et al, 2006; Sparrow et al, 2003; Vandebrouck et al, 2010). This 
mutation results in the accumulation of rod-shaped protein aggregates in the nuclei and the 
cytoplasm of the muscle cells (figure 2). 
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Figure 2: Intranuclear rods as a result of a mutation in the α-skeletal muscle actin protein 
(Vandebrouck et al, 2010). Intranuclear rods were induced by the transfection of V163L-actinEGFP 
in C2C12 myoblasts. Actin was stained with TRITC-phalloidin (red) and nuclei were labeled with 
emerin (blue). The arrows accentuate the intranuclear rods, which can be stained with phalloidin, 
indicating that they are formed by filamentous actin. 
 
The symptoms of the patients with this congenital disease comprise a delay in speech 
and walking development, early-onset hypotonia, hyporeflexia, generalized muscle 
weakness, absent tendon reflexes, feeding difficulties, or respiratory insufficiency 
(Kaimaktchiev et al, 2006). The nemaline bodies comprise mutated actin, nebulin, cofilin, 
troponin and tropomyosin but the exact composition, formation and biophysics of these rods 
are yet unknown. Possibly, due to continuous muscle contraction, the chromatin of the cell is 
harmed by the rod-shaped aggregates in the nucleus, finally leading to cell death 
(Hutchinson et al, 2006; Nowak et al, 1999; Sparrow et al, 2003). 
 
1.2 The WH2 domain containing proteins Spire and CAP2  
The Wiskott-Aldrich-Syndrome protein homology domain 2 (WH2) is a 17–27 amino acid long 
actin binding motif found in a number of different proteins. WH2 domains are intrinsically 
disordered and adopt an α-helical form upon binding to actin (Czisch et al, 1993). The main 
structural element for actin binding is a conserved N-terminal amphipathic helix of variable 
length (Chereau et al, 2005). The C-terminal part contains the consensus motif L++V/T, with 
‘+’ representing basic amino acids. As the fourth amino acid, threonine or valine, but also 
alanine or serine are found very often. The proteins Spire and CAP2 contain four and one 
WH2 domain, respectively.  
Spire was identified in D. melanogaster as a factor required for dorsal-ventral and 
anterior-posterior patterning of the embryo (Manseau & Schupbach, 1989) and was 
described as a WH2 domain containing actin nucleator (Quinlan et al, 2005). Figure 3 A 
shows the domain structure of D. melanogaster Spire. The KIND domain (the kinase 
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noncatalytic C-lobe domain, residues 90–328 in D. melanogaster Spire, figure 3 A, red) was 
identified to interact with the nucleating factor Cappuccino (fly formin) (Quinlan et al, 2007; 
Rosales-Nieves et al, 2006). Quinlan, Rosales-Nieves and others revealed that Spire by 
binding to Cappuccino, inhibits Cappuccino-driven nucleation and actin bundling, but at the 
same time enhances the WH2 domain driven nucleation of Spire. The four central WH2 
domains of Spire, namely A-B-C-D, contain motifs of about 20-21 amino acids and are 
separated by the following linker sequences: L1 between domains A and B contains 10 
amino acids, L2 between domains B and C 11 amino acids, and L3 between domains C and D 
12 amino acids. The C-terminus of Spire contains the FYVE zinc finger membrane localization 
domain (Kerkhoff, 2006; Otto et al, 2000), a domain which is found in many proteins 
involved in membrane trafficking. The Spir box is a highly conserved region and potential 
interaction site for Rab-GTPases (Kerkhoff et al, 2001; Ostermeier & Brunger, 1999). At the 
very C-terminus, the c-Jun N-terminal kinases (JNK) binding domain is localized. In this 
region the mitogen activated protein (MAP) kinase can bind and phosphorylate the protein 
(Otto et al, 2000). Spire was extensively discussed recently and until now, it is known that 
the four WH2 domains ABCD nucleate actin assembly at low Spire/actin ratios and sequester 
actin at high Spire/actin ratios (Bosch et al, 2007; Campellone & Welch, 2010; Ducka et al, 
2010; Quinlan et al, 2005; Quinlan et al, 2007). However, the mechanisms through which 
Spire nucleates or sequesters actin were a matter of debate.  
 The cyclase-associated protein (CAP) was first identified in S. cerevisiae (Field et al, 
1988; Field et al, 1990). It was then further found in various other species like plants, yeast, 
D. discoideum, D. melanogaster and mammals. In higher eukaryotes, two isoforms of this 
highly conserved and widely distributed protein can be found, namely CAP1 and CAP2, 
showing about 76 % similarity. CAP in lower eukaryotes and mouse CAP1 were described to 
be implicated in cell polarity, motility and receptor-mediated endocytosis (Bertling et al, 
2004; Noegel et al, 2004; Sultana et al, 2005). In mice, CAP1 is highly abundant and 
expressed in almost all cells and organs (Bertling et al, 2004) localizing to F-actin-rich 
regions (Peche et al, 2007). In contrast, CAP2 in mice is only expressed in brain, heart, 
skeletal muscle and skin (Peche et al, 2007). In these tissues, the less well studied CAP2 
localizes in the nucleus or to myofibrillar M-bands (Peche et al, 2007). The ablation of CAP2 
in mice leads to a dilated cardiomyopathy (Peche et al, 2013). The multifunctional, actin-
associated CAPs have a quadripartite domain structure (figure 3 B). The N-terminal domain 
mediates nutrition-dependent RAS signaling through binding to the adenylyl cyclase in yeast, 
but not in other organisms. In D. discoideum the amino-terminal domain is important for 
dimerization and localization of the protein to the cell cortex (Noegel et al, 1999). The N-
terminal domain is separated from the C-terminal domain by a proline-rich region which 
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allows binding of proteins containing SH3 domains (figure 3 B, green). The WH2 domain is 
followed by the C-terminal domain which binds to G-actin and is responsible for 
oligomerization (Zelicof et al, 1996). The interaction of CAP1 with G-actin was well 
investigated, and a role in the regulation of actin dynamics by regulating the ADP/ATP 
exchange on G-actin could be assigned (Bertling et al, 2004; Makkonen et al, 2013; 
Moriyama & Yahara, 2002). It is known that CAPs are involved in the organization of the 
actin cytoskeleton and that WH2 domains bind to G-actin, but the function of the WH2 
domain in mouse CAP2 is not clearly known. 
 
 
Figure 3: Domain organization of the WH2 domain containing proteins Spire and CAP2. A) 
D. melanogaster Spire consists of 1020 amino acids. The four WH2 domains (yellow) are located in 
the middle of the protein sequence. B) M. musculus CAP2 consists of 476 amino acids. The WH2 
domain (yellow) is situated in the C-terminal half of the protein. 
 
 
1.3 D. discoideum as a model system 
D. discoideum is a motile soil amoeba which was first isolated and characterized by Kenneth 
B. Raper (Raper, 1935). The social amoeba belongs to the phylum Mycetozoa and shows an 
extraordinary life cycle that classifies the amoeba as a linker between unicellular and 
multicellular organisms (figure 4). The professional phagocyte usually lives on forest soil and 
feeds on bacteria, but upon starvation it undergoes a specific development program leading 
to the formation of extremely stable spores. The wild type strain AX2 used in this work is 
derived from the strain NC4 isolated by Raper. AX2 can grow in the simplified axenic medium 
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AX and HL5 (Schwalb & Roth, 1970; Watts & Ashworth, 1970). In the laboratory, the entire 
life cycle of D. discoideum happens within about 24 hours (Chisholm & Firtel, 2004). The 
genome of D. discoideum is completely sequenced (Eichinger et al, 2005; Glockner et al, 
2002) and the haploid chromosome set allows direct analysis of molecular genetic defects 
(e.g. after specific gene disruption). D. discoideum cells share activities with human 
neutrophils (Devreotes & Zigmond, 1988; Parent, 2004), including cell motility, chemotaxis 
and phagocytosis. Since D. discoideum laboratory culture is easy and inexpensive, highly 
accessible for biochemical, molecular genetic and cell biological studies, it is a prime 
organism to analyze the activities of single molecules in their cellular environment. 
 
 
D. discoideum is a powerful model organism that has long been used particularly for 
studying the actomyosin cytoskeleton and chemotactic motility in non-muscle cells. 
Intriguingly, Dictyostelium amoebae comprise a great number of actin variants. D. 
discoideum harbors 33 actins and 8 actin-related proteins (ARPs) (Joseph et al, 2008). The 
D. discoideum ‘actinome’ comprises the act8-group, which contains 17 distinct genes that 
 
Figure 4: Life cycle of D. discoideum (M.J. Grimson & R.L. Blanton, Biological Sciences 
Electron Microscopy Laboratory, Texas Tech University). The amoebae undergo various 
developmental stages in response to nutritional stress. The unicellular, vegetative cells start to 
aggregate when deprived from nutrition until they form a fruiting body with a sorus that contains 
extremely stable spores. Once favorable conditions are restored, the spores will germinate and the 
life cycle starts again. The slug phase (16-18h) is sometimes bypassed in native conditions. 
Nevertheless, all indicated stages can be observed under laboratory conditions within about 24 hours. 
Scale bar, 500 µm.  
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encode identical actin proteins. 95 % of the total actin in a D. discoideum cell consists of this 
isoform (Joseph et al, 2008; Vandekerckhove & Weber, 1980). The functions of the 16 actin 
variants that differ more or less from the conventional actin remain to be characterized. 
 
 
1.4 Filactin, an actin variant in D. discoideum 
Filactin is a novel actin-like protein in D. discoideum with a molecular weight of 105,000. Its 
actin domain is located at the C-terminus and its N-terminus shows a distinct domain 
organization (figure 5). The filactin actin domain has such a high homology to conventional 
actin that filactin can be described as an actin variant with extended N-terminus. 
Interestingly, two short filamin-like sequences in the N-terminal part of the protein lead to 
filactin’s discovery during the Dictyostelium Genome Project at the University of Cologne 
(Eichinger et al, 2005; Glockner et al, 2002) when searching for filamin-like proteins. Due to 
the homology to filamin and actin the protein was named filactin. Filamins are large, 
homodimeric flexible actin binding proteins which can stabilize three-dimensional actin webs 
(Janssen et al, 1996). Furthermore, they can link these cross-linked actin networks to cellular 
membranes. Filamins combine cellular architectural and signaling functions and are crucial 
for development and cell movements (Stossel et al, 2001). The homology of filactin to 
filamin relies not on the actin binding domain of filamin but on the sequence that connects 
the actin binding domains. This sequence consists of highly homologous repeats of about 96 
amino acid residues, which adopt an immunoglobulin (Ig) -like fold (Popowicz et al, 2006). 
The N-terminal domain of filactin shows a homology to two of these repetitive motifs. 
Furthermore, at the very N-terminus of filactin, an Ist1-like domain was identified (figure 5, 
yellow), followed by a PEST-motif (figure 5, orange). The Ist1-like domain shows homology 
to the N-terminus of human and yeast IST1/Ist1 which is a protein implicated in the ESCRT-
pathway (ESCRT, endosomal sorting complexes required for transport).  
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Figure 5: Domain organization of the actin variant filactin. Filactin consists of 944 amino acids, 
resulting in a molecular mass of about 105,000 Da. The actin domain (red) which shows higher 
homology to muscle actin than to actin-related proteins is located at the C-terminus. The N-terminus 
harbors an Ist1-like domain (yellow), a PEST-motif (orange) and two filamin-like Ig-repeats (green). 
 
D. discoideum comprises one copy of the filactin gene, located on chromosome 4. 
The 3 kb gene contains two introns and the mRNA is present throughout the development. 
At the protein level the ratio of actin to filactin is approximately 200/1. 
Until now, the protein filactin was only found in Dictyosteliidae and some Entamoeba 
species, among them the protozoan pathogenic Entamoeba histolytica. This parasite causes 
amoebiasis in humans and is responsible for approximately 100,000 deaths annually, making 
it, after Plasmodium, the second leading cause of death due to a parasite infestation 
(Ralston & Petri, 2011). The WHO considers amoebiasis as one of the major health problems 
in developing countries (WHO, 1997). The active stage of E. histolytica exists only in the host 
and in fresh feces, but the more robust cysts survive outside the host in water, soils and on 
food. The transmission occurs mainly by uptake of contaminated food or water. Even though 
the presence of filactin is yet only confirmed in Dictyosteliidae and certain Entamoebae, 
homologues presumably exist also in higher organisms but have not been identified so far. 
 
 
1.5 The ESCRT machinery 
The endosomal sorting complexes required for transport (ESCRTs) catalyze one of the most 
peculiar and unusual membrane remodeling events known in cell biology. The protein 
complexes ESCRT-I and ESCRT-II direct membrane budding away from the cytoplasm by 
stabilizing the bud neck from the cytosolic face without being consumed in the bud and 
without coating the cytoplasmic side of the bud. ESCRT-III subsequently cleaves the bud 
neck. Thus, the topology of scission accomplished by the ESCRT machinery is basically 
opposite to that of the dynamin family of membrane-scission proteins, which cleave 
membrane necks by forming a spiral around the membrane neck and constricting it in a 
GTP-dependent fashion from the outside. The ESCRT machinery consists of five protein 
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complexes, ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III, the vps4-vta1 complex and several 
ESCRT-related proteins (Saksena et al, 2007; Williams & Urbe, 2007). The ESCRT machinery 
is conserved from archaea to mammals and was first characterized in yeast. ESCRT-III 
mediated cleavage is essential for many processes, especially for the biogenesis of 
multivesicular bodies (MVBs), viral budding, cytokinesis and most probably autophagy (figure 
6 and review Hurley & Hanson (2010)). 
The role of ESCRTs was initially investigated in the formation of MVBs (Babst et al, 
2002a; Babst et al, 2002b; Katzmann et al, 2001). MVBs are specialized endosomes 
containing intraluminal vesicles (Gruenberg & Stenmark, 2004; Piper & Katzmann, 2007). 
Ubiquitylated cell-surface receptors and other transmembrane proteins that are destined for 
degradation in the vacuole (yeast) or in the lysosome (mammals) are sorted through the 
formation of MVBs. In this case, ESCRT-0 clusters ubiquitylated cargo on the early 
endosome, ESCRT-I and –II induce the bud formation and confine the cargo, and 
subsequently recruit ESCRT-III which effects the membrane scission away from the 
cytoplasm into the lumen of the endosome, turning it into a multivesicular body. ESCRT-0, -I 
and -II are soluble complexes that cycle between cytosolic and membrane-bound states. In 
contrast, the ESCRT-III subunits stay bound to the membrane of the MVB as tightly bound 
filaments, tubes and spirals after completed cleavage of the membrane bud (Ghazi-
Tabatabai et al, 2008; Hanson et al, 2008; Lata et al, 2008). To recycle the ESCRT-III 
subunits back into the cytoplasm, the multimeric AAA-type ATPase vps4 and the protein vta1 
are needed. In the only energy requiring step of the ESCRT pathway, the ESCRT-III complex 
is disassembled in the ATP-dependent action of vps4-vta1 (Babst et al, 1997; Babst et al, 
1998). 
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Figure 6: Biological roles of the ESCRTs (Hurley & Hanson, 2010). a) Plasma membrane 
proteins are endocytosed and ubiquitylated after stimulation. This initial endocytosis is independent of 
the ESCRT machinery. b) Some receptors and cargos that are not destined for degradation are 
recycled. c) Multivesicular body (MVB) biogenesis involves clustering of ubiquitylated cargo, the 
formation of membrane buds and the cleavage of the buds to form intraluminal vesicles (ILVs). For 
this process all ESCRTs are required. d) All ESCRT-dependent virus budding needs ESCRT-III and 
vps4. HIV-1 budding additionally needs ESCRT-I. e) Cytokinesis in animal cells needs ESCRT-I, 
ESCRT-III and vps4. The final cleavage of the membrane neck resulting in the separation of the two 
daughter cells, is mediated by ESCRT proteins. In Crenarchaeota, ESCRT-III and vps4 are required 
for cytokinesis. f) Autophagy seems to require all ESCRTs, although it is not clear whether they act 
directly or indirectly. The presence of ESCRTs during the neck closure has never been confirmed. 
However, there is an intriguing analogy between the closure of the phagophore neck and the 
formation of ILVs. An autophagosome has the same topology as a MVB but just with a single ILV, 
thus it is tempting to speculate about the involvement of the ESCRT machinery in the neck closure 
process.  
 
The ESCRT pathway was recently investigated in yeast and human, and still new 
proteins implicated in the machinery continue to be identified. There is a lack of knowledge 
about the ESCRT machinery in D. discoideum. However, the homologous proteins of the 
ESCRT machinery were identified in Dictyosteliidae as well and there are a few studies that 
support an existence of the ESCRT pathway in D. discoideum (Blanc et al, 2009; Mattei et al, 
2006). Until now, no protein was found that links the ESCRT pathway to the microfilament 
system. 
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1.6 Thesis aims 
At the beginning of the experimental part of the thesis, two major questions had to be 
answered. 
 
(1) Have the well-known and well-studied WH2 domains more activities than just the 
sequestration of G-actin and how do they influence the dynamics of the actin 
cytoskeleton? 
 
(2) Do selected actin variants belong to the general pool of conventional actin isoforms 
or are they specific proteins that just share a sequence homology and are not 
primary components of the actin cytoskeleton? 
 
Therefore, one aim of this work was to analyze the function of the WH2 domains of D. 
melanogaster Spire and M. musculus CAP2 in vitro. To that end, recombinant proteins 
needed to be purified to test their influence on actin dynamics in fluorometric, viscosity, TIRF 
and spindown assays. In parallel, in vivo approaches should shed light on the function of 
these domains on cell migration and adhesion. A collaborative effort with crystallography 
groups should, if possible, explain the molecular mechanisms of these additional activities of 
WH2 domains. 
The second aim focused on filactin, a novel actin variant in D. discoideum. This protein 
carries a conserved actin domain, but also an extended N-terminus with a distinct domain 
organization. Therefore, the experiments had to investigate the influence of filactin on the 
microfilament system in vivo and in vitro. Using the example of filactin, the possible roles of 
actin variants in eukaryotic cells should be examined. Especially immunofluorescence and 
spindown experiments attempted to clarify whether filactin is part of the microfilament 
system; additionally, recombinant filactin was to be generated and purified to apply it in 
fluorometric, viscometric and gel filtration assays. Furthermore, a screen for interaction 
partners of the N-terminal domains of filactin aimed to identify filactin’s role within the cell.  
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2. Material and Methods 
 
2.1 Material 
2.1.1 Instruments 
ÄKTA purifier 100 Amersham Biosciences 
Balances Sartorius 
BioDocAnalyze Biometra 
Dounce homogenizer Braun/Wheaton 
Fluorescence Spectrometer LS 55 Perkin Elmer 
Gene pulse electroporator Xcell BioRad 
Gelsystem MiniPROTEAN BioRad 
PCR-Thermocycler Tpersonal Biometra 
pH-meter pH720 Inolab WTW series 
Power supplies BioRad, Biometra, Consort 
Protein Transfer Transblot Semi-Dry BioRad 
Protein Transfer TF 77XP Serva 
Shaker Orbital Incubator SI500 Stuart  
Shaking incubator with temperature control Memmert 
Shakers for Dictyostelium cultures Kühner 
Sonficator Sonifier250 Banson 
Thermomixer Eppendorf 
Tabletop Film Processor Curix 60 Agfa 
Vortex Genie 2 Bender & Hobein 
Waterbath GFL, Kühner 
 
Microscopes 
Axiovert 25 Carl Zeiss 
Axiovert 200M Carl Zeiss 
LSM 510 Meta confocal microscope Carl Zeiss 
  
Objectives 
10x A-Plan 0.25 Ph1 Carl Zeiss 
20x LD A-Plan 0.30 Ph1 Carl Zeiss 
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40x LD A-Plan 0.50 Ph2 Carl Zeiss 
63x Neofluar 1.4 oil immersion objective Carl Zeiss 
100x Neofluar 1.3 oil immersion objective Carl Zeiss 
 
Centrifuges 
GS-6KR Beckman 
J2-21M/E Beckman 
J6-HC Beckman 
Microcentrifuge 5415 D, 5417 R Eppendorf 
Optima LE-80K Beckman 
Optima TL ultracentrifuge Beckman 
 
Rotors 
JA-10, JA-14, JA-20 Beckman 
Ti35, Ti45, Ti70 Beckman 
TLA 100.3 Beckman 
 
2.1.2 Computer Programs 
Adobe Creative Suite 2 Adobe Systems 
ApE plasmid editor v1.10.4 M. Wayne Davis 
AxioVision Carl Zeiss 
BioDoc Analyze Biometra 
BioEdit 7.0.9.0 Tom Hall 
EndNote X5 Thomson Reuters 
FL WinLab Perkin Elmer 
ImageJ 1.44p Wayne Rasband 
LSM 5, 4.2 SP1 Carl Zeiss 
Microsoft Office Microsoft Corporation 
Multalin 5.4.1. Florence Corpet 
SigmaPlot 2000 SPSS Inc. 
Unicorn 5.20 GE Healthcare 
ZEN Carl Zeiss  
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2.1.3 Laboratory consumables 
1.5 ml centrifuge tubes Sarstedt 
Amersham Hyperfilm ECL GE Healthcare 
Cell culture plates, 24 wells Starlab Int.  
Cell culture dishes, Ø 100 mm x 20 mm Greiner bio-one 
Dialysis tubings Type 8, 20, 27 Biomol 
Gel-blotting paper 3MM Chr Whatman 
GFP-Nano-Trap Chromotek 
High Pure Plasmid Isolation Kit Roche 
High Pure PCR Product Purification Kit Roche 
High precision cuvettes 10mm Hellma 
Nitrocellulose transfer membrane Protran BA85 Whatman 
PCR tubes Thermo Tube 0.2 ml Peqlab 
PCR product cloning kit Qiagen 
Phusion High-Fidelity DNA Polymerase New England Biolabs 
Petri dishes Ø 92 mm x 16 mm Sarstedt 
Pipettes 10 ml, 25 ml Sarstedt 
Pipet tips Biozym, Gilson, Starlab  
Plasmid DNA Purification Maxi Kit Macherey Nagel 
Restriction Enzymes New England Biolabs 
RNeasy Mini Kit Qiagen 
Sterile filter, Filtropur S 0.2 Sarstedt 
Transcriptor High Fidelity cDNA Synthesis Kit Roche 
Tubes 15 ml, 50 ml Sarstedt 
Ultracentifuge tubes 1.5 ml Beckman 
  
 
2.1.4 Reagents 
Standard laboratory chemicals were mainly purchased from Biomol, Biorad, Fluka, 
Invitrogen, Merck, Peqlab, Roche, Roth, Serva or Sigma-Aldrich and had the degree of purity 
‘p.a.’ unless otherwise mentioned. Media and buffers used in this study were prepared with 
de-ionised water (Millipore), sterilized either by autoclaving or passing through a micro-filter 
(pore size 0.2 µm). 
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2.1.5 Antibodies 
 
Monoclonal antibodies used in this study: 
Actin, D. discoideum (Act-1) Simpson et al (1984) 
Actin, D. discoideum (224-236-1) Westphal et al (1997) 
GFP (K3-184-2) Noegel et al (2004) 
GST (268-44-6) Faix et al (1998) 
Filactin N-terminal (3S-55-4) Daniela Rieger 
Filactin C-terminal (4S-59-4) Daniela Rieger 
Interaptin (260-60-10) Rivero et al (1998) 
RFP (K64-372-1) Angelika Noegel 
  
Secondary antibodies used in this study: 
Goat-anti-mouse IgG Cy3-conjugated Invitrogen 
Anti-mouse IgG horseradish peroxidase-linked (ECL) GE Healthcare 
 
2.1.6 Vectors 
Constructs used in this study: 
pDEX-GFP(g418)-N1 Meino Rohlfs 
pDEX-GFP(g418)-N2 Meino Rohlfs 
pDEX-GFP(g418)-C2 Meino Rohlfs 
pDRIVE Qiagen 
pFastBac1 Invitrogen 
pGEX-6P-1 GE Healthcare 
pLPBLP Faix et al (2004) 
pDEXH (g418) mRFP-ATG8 Jan Matthias 
pDEXH (g418) mRFP-ATG8-like Jan Matthias 
pDEX (g418) GFP-cofilin (#249-5) Annette Müller-Taubenberger 
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Constructs generated in this study: 
pDEX-GFP(g418)-N2 filactin full length BamHI/SalI 
pDEX-GFP(g418)-C2 filactin full length BamHI/XhoI-SalI 
pDEX-GFP(g418)-N2 filactin Ist1-like BamHI/SalI 
pDEX-GFP(g418)-N2 filactin filamin-like Ig repeats BamHI/SalI 
pDEX-GFP(g418)-N1 filactin actin-like BamHI/SacI 
pDEX-GFP(g418)-C2 filactin actin-like BamHI/XhoI-SalI 
pDEX-GFP(g418)-N2 vta1 BamHI/SalI 
pDEX-GFP(g418)-N2 vps4 BamHI/SalI 
pDEX-GFP(g418)-N2 vps46 BamHI/SalI 
pGEX-6P-1 filactin full length BamHI/SalI 
pGEX-6P-1 filactin Ist1-like BamHI/SalI 
pGEX-6P-1 filactin filamin-like Ig repeats BamHI/SalI 
pGEX-6P-1 vta1 BamHI/SalI 
pGEX-6P-1 vps4 BamHI/SalI 
pGEX-6P-1 vps46 BamHI/SalI 
pFastBac1 filactin full length BamHI/SalI 
pFastBac1 GFP-filactin full length SalI/NotI 
pFastBac1 filactin actin-like BamHI/SalI 
pFastBac1 GFP-filactin actin-like SalI/NotI 
pLPBLP vps4 SalI/ClaI, PstI/NotI 
 
2.1.7 Bacterial strains 
E. coli DH5α Invitrogen 
E. coli DH10Bac  Invitrogen 
E. coli BL21 RIL Stratagene 
E. coli ArcticExpress RIL  Stratagene 
E. coli DH10Bac FLAG-filactin full length Present study 
E. coli DH10Bac FLAG-GFP-filactin full length Present study 
E. coli DH10Bac FLAG-filactin actin-like Present study 
E. coli DH10Bac FLAG-GFP-filactin actin-like Present study 
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2.1.8 D. discoideum strains 
Strain name Resistance Source 
AX2 (laboratory wild type strain)   
AX2 GFP G 10 Meino Rohlfs 
AX2 GFP-cofilin G 10 Annette Müller-Taubenberger 
AX2 GFP-actin18 B 5 Annette Müller-Taubenberger 
AX2 GFP-actin24 B 5 Annette Müller-Taubenberger 
AX2 GFP-actin25 B 5 Annette Müller-Taubenberger 
AX2 mRFP-actin G 10 Annette Müller-Taubenberger 
Filactin KO (FiaKO) B 5 Jan Faix 
AX2 GFP-filactin full length G 10 Present study 
AX2 GFP-filactin Ist1-like G 10 Present study 
AX2 GFP-filactin filamin-like Ig repeats G 10 Present study 
AX2 GFP-filactin actin-like G 10 Present study 
AX2 filactin full length-GFP G 10 Present study 
AX2 filactin actin-like-GFP G 10 Present study 
AX2 GFP-vta1 G 10 Present study 
AX2 GFP-vps4 G 10 Present study 
AX2 GFP-vps46 G 10 Present study 
FiaKO GFP-filactin full length B 5, G 10 Present study 
FiaKO GFP-filactin Ist1-like B 5, G 10 Present study 
FiaKO GFP-filactin filamin-like Ig repeats B 5, G 10 Present study 
FiaKO GFP-filactin actin-like B 5, G 10 Present study 
FiaKO filactin full length-GFP B 5, G 10 Present study 
FiaKO filactin actin-like-GFP B 5, G 10 Present study 
FiaKO GFP-vta1 B 5, G 10 Present study 
FiaKO GFP-vps4 B 5, G 10 Present study 
FiaKO GFP-vps46 B 5, G 10 Present study 
FiaKO GFP-cofilin B 5, G 10 Present study 
AX2 mRFP-ATG8 G 10 Present study 
AX2 GFP-filactin full length + mRFP-ATG8 G 10 Present study 
FiaKO mRFP-ATG8 B 5, G 10 Present study 
AX2 mRFP ATG8-like G 10 Present study 
AX2 GFP-filactin full length +mRFP-ATG8-
like 
G 10 Present study 
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FiaKO mRFP-ATG8-like B 5, G 10 Present study 
FiaKO GFP-filactin full length + mRFP-
ATG8-like 
B 5, G 10 Present study 
 
 
2.2 Methods 
2.2.1 Molecular methods 
Standard molecular biology protocols were performed essentially as described (Sambrook & 
Russel, 2001). Genomic DNA from D. discoideum strains was isolated using the LyB buffer 
(10 mM Tris pH 8.0, 50 mM KCl, 2.5 mM MgCl2, 0.45 % NP40, 0.45 % Tween20, 0.5 µg/µl 
Proteinase K) (Charette & Cosson, 2004). Total RNA from D. discoideum strains was purified 
using the RNeasy Mini Kit (Qiagen), and cDNA was subsequently synthesized using the 
Transcriptor High Fidelity cDNA Synthesis Kit (Roche). Polymerase chain reactions (PCRs) 
were performed with either Taq-Polymerase or Phusion High-Fidelity DNA Polymerase (New 
England Biolabs) according to the manufacturer’s manual. PCR products were cloned into 
expression vectors using standard restriction enzyme mediated cloning or via the PCR 
product cloning kit (Qiagen). Plasmid DNA was obtained from E. coli by using standard 
alkaline lysis miniprep or by using the silica-based mini- and maxiprep kits (Roche, Macherey 
Nagel). Chemically competent E. coli cells were prepared according to the CaCl2 method 
(Dagert & Ehrlich, 1979). The accuracy of the DNA sequences inserted into the respective 
expression vectors was controlled by sequencing using specific primers (Eurofins MWG 
Operon, Ebersberg). 
 
2.2.2 Biochemical methods 
2.2.2.1 SDS-polyacrylamide gel electrophoresis and western blotting 
Protein mixtures were separated by standard discontinuous SDS-PAGE (Laemmli, 1970) and 
either stained with Coomassie Brilliant Blue R 250 or transferred onto a nitrocellulose 
membrane via semi-dry western blotting using a transfer buffer (25 mM Tris pH 8.5, 190 mM 
glycine, 20 % methanol, 0.02 % SDS). The membranes were blocked with nonfat milk 
powder dissolved in NCP buffer (10 mM Tris pH 7.3, 150 mM NaCl, 0.05 % Tween20), 
incubated with the particular primary and secondary antibodies and developed using the 
Enhanced Chemiluminescence System (ECL). 
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2.2.2.2 GST-tagged protein expression, purification and pulldown assays 
Constructs in pGEX vectors, inducibly expressing the protein of interest with an N-terminal 
GST-tag, were transformed into BL21 RIL or ArcticExpress RIL E. coli strains. Cultures were 
inoculated and grown overnight in LB medium containing the particular antibiotics at 37°C, 
then diluted 1:20 and grown at 37 °C to an OD600 of 0.4 – 0.8. Expression was induced by 
adding 0.5 mM IPTG to the culture and cells were grown at 37°C for 2 hours or at 16°C or 
20°C overnight. The bacteria were pelleted and resuspended in PBS (137 mM NaCl, 2.7 mM 
KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4) containing 2 mM DTT, 1 mM EDTA, 5 mM 
benzamidine, 100 µM PMSF and one Complete Protease Inhibitor cocktail tablet (Roche) per 
50 ml lysis buffer. The cells were opened by sonification in the presence of 0.5 mg/ml 
lysosome, the lysates were centrifuged (35,000 g for 20-30 minutes at 4°C) and the 
supernatant was incubated with the glutathione-sepharose 4B resin (Sigma-Aldrich) at 4°C 
for 2-3 hours under slight agitation. The matrix was washed with 10-20 column volumes of 
lysis buffer and either kept on ice for protein interaction pulldown assays with D. discoideum 
cell lysates or eluted with TEDAB buffer pH 7.4 containing 30 mM reduced glutathione. The 
purity and quality of the protein in the appropriate fractions was analyzed by SDS-PAGE. 
In case a pulldown assay was performed, 5 x 107 – 1 x 108 D. discoideum cells were 
opened in 1 ml homogenization buffer (30 mM Tris pH 8.0, 4 mM EGTA, 2 mM EDTA, 2 mM 
DTT, 30 % sucrose, 5 mM benzamidine, 100 µM PMSF, 0.2 mM ATP, one Complete Protease 
Inhibitor cocktail tablet (Roche) per 20 ml buffer) by freezing and thawing them twice or by 
the addition of 1 % Triton X-100 to the homogenization buffer. The whole cell lysate was 
centrifuged at 10,000 g and 4°C for 15-30 minutes and the supernatant was used for 
incubation with the GST-tagged purified protein bound to the sepharose. After an incubation 
of about 90 minutes, the beads were washed with 10-50 column volumes of homogenization 
buffer and boiled in SDS sample buffer. The interaction of proteins was subsequently 
analyzed by SDS-PAGE and western blotting. 
 
2.2.2.3 Immunoprecipitation 
For the identification of interacting proteins the GFP-Nano-Trap (Chromotek) was used 
(Rothbauer et al, 2008). 5 x 107 – 1 x 108 D. discoideum cells overexpressing a recombinant 
GFP-tagged protein were harvested and opened in lysis buffer (25 mM HEPES pH 7.4, 50 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 5 mM benzamidine, 1 µM PMSF, one Complete 
Protease Inhibitor cocktail tablet (Roche) per 20 ml buffer, 5 % Glycerol, 1 % Triton X-100). 
The lysate was centrifuged for 15-30 minutes at 10,000 g and 4°C and subsequently the 
supernatant was incubated with 15 – 20 µl packed GFP-Trap agarose beads equilibrated in 
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lysis buffer. After about 60 – 90 minutes incubation at 4°C under gentle end-over-end mixing 
the beads were washed according to the manufacturer’s protocol and the GFP-tagged 
protein and additional bound proteins were eluted by boiling in SDS-sample buffer. Proteins 
were separated by SDS-PAGE and stained with Coomassie Brilliant Blue R 250 or with silver 
stain (O'Connell & Stults, 1997). Bands of interest were cut out from the gel and analyzed 
and identified by MALDI-TOF or Orbitrap mass spectrometry (ZfP, LMU Munich). 
 
2.2.2.4 FLAG-tagged protein expression using the baculovirus system 
Since actin and actin-like proteins cannot be properly expressed and folded in prokaryotes, 
the Bac-To-Bac baculovirus expression system was employed to express recombinant filactin 
constructs. The desired sequence with an N-terminal FLAG-tag was cloned into the 
pFastBac1 vector. 300 ng of the vector were transformed into DH10Bac cells which contain 
the baculovirus shuttle vector (bacmid) with a mini-attTn7 target site and a helper plasmid 
that encodes certain transposition proteins. These proteins support the transposition of the 
mini-Tn7 element on the pFastBac1 donor plasmid (containing the sequence of interest) to 
the mini-attTn7 target site on the bacmid. Successful recombination was identified by the 
disruption of the lacZ gene on the bacmid which allows a blue/white screening in the 
presence of X-Gal and IPTG. The bacmid was isolated via miniprep and used for transfection 
of the immortalized insect cells, namely Sf9 (a clonal isolate of Spodoptera frugiperda Sf21 
cells) which are cultivated at 28°C. Therefore, 30 – 100 µg bacmid DNA were mixed with 200 
µl Sf-900 II SFM medium (Invitrogen) and 10 µl Cellfectin (Invitrogen) and incubated at 
room temperature for 45 minutes. Subsequently, the mix was added to 2 ml cells (at a 
density of 5 x 105 cells/ml) which were placed in wells of a 6-well-plate and incubated for 5 
hours at 28°C. The transfection mixture was removed and Sf-900 II SFM medium 
supplemented with 5 % fetal bovine serum and gentamycin (0.1 mg/ml ) was added. The 
virus (P0 virus) is harvested after 72 hours of incubation at 28°C, sterile-filtered and stored 
at 4°C. The virus was amplified by generating P1 and P2 generations. For protein expression, 
>97 % viable Sf9 cells were infected at a density of 2 x 106 cells/ml with P2 virus at a ratio of 
about 1/10 (10 ml P2 virus + 90 ml cells), and incubated as a shaking culture at 110 rpm and 
28°C for 48 – 72 hours. Cells were harvested by centrifugation (2,000 g, 15 minutes, 4°C) 
and pellets of a 100 ml culture were resuspended in 5 ml lysis buffer (15 mM Hepes, pH 7.4, 
30 mM NaCl, 1 mM EGTA, 1 mM DTT, 0.1 mM magnesium-ATP, one Complete Protease 
Inhibitor cocktail tablet (Roche) per 20 ml buffer, 2 % glycerol, 1 % Triton X-100). The 
lysates were centrifuged at 30,000 g for 10 minutes at 4°C and the supernatant was 
incubated at 4°C under gentle end-over-end mixing for 90 minutes with 100 µl ANTI-FLAG 
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M2 Affinity Gel (Sigma) for lysates of a 100 ml culture. The matrix was washed in wash 
buffer (15 mM Hepes, pH 7.4, 30 mM NaCl, 1 mM DTT, 0.1 mM magnesium-ATP, one 
Complete Protease Inhibitor cocktail tablet (Roche) per 20 ml buffer, 2 % glycerol,) with 10-
30 column volumes in a Poly-Prep Chromatography column (Biorad). For elution, the column 
outlet was closed and 200 µl elution buffer (wash buffer containing 100 µg FLAG peptide 
(Sigma)) were used to elute the protein from 100 µl ANTI-FLAG M2 Affinity Gel for 60 
minutes. The eluate was collected, the concentration was determined by SDS-PAGE analysis 
and the purified protein used for further experiments or aliquoted and frozen in liquid 
nitrogen for storage at -80°C. 
 
2.2.2.5 Actin preparation from rabbit skeletal muscle 
Routine actin purification methods were used to obtain actin essentially as described 
(Spudich & Watt, 1971). The back and upper thigh muscles of a rabbit were chilled, ground 
twice and, to remove myosin, extracted with high-salt extraction buffer (0.5 M KCl, 0.1 M 
K2HPO4) for 10-15 minutes on a stirrer. The mixture was centrifuged (4,000 g, 4°C, 10 
minutes) and re-extracted. The pellet was then stirred in cold distilled water for 10 minutes 
and subsequently centrifuged as before with repeats until swelling of the sediment was 
observed. The pellet was incubated with cold acetone for about 30 minutes, filtered and 
dried overnight. The acetone powder was stored at -20°C for subsequent actin preparations. 
Usually, 10 g acetone powder were extracted with 200 ml G-actin buffer (2 mM Tris 
pH 8.0, 0.2 mM ATP, 0.5 mM DTT, 0.2 mM CaCl2, 0.01 % NaN3) at 4°C for 30 minutes, 
filtered through nylon nets and re-extracted for 15 minutes. The filtrate was centrifuged 
(30,000 g, 30 minutes, 4°C), actin polymerization was promoted by the addition of 50 mM 
KCl, 2 mM MgCl2 and 1 mM ATP dissolved in 100 mM NaOH and the mixture was incubated 
at 4°C for two hours or overnight. To remove tropomyosin, solid KCl was slowly added until 
a final concentration of 0.8 M was reached. Filamentous actin was subsequently pelleted by 
centrifugation (150,000 g, 3 hours, 4 °C), the supernatant was discarded and the pellet was 
homogenized in G-buffer with a douncer. For actin depolymerization, the homogenized F-
actin pellet was dialyzed against G-buffer for 2-3 days with a total of about 6 buffer changes. 
The solution was centrifuged at 150,000 g and 4°C for 3 hours, and about 65 % from the 
top supernatant were further purified using a Sephacryl S300 gel filtration column (2.5 x 45 
cm, Pharmacia). Fractions were collected and the actin concentrations determined by 
measuring the optical density at 290 nm (1 mg/ml pure actin: OD290nm = 0.65) (Wegner, 
1976) and their quality tested in a falling ball viscometry assay. The prepared G-actin could 
Material and Methods 
 
22 
 
be stored on ice for up to 3 weeks for most applications and was dialyzed against fresh G-
buffer before usage. 
 
2.2.2.6 Labeling of actin with pyrene 
Actin was labeled for in vitro polymerization assays with N-(1-pyrenyl) iodoacetamide 
(pyrene) essentially as described (Cooper et al, 1983; Kouyama & Mihashi, 1981). After the 
first ultracentrifugation step during actin preparation the F-actin pellet was dialyzed against 
P-buffer (1 mM NaHCO3 pH 7.6, 0.1 mM CaCl2, 0.2 mM ATP, 0.1 mM β-mercaptoethanol) for 
2-3 days with a total of about 6 buffer changes. After centrifugation (150,000 g, 4°C, 3 
hours), about 65 % of the supernatant were collected. Actin polymerization was induced by 
the addition of 100 mM KCl and 1 mM MgCl2 and a 3-5-fold molar excess of pyrene solved in 
DMSO was added immediately drop by drop to the vigorously stirred actin solution. In all the 
following work steps the solution was light protected since pyrene is light sensitive. The 
solution was incubated under gentle end-over-end mixing overnight in a 50 ml tube at room 
temperature and subsequently the filamentous actin was pelleted (150,000 g, 4°C, 3 hours). 
The F-actin pellet was homogenized in G-buffer and dialyzed against G-buffer to promote 
depolymerization. The dialyzed solution was centrifuged again (150,000 g, 4°C, 3 hours) and 
the pyrenylated G-actin was purified by gel filtration as described earlier in the actin 
preparation. The percentage of labeled actin was calculated by measuring actin 
concentration and pyrene concentration using the respective extinction coefficients (OD290nm 
= 2.6  100 µM actin; OD344nm =2.2  100 µM pyrene; micromolar concentrationpyrene / 
micromolar concentrationactin = % of pyrene-labeled actin). The percentage of labeled actin 
should be around 60-90 %. The aliquots were stored at -80°C and dialyzed against G-buffer 
before use. 
 
2.2.2.7 Actin labeling with amino-reactive dyes 
Actin was labeled with the Alexa-fluor carboxylic acid succinimidyl esters Alexa488 and 
Alexa568 (Invitrogen) to investigate actin dynamics at the TIRF and at the confocal 
microscope. Actin was prepared as described. Two fractions (2-3 mg actin/ml) were pooled 
to obtain a solution of about 8 – 10 ml. The G-actin was dialyzed against borate buffer pH 
8.00 (50mM boric acid, 0.2 mM CaCl2, 0.2 mM ATP) at 4°C for at least 3 hours with one 
buffer change each hour. The actin concentration was identified spectroscopically and 10x 
polymerization buffer (100 mM Imidazole pH 7.2, 30 mM MgCl2, 10 mM ATP, 2 mM CaCl2) 
was added in a ratio of 1/10 to allow polymerization at room temperature. The dye solved in 
DMSO was then added drop by drop in a 1–2-fold molar excess to the vigorously stirred actin 
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solution. From this step onwards, all activities were carried out in the dark since the dyes are 
light sensitive. The solution was incubated under gentle end-over-end mixing overnight at 
room temperature and centrifuged (150,000 g, 4°C, 2 hours) to sediment the filamentous 
actin. The pellet was homogenized in G-buffer to reach a calculated final actin concentration 
of about 2-3 mg/ml and dialyzed against G-buffer at 4°C for at least 3 hours with one buffer 
change each hour. After another centrifugation (150,000 g, 4°C, 2 hours) the supernatant 
was collected and the percentage of labeled actin was determined by spectroscopic methods 
using the respective extinction coefficients (actin: OD290nm = 2.6  100 µM actin; Alexa488: 
OD495nm =7.1  100 µM Alexa488; Alexa568: OD578nm =9.13  100 µM Alexa568; 
micromolar concentrationAlexa / micromolar concentrationactin = % of Alexa-labeled actin). The 
percentage of labeled actin should be around 20 %. The aliquots were stored at -80°C and 
dialyzed against G-buffer before use. 
 
2.2.2.8 In vitro actin polymerization assay (fluorometry)  
Fluorometric actin polymerization assays were carried out on a Perkin Elmer fluorometer 
using pyrenylated actin. Upon actin polymerization the environment of the pyrene label 
changes which results in a 20-fold increase of fluorescence. Only about 10 % of pyrenylated 
actin are required to produce a convenient signal. Usually 2 µM actin (10 % pyrenylated) in 
800 µl volume were used for the measurements. The polymerization-induced fluorescence 
was captured at 386 nm using an excitation wavelength of 365 nm and 8 nm slit widths. 
Actin polymerization measurements were carried out in polymerization buffer (10 mM 
Imidazole pH 7.2, 3 mM MgCl2, 1 mM Na-ATP, 0.2 mM CaCl2). Native WH2 domain 
constructs, FLAG-filactin or purified SpireWH2-actin complexes and G-actin were mixed and 
preincubated for about 1-2 minutes prior to addition of polymerization buffer and recording. 
Filament-disrupting measurements were performed with prepolymerized actin samples. 
Increasing concentrations of WH2 domain constructs were added and mixed shortly with the 
F-actin sample prior to starting the measurements approximately five seconds after addition 
of the respective constructs. The seeded nucleation assay was performed with 20 µl of F-
actin seeds. To create actin seeds, 16 µM unlabeled G-actin was polymerized for about 15 
hours in 50 mM KCl, the solution was mixed 1:1 with G-buffer, vigorously vortexed to shear 
the filaments and subsequently kept at room temperature for about 1-2 hours. For the 
dilution induced depolymerization assay 4 µM 65 % pyrenylated actin was polymerized for at 
least 4 hours in polymerization buffer and 16 µl of the F-actin solution were subsequently 
incubated with FLAG-filactin constructs for 1-2 minutes prior to the addition of 780 µl of 
polymerization buffer and recording. 
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2.2.2.9 Low shear viscometry 
Low shear viscometry assays were carried out in a falling ball viscometer (MacLean-Fletcher 
& Pollard, 1980). The reaction mixture (160 µl) usually contained 0.5 mg/ml rabbit skeletal 
muscle actin which was pre-incubated for 1 minute with the respective proteins described in 
the results. Polymerization was started by the addition of polymerization buffer (10 mM 
Imidazole pH 7.2, 3 mM MgCl2, 1 mM Na-ATP, 0.2 mM CaCl2). The mixture was briefly 
vortexed, immediately filled into the capillary and allowed to polymerize for 15 minutes. 
Then the apparent viscosity of the solution was measured by recording the time a mini steel 
ball took to pass a certain distance. 
 Low shear viscometry assays were additionally carried out using an Ostwald 
viscometer. The reaction mixture (1.6 ml) contained 12 µM polymerized actin. The viscosity 
of the solution was measured by recording the time required for the solution to flow through 
a capillary of a known diameter. Then, increasing concentrations of SpireDDD were added. 
The viscosity of the solution for each SpireDDD concentration was assessed five times. 
 
2.2.2.10 Confocal microscopy 
Confocal microscopy data were acquired on an inverted Axiovert LSM 510 Meta confocal 
microscope (Zeiss) with a 63x or 100x oil immersion objective with a numerical aperture of 
1.4 and 1.3, respectively. Excitation of fluorophores was achieved with the 488 nm argon ion 
laser line, the 543 nm and 633 nm helium neon laser lines, and emission was collected using 
510-525 nm band-pass, 585-615 nm band-pass or 650 nm long-pass filters. When imaging 
fluorescent D. discoideum mutants, cells were transferred into an open glass-bottomed 
chamber and recorded at 10 seconds intervals. To observe actin dynamics in vitro at the 
confocal microscope, coverslips were coated with 0.1 % collodion diluted in isoamylalcohol 
and dried. An open flow chamber was built up on the coverslip. 5 µM Alexa488-labeled actin 
(20 % labeled) were prepolymerized for at least one hour in polymerization buffer (10 mM 
Imidazole pH 7.2, 3 mM MgCl2, 1 mM Na-ATP, 0.2 mM CaCl2). The F-actin solution was 
subsequently diluted with polymerization buffer to 0.5 – 1 µM and the actin bundling protein 
fascin was added at a 1/1 molar ratio. The flow chamber was filled with 0.1 mg/ml NEM-
HMM diluted in NEM buffer (25 mM Imidazole pH 7.4, 4.4 mM MgCl2, 1 mM EGTA, 0.3 mM 
KCl, 10 mM DTT; Ali et al (2007)) and incubated for 3 minutes. Subsequently, the flow 
chamber was washed with polymerization buffer and the F-actin dilution was applied and 
incubated for 5 minutes before another washing step was carried out to remove unbound 
filament bundles. WH2 domain constructs were added with a pipet to the inlet of the 
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chamber by removing the buffer at the outlet with a filter paper while recording at two 
frames per second. 
 
2.2.2.11 Total internal reflection fluorescence microscopy 
Total internal reflection fluorescence (TIRF) microscopy was performed at the Bausch 
laboratory (Technische Universität München) with the help of Michael Wohlhöfler. Microscopy 
data were acquired on an Axiovert 200 inverted microscope (Zeiss) with a 100x oil 
immersion objective with a numerical aperture of 1.4. Alexa555-actin (20 % labeled) was 
prepolymerized for at least 30 minutes in TEGA polymerization buffer (2 mM Tris pH 8.0, 2 
mM MgCl2, 0.2 mM DTT, 0.5 mM ATP, 1 mM EGTA). The samples were observed in a flow 
chamber which was prepared with nitrocellulose-coated coverslips. After the incubation with 
α-actinin (0.3 µM), surfaces were first passivated using 1 mg/ml BSA and then the prepared 
F-actin was applied. SpireWH2 domain constructs were added by a syringe pump attached to 
the flow chamber. The disintegration of actin filaments and bundles after addition of 
SpireDDD was recorded at two frames per second. 
 
2.2.2.12 Transmission electron microscopy (negative stain) 
Transmission electron microscopy was performed at the Baumeister laboratory (Max-Planck-
Institut für Biochemie, Martinsried) with the help of Oana Mihalache. Electron microscopy 
grids were first cleaned in a plasma cleaner (Diener, Ebhausen). About 5 µl of the protein 
samples (1-5 µg/ml) were pipetted on a parafilm and the grids were placed on the sample 
drops with their carbon coated side and incubated for 1-2 minutes, after washing in two 
drops of buffer the protein was solved in for 1 second each. Superfluous buffer was removed 
with a filter paper and the grid was placed in a 2 % uranylacetate solution, incubated for 2 
minutes and dried. Data were acquired on a CM20 electron microscope at 160kV and 58,000-
fold magnification. 
 
2.2.2.13 Gel filtration using the ÄKTA 100 system 
For protein size analysis and protein purification, the gel filtration columns Superose 6 
10/300 GL and Superose 12 10/300 GL (GE Healthcare) were used. The columns were 
equilibrated with a modified G-buffer (5 mM Tris pH 8.0, 50 mM NaCl, 0.2 mM ATP, 0.5 mM 
DTT, 0.2 mM CaCl2, 0.01 % NaN3). The flow rate was set between 0.1–0.5 ml/min for 
Superose 6 and 0.5–1 ml/min for Superose 12. The columns were calibrated using protein 
molecular weight standards range 12.4 – 450 kDa (Serva). The void volume was identified 
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with Dextran blue 2000 (GE Healthcare). Usually 0.1-3 mg purified protein were injected, 
and 500 µl-fractions were collected and analyzed by SDS-PAGE. 
 
2.2.3 Cell biological methods 
2.2.3.1 D. discoideum cell culture and transformation 
D. discoideum AX2 (laboratory wild type strain) and mutant cells derived from AX2 were 
cultivated axenically in sterile HL5 medium (Formedium), either in cell culture dishes, in 
shaking culture at 150 rpm or on lawns of Klebsiella aerogenes. For long term storage, cells 
were frozen in D. discoideum storage medium (82 % AX-medium, 9 % horse serum, 9 % 
DMSO) or spores were obtained from phosphate agar plates and frozen in Soerensen buffer 
pH 6.0 (14.6 mM KH2PO4, 2 mM Na2HPO4).  
D. discoideum wild type or mutant cells were transformed with the appropriate 
plasmids by electroporation. 2 x 107 cells were extensively washed in cold Soerensen buffer 
and electroporation buffer pH 6.1 (50 mM sucrose, 10 mM KH2PO4), resuspended in 1 ml 
cold electroporation buffer, and then electroporated in the presence of about 25 µg DNA in a 
4 mm electroporation cuvette using a Gene Pulser XCell (Biorad) and the standard settings 
(square wave, V= 1.0 kV, 1 ms pulse length, two pulses, 5 seconds pulse interval). 
Subsequently the cells were transferred to a cell culture dish and after gentle shaking (50 
rpm, room temperature, 15 minutes) 2 µM CaCl2 and 2 µM MgCl2 were added. After another 
15 minute incubation, HL5 medium was added and the cells were allowed to recover for 
about 24 hours before the respective antibiotic (either 10 µg/ml G418 or 5 µg/ml blasticidin) 
was added to select the transformants. Single clones were obtained by spreader dilution on 
K. aerogenes lawns. Cloned transformants were checked by microscopy and western blot 
analysis using the appropriate antibodies. 
To obtain overexpression mutants, constructs for the expression of fluorescently 
labeled proteins (with C- or N-terminal GFP or mRFP tags) were transformed into D. 
discoideum cell lines. All GFP- and mRFP-constructs were expressed under the actin15 
promoter. To generate knock out (KO) mutants, gene replacement constructs with a 
blasticidin resistance cassette were transformed and successful transformants were checked 
by PCR analysis. 
The filactin KO strain was generated by Jan Faix (Medizinische Hochschule Hannover) 
by replacement approach with a blasticidin resistance cassette. The filactin gene targeting 
vector was constructed by cloning the genomic PCR products BamHI/PstI at the 5' end 
(nucleotides 126 – 885 of filactin genomic DNA) and HindIII/SalI at the 3' ends (nucleotides 
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1623 – 2192 of filactin genomic DNA) into the corresponding sites of pLPBLP (Faix et al, 
2004). The target vector was then digested with BamHI/SalI and used to disrupt the filactin 
gene in wild type cells. Null mutants were initially screened by PCR using two sets of primers 
as shown in the scheme (figure 7).  
 
 
Figure 7: Filactin gene disruption strategy, courtesy of Jan Faix. A) The schematic diagram 
represents the strategy for knocking out filactin in the AX2 wild type strain. B) The insertion of the 
blasticidin resistance cassette was confirmed by PCR analysis with primer 1 and primer 2 indicated in 
A). The insertion of the blasticidin resistance cassette increases the size of the PCR fragment 
compared to the wild type. C) The insertion of the blasticidin resistance cassette was further 
confirmed by PCR analysis with primer 2 and primer 3 that binds within the blasticidin sequence. Only 
in clones with successful filactin gene disruption a PCR product can be generated. 
 
2.2.3.2 Immunofluorescence 
To study subcellular localization of proteins, indirect immunofluorescence was performed. 
Exponentially growing t0 cells were seeded on coverslips which were previously washed with 
3.6 % HCl and rinsed with H2O. After allowing the cells to settle on the coverslips the 
medium was removed and the cells were fixed with -20°C methanol unless otherwise noted. 
After a 10-15 minute incubation at -20°C, the coverslips were washed several times with PBS 
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(137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4) supplemented with 
100 mM glycine. Subsequently, the fixed samples were washed with PBG (PBS + 0.5 % BSA, 
0.045 % fish gelatin) and incubated with the primary antibody overnight at 4°C. The fixed 
preparations were washed with PBG and incubated for 60 minutes with the secondary 
fluorescence-dye coupled adequate antibody (goat-anti-mouse IgG Cy3-conjugated, unless 
otherwise mentioned). DNA was stained with either TO-PRO-3 iodide or DAPI (Invitrogen). 
The stained samples were quickly rinsed with ddH2O, embedded in gelvatol and stored in the 
dark at 4°C. 
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3. Results I: WH2 domain containing proteins 
3.1 Analysis of Spire and CAP2 protein sequences 
In this part of the study the focus was exclusively put on the G-actin binding WH2 motifs of 
the proteins Spire and CAP2. As mentioned above, the Spire protein contains the four WH2 
domains A-B-C-D in tandem. They contain motifs of about 20-21 amino acids and are 
separated by the following linker sequences: L1 between domains A and B, L2 between 
domains B and C, and L3 between domains C and D. CAP2 comprises only one WH2 domain. 
Figure 8 displays an alignment of the WH2 domains of Spire and CAP2. The regions forming 
the amphipathic helices during actin binding and the C-terminal extension with the L++V/T 
motif (‘+’ representing basic amino acids) are conserved. 
 
 
Figure 8: Alignment of the WH2 domains of Spire, CAP2 and N-WASP from different 
organisms. Spire contains four WH2 domains, CAP2 only one and the reference N-WASP comprises 
two WH2 domains. SpireABCD_dm (D. melanogaster, Q9U1K1) aa 366-485, Spire1_hs (Homo sapiens, 
Q08AE8) aa 269-390, Spire2_hs (H. sapiens, Q8WWL2) aa 241-363, NWASP_hs (H. sapiens, O00401) 
aa 401-460, CAP2_hs (H. sapiens, P40123) aa 261-290 and CAP2_mm (M. musculus, Q9CYT6) aa 
261-290 were used. Identical residues are shown on a black background; similar residues are 
displayed on a grey background. Blosum 62-12-2 was used as alignment parameter and the threshold 
for shading was set to 50 %. The secondary structure during actin binding of Drosophila Spire is 
schematically depicted above the sequence, with a tube representing an amphipathic helix followed by 
a straight line that highlights the location of the conserved L++V/T motif. 
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3.2 The different WH2 constructs used in this study 
 
Table 1: The different WH2 domain constructs used in this study 
No. Designation (amino acids) Molecular mass (Da) 
1 SpireNT (1-520) 58,977 
2 SpireABCD (371-480) 12,920 
3 SpireBCD (396-480) 9,900 
4 SpireBC (396-450) 6,380 
5 SpireCD (432-480) 5,590 
6 SpireD (463–485) 2,370 
7 SpireC-L3 (428-460) 3,820 
8 SpireL3-D (448-485) 3,810 
9 SpireL3 (448-462) 1,460 
10 SpireDDD 9,611 
11 CAP2-WH2 (247-310) 8,000 
 
 
Table 1 shows the different WH2 domain constructs used in this work. The CAP2-
WH2 construct (table 1, construct no. 11) was cloned and purified by Vivek Peche from the 
Angelika Noegel laboratory (Universität zu Köln). The sequence was cloned into the pGEX 
4T-3 vector, the GST-CAP2-WH2 fusion protein was purified and the GST-moiety was cleaved 
by thrombin. All Spire constructs (table 1, construct no. 1-10) were cloned and purified by 
Tomek Sitar and Anna Ducka from the Tad Holak laboratory (Max-Planck-Institut für 
Biochemie, Martinsried) as described (Ducka, 2011). The proteins were expressed as GST-
fusion proteins (pGEX-6P-1 vector), except for the SpireNT construct, which was cloned in 
the pET16b vector and isolated by His-tag purification. After cleavage of the tags the 
proteins were further purified on a gel filtration column using Superdex 200, Superdex 75, or 
Superdex 30 resins, depending on the molecular weight of the protein. 
The influence of 1–4 WH2 domains on actin dynamics was investigated by different 
means. SpireNT (table 1, construct no. 1) contains all four WH2 domains and additionally the 
KIND domain at the N-terminus. Also the effect of linker 3 between WH2 domain C and D 
(L3, table 1, construct no. 9) was tested, since it was previously described as an actin 
monomer binding protein with weak nucleating activity (Zuchero et al, 2009). The artificial 
construct SpireDDD (table 1, construct no. 10) which carries three identical WH2 domains 
separated by L3 was used to avoid more complex Spire-actin interactions that might 
complicate the interpretation of the data, e.g. cooperative binding of actin to the WH2 
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domains. The WH2 domain D was used to generate the artificial construct since it was 
reported in previous studies that it is the most important domain for nucleation of actin 
filaments (Quinlan et al, 2005). Furthermore, WH2 domain D and B exhibit the strongest 
actin binding, with a Kd = 0.17 µM as investigated by Isothermal Titration Calorimetry (Sitar 
et al, 2011). Figure 9 shows some of the constructs as they will be displayed in the following 
results in this part of the thesis. 
 
 
Figure 9: Representation of selected constructs used in this study. A) Spire NT (aa 1-520) 
comprising the N-terminal KIND-domain. B) SpireABCD (aa 371-480). C) SpireBCD (aa 396-480). D) 
SpireCD (aa 432-480). E) SpireL3+D (aa 448-480). F) The artificial construct SpireDDD with three 
identical WH2 domains D separated by linker L3. G) Depiction of schematical G-actin and the WH2 
domain construct SpireABCD in complex with actin. 
 
3.3 CAP2 exhibits a G-actin sequestering activity and can disrupt actin  
filaments 
A single WH2 domain was identified in CAP (cyclase-associated protein) (Ksiazek et al, 
2003). Here, the function of the WH2 domain of mouse CAP2 was investigated. The purified 
CAP2-WH2 protein usually ran at ca. 15 kDa even though its calculated size is 8 kDa (figure 
10 A). Furthermore, it appeared in a cloudy shape on the gel and was often difficult to stain 
at all. To test whether the WH2 domain was able to disrupt existing filaments, 2 µM actin (10 
% pyrenylated) were polymerized. Then, increasing concentrations of CAP2-WH2 were 
added to the filaments. Upon addition of the WH2 domain, the pyrene-fluorescence 
decreased immediately in a dose-dependent manner (figure 10 C). The complete 
disappearance of filaments (and hence of the pyrene-fluorescence) was set to 100 %. In a 
spindown experiment the disruption of the filaments was investigated as well (figure 10 B). 
F-actin can be separated from G-actin and other soluble proteins by ultracentrifugation at 
120,000 g. In the control with polymerized actin only, most of the actin is in the pellet. When 
the CAP2-WH2 protein was added, most of the actin shifted to the supernatant fraction 
together with the CAP2-WH2. When the actin filaments were stabilized with phalloidin, the 
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WH2 domain could not disrupt these filaments and most of the actin was found in the pellet. 
Since CAP2-WH2 stayed in the supernatant, it is clear that it did not decorate the filaments. 
 
 
Figure 10: Purified CAP2-WH2 disrupts preformed actin filaments. A) Purified rabbit skeletal 
muscle actin and CAP2-WH2 on a Coomassie Blue stained SDS-gel. The CAP2-WH2 has a molecular 
weight of ca. 8,000 but runs at ca. 15,000. The band usually appears in a cloudy shape. B) Coomassie 
Blue stained gel of the fractions of a F-actin spindown after addition of CAP2-WH2 to actin and 
phalloidin-stabilized actin filaments. The first gel piece shows the actin control. 2 µM actin were 
polymerized, then ultracentrifuged, and supernatant and pellet fractions were analyzed on the SDS-
gel. In the control, most of the actin is found in the pellet. On the second gel piece, 2 µM 
prepolymerized actin was incubated with 12 µM CAP2-WH2 and the sample was ultracentrifuged. In 
contrast to the control, most of the actin is now found in the soluble fraction together with the CAP2-
WH2 protein. In the third gel piece 2 µM prepolymerized actin was stabilized with 1.3 µM phalloidin. 
Then, 12 µM CAP2-WH2 was added. Most of the actin is found in the pellet, whereas the CAP2-WH2 
remains in the supernatant. C) F-actin disrupting activity of CAP2-WH2. The ability of CAP2-WH2 to 
disintegrate actin filaments was measured in fluorometric assays, where the complete disappearance 
of actin filaments was set to 100 %. 
 
 
The disruption of filaments and filament bundles was also investigated at the confocal 
microscope (figure 11). Alexa488-actin was polymerized and bundled with fascin. 6 µM 
CAP2-WH2 diluted in polymerization buffer was added and the disappearance of the 
filaments was recorded. Several filament bundles depolymerized apparently from their ends, 
but the bundles were also disintegrated by removal of actin from their middle, resulting in 
randomly distributed gaps along the bundles (figure 11, arrowheads indicate gaps at e.g. 
01:22 minutes). After about 5 minutes, the bundles completely disappeared. 
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Figure 11: Disruption of F-actin-fascin bundles by the CAP2-WH2 domain imaged with a 
confocal microscope. 1 µM Alexa488-actin bundled with 0.3 µM fascin was bound onto the coverslip 
via NEM-HMM. At 00:00 minutes 6 µM CAP2-WH2 in polymerization buffer was added to the F-actin 
sample. In the beginning the bundles depolymerize mainly from their ends (compare areas marked by 
arrowheads and asterisks at 00:21 minutes with the first panel). The filaments also disintegrate, 
especially along the bundles, in randomly distributed gaps (see areas marked by arrowheads at 00:34, 
00:53, 01:22 and 02:07 minutes). Scale bar, 5µm. 
 
3.4 Functional analysis of Spire 
Here, the effect of SpireWH2 domains on actin dynamics was investigated. Under certain 
conditions, they can (1) nucleate actin polymerization, (2) disintegrate actin filaments and 
(3) sequester actin monomers. 
 
3.4.1 Nucleating activities of SpireWH2 domains 
Concerning actin dynamics, the Spire protein was initially described as an actin nucleator 
(Quinlan et al., 2005). Here, the nucleating activity could be confirmed, however only at 
substoichiometric concentrations of WH2 domains over actin and it required at least two 
WH2 domains in tandem. 
 
3.4.1.1 Free SpireWH2 domains nucleate actin polymerization only at 
substoichiometric concentrations 
Free SpireWH2 domains in tandem nucleate actin polymerization at substoichiometric 
concentrations. This finding which was already described previously for SpireNT, -ABCD, -
BCD and –CD (Bosch et al, 2007; Campellone & Welch, 2010; Ducka et al, 2010; Quinlan et 
al, 2005; Quinlan et al, 2007) could be confirmed in this study. Even the artificial construct 
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SpireDDD exhibits this activity (figure 12 C). The nucleating activities of SpireNT, SpireBCD 
and SpireDDD are displayed in representative polymerization assays (figure 12). When the 
SpireWH2 domains are present at substoichiometric ratios in the polymerization assay (1 
WH2 domain over 10 actin monomers), actin polymerization and thereby the increase of 
fluorescence occurs faster than in the control. This observation accounts for all measured 
SpireWH2 constructs (table 1) that comprise at least two WH2 domains in tandem. At higher 
ratios, the sequestering activity takes over which will be presented in more detail below (see 
3.4.2.1). The decrease of pyrene-fluorescence at the steady state compared to the control 
will also be discussed in the following (see 3.4.2.2). 
 
 
 
Figure 12: Free SpireWH2 domain 
constructs nucleate actin polymerization 
only at sub-stoichiometric concentrations. 
The graphs show representative actin 
polymerization assays measured on a fluorometer. 
The blue dashed line represents the control (2 µM 
actin, 10 % pyrenylated). The green graphs show 
the actin polymerization in presence of different 
WH2 domain constructs in a molar WH2 domain 
to actin ratio of 1/10. The upper left corner of 
each graph shows the cartoon of the WH2 
construct used in the measurement. A) SpireNT 
nucleates actin polymerization, B) SpireBCD, C) 
SpireDDD. 
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3.4.1.2 Preformed SpireWH2-actin complexes act as perfect nuclei for 
actin polymerization 
To prepare the SpireWH2-actin complexes, the purified SpireWH2 domain constructs 
SpireNT, SpireBCD and SpireCD were mixed with an abundant amount of actin (molar ratio 
WH2 domain/actin, 1/2-4) and the formed complexes were separated by gel filtration (Sitar 
et al, 2011). These actin-loaded WH2 domains perfectly nucleate polymerization in a 
transient fashion in polymerization assays. Both substoichiometric and stoichiometric 
concentrations of these complexes form efficient F-actin nuclei (figures 13 A-C). Free WH2 
domains would sequester under these conditions (compare figure 14). In contrast, the 
purified SpireWH2-actin complexes completely saturated with unlabeled actin cannot remove 
G-actin molecules from the solution and the nucleating activity is not obscured by G-actin 
sequestering. However, the decrease of fluorescence at steady state can be observed under 
these conditions as well as for uncomplexed SpireWH2 constructs (compare figures 12 and 
14). Moreover, SpireWH2-actin complexes cannot disrupt preformed actin filaments like 
uncomplexed SpireWH2 domains (see 3.4.2.3). When adding increasing concentrations of 
SpireBCD-actin to preformed actin filaments (10 % pyrenylated) at steady state, the level of 
fluorescence remained unchanged and thus no F-actin disrupting activity could be observed 
(figure 13 D). Only when the mixture of SpireBCD-actin and F-actin was incubated for a 
longer period of time and measured again, a drop of the pyrene-fluorescence could be 
detected (figure 13 D, red dot at WH2/actin ratio 1.0).  
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Figure 13: Preformed SpireWH2-actin complexes act as perfect nuclei for actin 
polymerization and cannot disrupt filaments like free WH2 domains. The graphs A-C show 
representative actin polymerization assays measured at the fluorometer. The blue dashed lines 
represent the polymerization of 2 µM actin (10 % pyrenylated) alone. The green and red graphs show 
the actin polymerization in the presence of SpireWH2-actin complexes in a molar ratio of 1/10 (WH2 
domain/actin monomers) and 1/1, respectively. The upper left corner of each graph shows the cartoon 
of the WH2 construct used in the measurement. All complexes nucleate actin polymerization at sub- 
and even at stoichiometric concentrations. D) SpireBCD-actin complexes cannot disrupt preformed 
actin filaments as uncomplexed SpireBCD does. Adding increasing concentrations of these complexes 
to F-actin does not decrease the pyrene-fluorescence immediately. However, the pyrene-fluorescence 
decreases over time. When measuring the sample two hours after addition of the SpireBCD-actin 
complexes to F-actin at a 1/1 molar ratio, a decrease of fluorescence of about 30 % is observed (red 
dot at WH2/actin ratio 1/1) which suggests that actin is released from the SpireBCD-actin complex and 
pyrenylated actin is removed by the now unoccupied SpireWH2 construct (figure modified after Sitar et 
al (2011)). 
 
 
3.4.2 Actin sequestering and filament-disrupting activities of SpireWH2 
domains 
3.4.2.1 WH2 domains sequester actin at stoichiometric concentrations 
As already mentioned above, SpireWH2 domains sequester actin at stochiometric 
concentrations. Figure 14 shows that Spire constructs with at least two WH2 domains in 
tandem nucleate filaments at substoichiometric concentrations (eg. WH2/actin ratio=0.1) but 
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sequester actin at higher concentrations (WH2/actin ratio=1). The same constructs in 
complex with actin would still nucleate actin polymerization at these high concentrations 
(compare figures 13 A-C). SpireWH2 constructs possessing only a single WH2 domain cannot 
nucleate filaments, but exhibit the expected sequestering activity, e.g. SpireL3+D, and the 
smallest possible construct SpireD without the linker, consisting of 24 amino acids only (aa 
463–485). The dose dependent decrease of fluorescence at steady state after polymerization 
can be observed for all constructs. 
 
 
Figure 14: SpireWH2 domains in tandem show nucleation only at substoichiometric ratios 
and sequester actin at increasing concentrations. The graphs show representative actin 
polymerization assays measured at the fluorometer. The blue dashed line represents the control (2 µM 
actin, 10 % pyrenylated). A) - C): The green and the red graphs show the actin polymerization in the 
presence of WH2 domain constructs at the molar ratios indicated. D) SpireL3+D cannot nucleate actin 
polymerization since it comprises only one single WH2 domain, but it shows the expected 
sequestering activity (figure modified after Sitar et al (2011)). 
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3.4.2.2 Dose-dependent decrease of polymerization-induced fluorescence 
signal at steady state 
As compared to control levels (actin alone), the lower steady state fluorescence appears with 
all SpireWH2 constructs (figures 12, 13, 14). This is puzzling because all samples contained 
the same amounts of pyrenylated actin. Figure 15 shows a comparison of the decrease of 
fluorescence at steady state for selected SpireWH2 constructs with and without bound actin. 
This suggests that Spire is released from the emerging filament after nucleation, can then 
sequester free G-actin molecules and thus reduce the free labeled or unlabeled G-actin 
concentration.  
 
Figure 15: Decrease of pyrene-fluorescence at steady state after actin nucleation or 
sequestration by SpireWH2 constructs. The decrease of fluorescence compared to control 
levels (actin alone) after the polymerization assays as shown in figures 13 and 14 was analyzed and 
plotted. No decrease of fluorescence occurs in the absence of SpireWH2 constructs, but occurs 
when SpireWH2 constructs are added in a WH2 domain/actin ratio of 0.1 and 1.0. The error bars 
represent the standard error of the mean. 
 
3.4.2.3 SpireWH2 domains disintegrate actin filaments extremely fast 
It was very surprising that SpireWH2 constructs efficiently disrupt preformed actin filaments, 
because that implicates that the WH2 domains, being G-actin binding motifs, had bound to 
F-actin as well. The WH2 domains seem to have such a high affinity for actin that they can 
forcefully sequester monomers from filaments, thus breaking the whole structures. Figure 16 
A shows a representative fluorometric assay. First, actin (2 µM, 10 % pyrenylated) was 
completely polymerized for about 80 minutes (blue graph). Then, increasing concentrations 
of SpireDDD were added, starting with a molar WH2/actin ratio of 1/30 (red graph). 
Surprisingly, the pyrene-fluorescence drops in only a few seconds to a much lower and 
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stable plateau. No slow decline of the fluorescence could be observed as, for example, the 
well-known dilution-induced actin depolymerization from the barbed ends. Adding higher 
concentrations to the F-actin sample resulted in subsequent rapid fluorescence drops until no 
fluorescence could be measured anymore. In the graphs of figures 16 B-D the complete 
disappearance of fluorescence and thus of actin filaments was set to 100 % 'F-actin 
disrupting activity'. This activity could be observed for all SpireWH2 constructs, including the 
constructs with only one WH2 domain (SpireL3+D, SpireD, SpireC+L3). Addition of the linker 
construct L3 (linker between WH2 domain C and D) to polymerized labeled F-actin did not 
decrease the fluorescence, thus the linker alone could not disrupt preformed filaments (data 
not shown). The F-actin disrupting activity of SpireDDD, SpireABCD and SpireL3+D is 
depicted in figures 16 B, C and D, respectively. When F-actin is stabilized by phalloidin, 
filament disruption was inhibited. However, phalloidin treated F-actin could co-sediment the 
WH2 domains (compare figure 20). 
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Figure 16: SpireWH2 constructs disrupt preformed actin filaments extremely fast. A) 2 µM 
actin (10 % pyrenylated) was polymerized until the steady state was reached. Addition of increasing 
concentrations of SpireDDD reduced the fluorescence signal in a dose-dependent manner: molar 
WH2/actin ratios 1/30 (red), 1/10 (green), 1/8 (pink), 1/5 (cyan), 1/3 (brown), 1/2 (violet), 1/1 (dark 
blue). The pyrene-fluorescence drops immediately to a stable plateau without any slow decline of the 
fluorescence. B-D) Relative activity of different SpireWH2 constructs, the error bars represent the 
standard error of the mean (figure modified after Sitar et al (2011)). 
 
 
To exclude the possibility that SpireWH2 constructs quench pyrene-fluorescence, 
viscometry measurements were carried out as well. Any possible fluorescence quenching 
effect could be excluded, since addition of SpireWH2 domains to actin reduced the viscosity 
of the actin gel, both when co-polymerized with SpireWH2 constructs (figures 17 A and B) 
and when the SpireWH2 domains were added to completely polymerized actin (figure 17 C). 
Falling ball viscometry experiments confirmed the strong sequestering activity of SpireWH2 
domains (figures 17 A and B). The F-actin disrupting activity of SpireWH2 domains was 
confirmed by low shear Ostwald viscometry measurements (figure 17 C). Hence, the 
sequestering and F-actin disrupting activities of SpireWH2 domains are independent from the 
nucleating activity since the rapid decrease of pyrene-fluorescence and the dose-dependent 
loss of viscosity in an F-actin solution can be detected with single WH2 domains as well. 
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Figure 17: SpireWH2 domains efficiently 
sequester actin and disrupt filaments as 
shown by viscosity measurements. A) and B) 
The sequestering activity of SpireWH2 constructs 
was measured with a falling ball viscometer. Both 
SpireDDD and SpireL3+D sequester actin 
effectively and thereby reduce the viscosity of the 
F-actin solution. C) The high F-actin disrupting 
activity of SpireWH2 constructs was confirmed by 
low shear Ostwald viscometry measurements. 12 
µM actin was completely polymerized. Upon 
stepwise addition of SpireDDD, viscosity of the 
actin gel decreased very fast, reaching a stable 
plateau at each concentration until finally all 
filaments disappeared. The error bars represent the 
standard error of the mean (figure modified after 
Sitar et al (2011)). 
 
 
The breakage of the filaments by SpireWH2 domains was also shown by total internal 
reflection fluorescence (TIRF) microscopy (figure 18 and movie S1 
http://www.pnas.org/content/suppl/2011/11/17/1115465108.DCSupplemental/SM01.mov). The 
SpireWH2 constructs attack the filaments at multiple places, resulting in initially randomly 
distributed gaps which then increase at both ends. Figure 18 B shows a kymograph of a 
filament which was disrupted by SpireDDD. It is clear that the filament was disintegrated 
from its ends but especially from its middle where the gaps in the filament become visible 
after about 20 seconds. 
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Most intriguingly, SpireDDD can even disrupt actin-fascin bundles very quickly. These 
bundles usually consist of about 20 actin filaments (Claessens et al, 2008). Recent studies 
revealed that actin-fascin bundles are extremely stable and resistant against disruption by 
cofilin over days (Schmoller et al, 2011). Alexa555-actin was bundled with fascin in a 1/1 
ratio and the bundles were seeded onto a coverslip. In a TIRF assay, 3 µM SpireDDD were 
added to the bundles. SpireDDD can forcefully sequester actin monomers even from these 
filament bundles. Like observed for the the filaments, also the bundles showed initially 
randomly distributed gaps when treated with SpireWH2 constructs. The bundles completely 
disappeared within about 80 seconds (movie S2 
http://www.pnas.org/content/suppl/2011/11/17/1115465108.DCSupplemental/SM02.mov). 
 
Figure 18: SpireWH2 constructs disrupt preformed actin filaments extremely fast as 
shown by TIRF microscopy. The kinetics of filament disruption (see also movies S1 and S2) have 
been visualized on a TIRF microscope. A) Alexa555-actin was polymerized and the filaments were 
treated with SpireDDD (time t0). Red arrowheads indicate areas of initial filament disruption. Note 
that the F-actin is disrupted in a matter of seconds and does not follow the well-known 
depolymerization kinetics from barbed ends only. B) Kymograph depiction of filament disruption by 
SpireDDD (generated by Michael Wohlhöfler, Bausch laboratory, TU München). The 8 µm filament is 
displayed in the vertical, and its disruption over time is shown in the x-axis. The filament consists of 
20 % Alexa555-actin. Upon addition of SpireDDD, the filament was disrupted from its ends but also 
pieces were ripped out from its middle. The filament almost completely disappeared within 80 
seconds (figure modified after Sitar et al (2011)). 
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3.4.3 SpireWH2 domains bind G-actin but are not stably associated with 
actin filaments 
SpireWH2 tandem constructs nucleate actin polymerization at substoichiometric 
concentrations, at higher concentrations G-actin sequestration is the most prominent activity, 
the decrease of pyrene-fluorescence at steady state is present both after nucleation and 
sequestration. These observations clearly suggest that SpireWH2 domains interact with G- as 
well as F-actin. To investigate whether the SpireWH2 tandem constructs remain bound along 
filaments over a prolonged time, spindown assays were performed. First, a standard 
polymerization assay was carried out with 15 % tetramethylrhodamine (TMR)-labeled 
SpireDDD (figure 19 A). The sample to which Spire was added in a WH2/actin ratio of 1/30 
(figure 19 A, green graph) was ultracentrifuged to separate F-actin from the soluble fraction. 
Subsequently, a scan between 550 and 590 nm was performed at the fluorometer with 
supernatant and pellet fractions (figure 19 B). The emission maximum of TMR is at about 
575 nm. Clearly, TMR-SpireDDD could only be detected in the soluble fraction (figure 19 B, 
red graph), whereas no TMR-signal could be measured in the F-actin pellet fraction (figure 
19 B, green graph) and thus TMR-SpireDDD could not be co-sedimented with filamentous 
actin. These data suggest that SpireWH2 constructs are released from the emerging filament 
after effected nucleation. 
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Figure 19: SpireWH2 domains are not associated with actin filaments after effected 
nucleation as shown by a spindown assay with TMR-labeled SpireDDD. A) 2 µM actin (10 % 
pyrenylated) were polymerized in presence of the indicated ratios of 15 % TMR-labeled SpireDDD. 
SpireDDD shows nucleation of actin polymerization when added at substoichiometric concentrations 
and sequesters actin when added in higher concentrations. B) The nucleation sample (green graph 
from A) was ultracentrifuged and supernatant and pellet were scanned at the fluorometer. The 
emission maximum of TMR is at around 575 nm (compare TMR-SpireDDD control, blue graph). TMR-
SpireDDD could only be detected in the supernatant (red graph) but not in the F-actin pellet fraction 
(green graph). 
Another F-actin spindown assay was conducted in which the centrifugation was 
performed after the addition of SpireDDD to preformed filaments. In one sample, the actin 
filaments were stabilized with phalloidin, then SpireDDD was added and the sample was 
subsequently centrifuged and analyzed on a Coomassie Blue stained SDS-gel (figure 20). 
After effected disruption of preformed actin filaments, SpireWH2 constructs were found in 
the supernatant (figure 20, SpireDDD in lane 7), where now also most of the actin was 
located (at ca. 42 kDa). Thus, SpireWH2 constructs disrupt the F-actin, sequester the actin 
molecules and take them into the soluble fraction. However, when the filaments were 
stabilized with phalloidin, SpireWH2 constructs could not disrupt these filaments. 
Nevertheless, the affinity to actin seems to be so high that they can bind to the filaments 
and even can be co-sedimented together with the phalloidin-F-actin (figure 20, SpireDDD in 
last lane) although WH2 domains are G-actin binding motifs in principle. This accounts for 
single SpireWH2 domains as well; an assay with SpireL3+D leads to the same result. These 
data suggest that phalloidin connects F-actin subunits so tightly that SpireWH2 domains can 
bind but not break the filaments by removing monomers and that the affinity of SpireWH2 
domains is so high that they even bind to actin in the filament conformation. Concluding, 
SpireWH2 domains are not associated with F-actin unless the filaments are stabilized with 
phalloidin. Usually, after effected nucleation, sequestration or disruption of actin filaments 
they are always found in the soluble fraction. 
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Figure 20: SpireWH2 domains only 
efficiently disrupt F-actin if not 
phalloidin-stabilized. Coomassie Blue 
stained SDS-gel showing an F-actin 
spindown. SpireWH2 domains chop up 
actin filaments, thereby shifting the actin 
into the soluble fraction in an F-actin 
spindown. However, SpireWH2 domains 
cannot disrupt phalloidin-stabilized 
filaments, but decorate them. In the 
assay, 2 µM actin was polymerized, then 
stabilized with phalloidin where noted. 
SpireDDD was added in a ratio of 2 WH2 
domains / 1 actin molecule. The samples 
were ultracentrifuged and the pellet and 
soluble fractions were analyzed on a SDS-
gel as indicated. Pellet fractions are 
concentrated 10-fold.  
 
 
 The binding of SpireDDD to actin was investigated in a preliminary fluorescence 
resonance energy transfer (FRET) experiment. TMR-labeled SpireDDD was used as a donor, 
and QSY 7-labeled actin as an acceptor. QSY 7 is an essentially non-fluorescent quencher, 
having its absorption maximum at about 560 nm. The emission maximum of TMR is at about 
575 nm, while its excitation maximum is at around 540 nm. The fluorescence of TMR-
SpireDDD was monitored in a scan from 550 to 585 nm (figure 21). When TMR-SpireDDD in 
water was measured, a fluorescence peak at around 575 nm could be captured (figure 21, 
blue graph). QSY 7-labeled actin or water alone did not show any emission of fluorescence in 
this spectrum (figure 21, green graph). When QSY 7-labeled actin was incubated together 
with TMR-SpireDDD, the fluorescence was decreased and a quenching efficiency of about 60 
% could be detected, indicating that QSY 7-actin and TMR-SpireDDD were binding to each 
other under non-polymerizing conditions.  
 
Figure 21: SpireWH2 constructs bind 
to G-actin as shown by FRET. The 
emission spectrum of TMR-SpireDDD was 
measured. TMR-SpireDDD alone shows a 
peak of fluorescence at about 575 nm 
(blue graph). Water and QSY 7-labeled 
actin alone do not show any peak in this 
emission spectrum (green and black 
graph). When QSY 7-actin and TMR-
SpireDDD were incubated together, the 
fluorescence intensity was decreased by 
about 60 %, indicating a binding of actin 
and SpireDDD, which resulted in 
fluorescence quenching. 
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3.5 D. discoideum amoebae respond to treatment with SpireWH2 
constructs  
Most surprisingly, D. discoideum amoebae respond to the treatment with SpireWH2 
constructs. This is an unexpected behavior since proteins usually cannot simply enter cells to 
trigger intracellular processes. However, starting from a concentration of 3 µM SpireDDD 
either diluted in HL5 medium or Soerensen buffer, the cells stop migrating and round up 
(figure 22 A). The cells perfectly recover if SpireDDD is removed by washing the cells. The 
amoebae did not respond to heat-inactivated SpireDDD. Adding SpireDDD to migrating 
fluorescent GFP-cofilin and RFP-actin expressing cells seems to affect their actin cytoskeleton 
(figure 22 B). Upon addition of SpireDDD the cells look like as if they would have been 
treated with the toxin Latrunculin A which inhibits actin polymerization by sequestering 
monomeric actin. 
 
 
Figure 22: D. discoideum amoebae respond to treatment with SpireWH2 domains. . A) D. 
discoideum amoebae respond to treatment with SpireDDD starting from a concentration of 3 µM 
diluted in Soerensen buffer. B) GFP-cofilin and RFP-actin expressing cells were treated with 10 µM 
SpireDDD diluted in HL5 medium. Scale bar, 10 µm. 
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Even more intriguingly, the addition of increasing concentration of SpireWH2 domains 
induced the formation of cytoplasmatic rods in Dictyostelium amoebae. When incubating 
GFP-cofilin expressing cells with 30 µM SpireDDD for one hour, the cells form cytoplasmic 
rods and look clearly different to untreated cells (figure 23). The addition of SpireWH2 
domains seems to exert a certain stress on the cells. Possibly, the SpireWH2 constructs 
might pass the membrane of D. discoideum cells and disrupt the filamentous actin network. 
To further investigate whether SpireWH2 domain constructs would enter a D. discoideum 
cell, the addition of 5 µM TMR-labeled SpireBCD to GFP-cofilin expressing D. discoideum cells 
was recorded at the confocal microscope. During this experiment, the cells responded to the 
treatment, rounded up and even formed GFP-cofilin rods. However, no TMR-SpireBCD could 
be detected within the cells (data not shown). 
 
 
Figure 23: D. discoideum cells round up and form cytoplasmic cofilin rods upon addition 
of high concentrations of SpireDDD. Fixed AX2 GFP-cofilin cells. The DNA was stained by ToPro 
(blue). Scale bar, 5 µm. A) Untreated AX2 GFP-cofilin control cell. The GFP-cofilin localizes at the cell 
cortex, in this cell especially in the leading edge. B) The AX2 GFP-cofilin cells were incubated with 30 
µM of SpireDDD diluted in HL5 medium for 60 minutes. The cells rounded up and formed cytoplasmic 
cofilin-rods. 
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4. Results II: Actin variants in Dictyostelium amoebae 
In this part of the thesis, D. discoideum actin variants and in particular filactin were 
analyzed. The identity of actin variants with conventional D. discoideum actin ranges from 37 
% - 97 %. Act3 differs from conventional actin by only 8 amino acids, whereas act31 is 
highly divergent with only 143 identical residues out of 365 amino acids. Act24 and act25 are 
82 % and 78 % identical with conventional actin, respectively. Filactin is the most 
extraordinary actin variant in D. discoideum, since it comprises besides its actin domain a 
large extended N-terminus. Previous studies confirmed that the genes encoding these actin 
variants are transcribed in vegetative and developing D. discoideum NC4 cells (Romans et al, 
1985). For filactin, act24 and act25 more than 15 expressed sequence tags (ESTs) were 
found. For act3, act18 and act31 one to 5 ESTs were documented (Joseph et al, 2008; 
Urushihara et al, 2004). Hypothetically, act3, act24, act25 and filactin could be part of the 
cytoskeleton, whereas other more divergent actin variants, e.g. act18 or act31 might have 
rather regulatory than structural functions. Table 2 shows a summary of information 
available about the actin variants investigated in more detail in this study. 
 
Table 2: Actin variants analyzed in this study. (Sources: Dictybase.org, NCBI Blast) 
 
 act24 act25 filactin actin 
domain (aa 574-
944) 
Dictybase 
Gene ID 
DDB_G0289505 DDB_G0289507 DDB_G0284389 
Identity with D. 
discoideum 
conventional actin 
(P07830) 
82 % 78 % 64 % 
Identity with human 
beta-actin (P60709) 
80 % 74 % 67 % 
Identity with rabbit 
muscle actin 
(P68135) 
78 % 72 % 65 %  
location of the gene Chromosome 5 Chromosome 5 Chromosome 4 
number of amino 
acids 
377 aa 385 aa 370 aa 
Number of identified 
ESTs 
>15 >15 >15 
predicted molecular 
function 
nucleotide binding; 
structural molecule 
activity; structural 
constituent of the 
cytoskeleton; protein 
binding; ATP binding; 
myosin binding 
nucleotide binding; 
structural molecule 
activity; structural 
constituent of the 
cytoskeleton; protein 
binding; ATP binding; 
myosin binding 
nucleotide binding;  
structural molecule 
activity; protein 
binding; ATP binding  
predicted cellular 
component 
cytoskeleton; actin 
cytoskeleton 
cytoskeleton; actin 
cytoskeleton 
cytoskeleton 
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The protein sequences of the actin variants show high similarity to D. discoideum 
conventional actin and rabbit muscle actin (figure 24). 
 
Figure 24: Alignment of selected D. discoideum actin variants. Rabbit muscle actin 
(Oc_ACTA1, P68135) and Dd_act8 as the conventional actin in D. discoideum (P07830) were set as a 
reference. The filactin actin domain is defined as aa 574-944 of the filactin protein. Identical residues 
are shown on a black background, similar residues are displayed on a grey background. Blosum 62-
12-2 was used as alignment parameter and the threshold for shading was set to 56 %. The five 
conserved actin sequence motifs of rabbit muscle actin and the D. discoideum act8 group are 
highlighted by red brackets: PH1, phosphate binding loop 1; C1, connecting motif 1; PH2, phosphate 
binding loop 2; AD, adenosine binding loop; C2, connecting motif 2. 
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4.1 Analysis of the actin variant filactin, a potential new player in the 
ESCRT pathway 
The protein filactin belongs to the actin variants of D. discoideum. It distinguishes itself from 
the other 15 known actin variants by its long N-terminal extension with a distinct domain 
organization (figures 5 and 25). The actin domain which shows 64 % identity to the 
conventional D. discoideum actin (act8-group, figure 24) and 67 % identity to human β-
actin, is located at the very C-terminus (aa 574-944). The N-terminus shows homology to 
three different sequence motifs: (1) an Ist1-like domain at the very N-terminus, (2) a PEST-
motif and (3) two filamin-like Ig repeats. 
 
 
Figure 25: Amino acid sequence and domain organization of filactin. Filactin is composed of 
944 amino acids, resulting in a molecular weight of about 105,000. The actin domain (red) showing 
higher homology to muscle actin than to actin-related proteins (ARPs) is located at the C-terminus. 
The N-terminus exhibits a distinct domain organization, including an Ist1-like domain (yellow), a 
PEST-motif (orange) and two filamin-like Ig repeats (green). 
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Homologs of filactin were identified via BLASTp sequence analysis in D. fasciculatum, 
D. purpureum, Polysphondylium pallidum as well as in E. histolytica, E. nuttalli, E. invadens 
and E. dispar (figure 26). 
 
 
Figure 26: Evolutionary tree for the filactin protein family. MUSCLE alignments of D. 
discoideum filactin (XP_638602.1) and its homologs in D. fasciculatum (XP_004357688.1), D. 
purpureum (XP_003289904.1), P. pallidum (EFA82454.1), E. invadens (XP_004261427.1), E. dispar 
(XP_001734710.1), E. histolytica (XP_652978.1) and E. nuttalli (EKE41601.1) were used to create 
dendrograms with the CLUSTALX Tree View program. Bootstrap values are provided at the node of 
each branch. The scale bar indicates amino acid substitutions per site. 
 
The filactin-like protein in D. purpureum is 74 % identical to filactin and shows high 
similarity even at the nucleic acid sequence level. In the other Dictyosteliidae shown in figure 
26, the filactin homologs are about 63 – 65 % identical to filactin. In Entamoebae, the PEST-
motif is missing as well as the ‘unstructured’ region between the filaminlike Ig repeats and 
the actin domain. Apart from the harmless E. dispar, the Entamoebae species shown in the 
tree are pathogens of either reptiles (E. invadens), macaques (E. nuttalli) or humans (E. 
histolytica). 
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4.1.1 Analysis of the filactin protein sequence 
In this study, an Ist1-like domain (Ist1 = Increased sodium tolerance 1) was identified at the 
very N-terminus of filactin. Until now, the N-terminal domain was described as ‘DUF292’ 
(domain of unknown function 292) in dictybase.org. Via sequence analysis, the homology to 
the N-terminal part of yeast and human Ist1/IST1 was assigned (figure 27 and 28). Ist1 was 
first identified in S. cerevisiae and shown to be implicated in the ESCRT pathway, especially 
in the regulation of membrane scission and ESCRT-III disassembly (Dimaano et al, 2008; 
Entian et al, 1999). 
 
 
Figure 27: Homology of the filactin Ist1-like domain to the N-terminal part of human 
IST1. The filactin Ist1-like domain shows 35 % identity to the N-terminal domain of human IST1. In 
difference to filactin, the human IST1 harbors an ELYC-motif, responsible for protein interactions. The 
C-terminal part of human IST1 contains two MIMs (MIM, MIT-interacting motif; MIT, microtubule-
interacting and transport) which seem to be specific for distinct targets. The interaction partners of 
human IST1 are indicated in capital letters below the both-way arrows, the corresponding homologs 
in D. discoideum follow in brackets. CHMP1, charged multivesicular body protein 1; vps46, vacuolar 
protein sorting 46; vps4, vacuolar protein sorting 4; LIP5, lysosomal trafficking regulator-interacting 
protein 5; vta1, vps twenty associated 1. 
 
The D. discoideum genome encodes an Ist1-like protein (gene ID DDB_G0289029), 
which contains the domains present in human IST1. Filactin, however, only shares homology 
to IST1 only in its N-terminal Ist1-like domain and lacks the MIM domains (MIM, MIT-
interacting motif; MIT, microtubule-interacting and transport). MIM domains are sequence 
motifs of ESCRT-III proteins that were found to interact with MIT domains (MIT, 
microtubule-interacting and transport). MIT domains were first identified in endosomal 
trafficking proteins (Ciccarelli et al, 2003) and the ESCRT proteins vta1 and vps4 contain 
these motifs as well. 
The Ist1-like domain of filactin shows 35 % identity to the N-terminal part of human 
IST1 (figure 27). A ribbon model of the filactin Ist1-like domain was generated using human 
IST1 (Bajorek et al, 2009b) as a template (figure 28). Proteins belonging to the ESCRT-III 
complex vary significantly in primary sequence, but share a common secondary structure of 
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N-terminal core domains (ca. 150 residues), containing various α-helices (figure 28 A). In 
ESCRT-III proteins, the C-terminal α5 helix seems to be responsible for autoinhibiting the N-
terminal core domains, especially hydrophobic residues near the tip of the helical hairpin of 
the α1 and α2 helices (Bajorek et al, 2009b; Muziol et al, 2006; Xiao et al, 2009). In the 
‘closed’ and monomeric conformation, residues along the hairpin surface responsible for 
membrane binding and polymer assembly remain hidden and prevent premature membrane 
binding and oligomerization, consequently the protein remains in the cytoplasm. In the 
‘open’ conformation, autoinhibitory interactions are released and the subunits can bind to 
each other and to the membrane during their assembly into functional ESCRT‑III polymers. 
ESCRT-III proteins can assemble into filamentous polymers on membranes. These filaments 
have an intrinsic tendency to curve and form ring-like spiral filaments on the membrane 
(Ghazi-Tabatabai et al, 2008; Hanson et al, 2008; Saksena et al, 2009).  
 
 
 
Figure 28: Ribbon model of the N-terminal part of human IST1 used as template and 
the modeled filactin Ist1-like domain. Swiss Model Expasy was used (Arnold et al, 2006). The 
color code is a rainbow gradient starting at the N-terminus in blue and ending at the C-terminus in 
red. A) Human IST1 (PDB 3FRRA, residues 1-189) was used as a template (Bajorek et al, 2009b). 
The N-terminal domain of human IST1 shares the common secondary structure of ESCRT-III 
proteins and contains 8 α-helices. B) Filactin Ist-like domain (aa 1- 240) modeled to the N-terminal 
part of human IST1. 
 
In humans and yeast, the Ist1 protein was shown to interact with other proteins of 
the ESCRT machinery, namely CHMP1/Did2, VPS4/vps4 and LIP5/vta1 via its different 
domains, (Bajorek et al, 2009a; Dimaano et al, 2008; Rue et al, 2008). The filactin Ist1-like 
domain shows only a homology to the N-terminal part of IST1/Ist1 which binds to 
CHMP1/Did2 in human or yeast. The N-terminal ELYC motif of yeast Ist1 was described to be 
involved in the binding to the yeast CHMP1-like protein Did2 (Dimaano et al, 2008), 
corresponding to D. discoideum vps46. However, another study specifies different residues 
to be responsible for CHMP1/Did2 binding. On a structural basis, Xiao and others (2009) 
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identified residues forming a conserved binding groove for Ist1-Did2 interaction, highlighted 
by red arrows in figure 29. In human IST1, different residues mostly in the same regions 
were described to be important for CHMP1B binding (figure 29, blue arrows, Bajorek et al, 
2009b). Both in filactin and D. discoideum Ist1-like protein, the ELYC motif is not conserved 
as in human and yeast. However, about 60 % of the residues predicted to be responsible for 
protein-interaction are conserved in the filactin Ist1-like domain. Compared to the residues 
described to be essential in human IST1 to bind to CHMP1B, four out of five residues are 
conserved in the filactin Ist1-like domain, and all of them are conserved in D. discoideum 
Ist1-like. To test a possible interaction of D. discoideum vps46 with the Ist1-like domain of 
filactin, a GFP-vps46 overexpressing D. discoideum strain was generated in this study, as 
well as a GST-vps46 fusion protein. The data of these experiments are presented below (see 
4.2.4.). 
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Figure 29: Alignment of the filactin Ist1-like domain (aa 1-190) to the N-terminal part of 
human IST1, yeast Ist1 and D. discoideum Ist1-like. Amino acid 1-198 of H. sapiens IST1 
(Swiss Prot P53990), aa 1-204 of S. cerevisiae Ist1 (Swiss Prot P53843) and aa 1-198 of D. 
discoideum Ist1-like (DDB_G0289029) were used. The yeast and human Ist1/IST1 proteins harbor an 
ELYC-motif (red box, alignment aa 75-78,) responsible for protein interactions. This ELYC-motif is not 
completely conserved in the filactin Ist1-like domain and also not in the D. discoideum Ist1-like 
protein. Residues described to be involved in forming the conserved binding groove for the human 
CHMP1B and yeast CHMP1-like protein Did2 are marked with blue and red arrows, respectively. 
Residues essential for that binding (Bajorek et al, 2009b; Xiao et al, 2009) are additionally highlighted 
by stars. The secondary structure of human IST1 is depicted above the sequence. 
 
 
A putative PEST-motif can be found downstream from the Ist1-like domain (figure 25, 
orange). A PEST motif is a peptide sequence with relatively high local concentrations of the 
amino acids proline (P), glutamic acid (E), serine (S), threonine (T) and to a lesser extent 
aspartic acid (D) (Rechsteiner & Rogers, 1996; Rogers et al, 1986). These internal sequences 
are recognized by protein degrading enzymes, e.g. the proteasome or calpain, reducing the 
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half-life of the protein drastically. This could explain why filactin is so sensitive to proteolytic 
cleavage. 
Filactin contains two central domains which are homologous to typical filamin-like Ig 
repeats. Filamins are homodimeric F-actin-crosslinking proteins. Each monomer consists of 
an actin binding domain and a rod segment containing 6 (D. discoideum) to 24 (H. sapiens) 
highly homologous repeats of about 96 residues which are arranged in an Ig-like fold 
(Popowicz et al, 2006). The filactin filamin repeats are 32 % and 37 % identical to D. 
discoideum filamin Ig repeat #5 and 31 % and 33 % identical to human filamin B Ig repeat 
#13, respectively. Figure 30 shows a model of D. discoideum filamin and a ribbon model of 
the predicted structure of filactin's filamin-like Ig repeats. 
 
 
Figure 30: Filamin-like Ig folds in D. discoideum filactin. A) Model of D. discoideum filamin 
(modified after Popowicz et al, 2004). Each subunit in the dimer contains an N-terminal F-actin 
binding domain, a rod with 6 Ig repeats, and the dimerization is based on a direct interaction of the 
domains #6 (McCoy et al, 1999; Popowicz et al, 2004). The filactin filamin repeats are homologous to 
these repeats. B) Ribbon model of D. discoideum filamin Ig repeats #4 and #5 of the filamin rod 
segment (modified after Popowicz et al, 2004). C) Ribbon model of filactin filamin-like Ig repeats (aa 
241- 490) modeled to the crystal structure of D. discoideum filamin rod repeats (PDB 1wlh1A, Swiss 
Model Expasy).  
 
 
The actin domain of filactin is located at the C-terminus of the protein (aa 574-944). 
The alignment displayed in figure 24 demonstrates that it is highly similar to other actins. It 
shares 67 % identity with human β-actin and has higher homology to muscle actin than to 
actin-related proteins. Filactin thus belongs to the bona fide actins and can be classified as 
an actin with elongated N-terminus. The putative structure of the filactin actin domain 
(figure 31 B) shows that it fits very well into the 3D structure of rabbit muscle actin. 
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Consequently, the putative structure is organized like conventional actins with a large left 
side and a small right side which both can be subdivided further into a total of four 
subdomains (SD 1 - SD 4, figure 31 C; Joseph et al (2008)). The five conserved sequence 
motifs which are present in actins seem to be conserved in the filactin actin domain as well: 
the adenosine binding loop (AD), two phosphate binding loops (PH1 and PH2) and two 
connecting domains (C1 and C2) (figure 31 C). Most likely the filactin actin domain can bind 
ATP in its cleft between the main-domains one and two. 
 
Figure 31: Ribbon model of rabbit muscle actin and the modeled filactin actin domain (aa 
574-944). A) Ribbon model of the crystal structure of uncomplexed Oryctolagus cuniculus actin in 
the ADP state (PDB 1J6ZA; Otterbein et al, 2001) which was used as a template to model the 
putative structure of the filactin actin domain shown in B. C) Model of D. discoideum act8 organized 
in 4 subdomains (SD 1-SD 4) (modified after Joseph et al, 2008). Five extremely conserved sequence 
motifs line the nucleotide binding pocket: the adenosine binding loop AD (green), the two phosphate 
binding loops PH1 and PH2 (red and purple, respectively) and the subdomain connecting motifs C1 
and C2 (blue and violet, respectively).  
 
 
4.1.2 Filactin antibodies 
In this thesis, two monoclonal filactin antibodies were used, namely 3S-55-4 and 4S-59-4. 
The hybridoma cell lines were generated by Daniela Rieger. To generate the 4S-59-4 
antibody, a mouse was immunized with the C-terminal part of filactin containing the actin 
domain. This antibody recognizes the actin domain of filactin and exhibits a weak cross-
reaction with conventional actin (blue cross, 42 kDa, figure 32 C). The 3S-55-4 antibody 
recognizes the N-terminus of filactin and is even more specific than the 4S-59-4 since it does 
not cross-react with other actin proteins (figure 32 B). The specificity of both antibodies was 
tested using the filactin knock out (KO) cell line (generously provided by Jan Faix, 
Medizinische Hochschule Hannover). The 105 kDa filactin band present in the wild type AX2 
cell line (figures 32 B and C, lane 1) is clearly missing for the filactin KO cell line (figures 32 
B and C, lane 2). 
In this study, the binding epitope of the 3S-55-4 antibody could be narrowed down to 
the filactin filamin repeats. Cell lines overexpressing the following different GFP-tagged 
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filactin domain constructs were used for western blot analysis: GFP-filactin (GFP-FiaFL, aa 1–
944), GFP-filactin Ist1-like (GFP-FiaIst1, aa 1-196), GFP-filactin filamin repeats (GFP-FiaFilR, 
aa 259-488) and GFP-filactin actin (GFP-FiaAct, aa 570 – 944). The anti-GFP antibody K3-
184-2 was used as a control (figure 32 A). As displayed in figure 32 B, the antibody 3S-55-4 
binds to endogenous full length filactin (red arrow head, 105 kDa) and to the overexpressed 
GFP-filactin filamin repeats (red star, 52 kDa). The antibody 4S-59-4 (figure 32 C) recognizes 
endogenous full length filactin (blue arrow head, 105 kDa) as well as GFP-tagged full length 
filactin (data not shown), the GFP-filactin actin domain (blue star, 70 kDa) and it cross-reacts 
with another actin at around 42 kDa (blue cross).  
 
Figure 32: Defining the binding epitopes of the monoclonal filactin antibodies 3S-55-4 
and 4S-59-4. A) Western blot using the monoclonal GFP antibody K3-184-2 to test the 
overexpression of the GFP-tagged filactin constructs. B) Western blot using the monoclonal antibody 
3S-55-4. The antibody recognizes the endogenous filactin at around 105 kDa (lane 1 and 3, red 
arrow head) and the overexpressed GFP-tagged filamin repeats in lane 5 (red star). The antibody 
shows a reaction with an unknown protein at around 90 kDa (red arrow). C) Western blot using the 
monoclonal antibody 4S-59-4. The antibody binds to the endogenous filactin at around 105 kDa (lane 
1, 3 and separate lane 6, blue arrow head) and to the GFP-tagged filactin actin domain (separate 
lane 6, blue star). Moreover, it shows a cross-reaction with an actin at around 42 kDa (blue cross) 
and with an unknown protein at around 90 kDa (blue arrow). 
 
It is noteworthy that the filactin C-terminal antibody 4S-59-4 shows a cross reaction 
with another actin (probably conventional actin), whereas the actin antibody act-1 
recognizing D. discoideum conventional actin (Simpson et al, 1984) cannot bind to the 
filactin actin domain (data not shown). In addition, the actin antibody 224-236-1 (Westphal 
et al, 1997) is also not binding to filactin (data not shown). 
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4.1.3 Filactin is associated with the actin cytoskeleton 
4.1.3.1 Localization studies of filactin in D. discoideum using fluorescence 
microscopy 
 
GFP-filactin (GFP-tag at the N-terminal side) co-localizes with conventional actin at the cell 
cortex (figure 33 C) and is also found in the cytoplasm where it localizes at vesicle-like 
structures. Filactin full length with the GFP-tag at the C-terminus (filactin-GFP) shows the 
same localization (data not shown). Immunofluorescence studies using the filactin antibodies 
3S-55-4 and 4S-59-4 confirm the cortical and cytoplasmic localization (figures 33 A and B). 
 
 
Figure 33: Localization of filactin in D. discoideum cells. The cells were fixed and incubated 
with the respective primary antibody. Scale bar, 5 µm. A) AX2 cell treated with the filactin antibody 
3S-55-4, recognizing the N-terminal part of filactin. The antibody clearly marks the cortex of the 
cell and vesicle-like structures in the cytoplasm. B) AX2 cell treated with the filactin antibody 4S-
59-4 which binds to the actin domain of filactin and shows a minor cross-reaction with actin. The 
cortical stain is more pronounced than in A. Also vesicle-like structures are visible. C) AX2 GFP-
filactin cell incubated with act-1 antibody. GFP-filactin localizes to the cell cortex, thus co-localizes 
with conventional actin. GFP-filactin also localizes in the cytoplasm in vesicle-like structures. In the 
merge panel, the DNA is displayed in blue (stained with ToPro). 
 
Results II: Actin variants in Dictyostelium amoebae 
 
60 
 
In addition to the full length filactin the localization of the different filactin domains 
was investigated. The GFP-tagged filactin actin domain (aa 574-944) co-localizes with actin 
in the cell and is additionally present in the cytoplasm (figure 34).  
 
 
Figure 34: Localization of the GFP-tagged filactin actin domain in D. discoideum cells. The 
fixed cells were incubated with the act-1 antibody. GFP-filactin actin co-localizes with actin. 
Furthermore, it is also present in the cytoplasm. Scale bar, 5 µm.  
 
GFP-filactin Ist1-like (aa 1-196) and the GFP-filactin filamin repeats (aa 259-488) 
localize predominantly in the nucleus and in the cytoplasm (figure 35) in vegetative D. 
discoideum cells. This is a surprising finding since the sequences do neither contain a nuclear 
localization signal nor does filactin full length localize in the nucleus in vegetative cells. The 
constructs do not show a co-localization with conventional actin.  
 
 
Figure 35: Localization of GFP-tagged N-terminal filactin domains in D. discoideum cells. 
The cells were fixed under agar with picric acid and incubated with the interaptin antibody (260-60-
10). Interaptin marks the nuclear envelope. The N-terminal filactin domains localize in the cytoplasm 
and in the nucleus. Scale bar, 5 µm. A) Filactin KO cells expressing the GFP-Ist1-like domain stained 
with interaptin antibody. B) Filactin KO cells expressing GFP-filamin repeats stained with interaptin 
antibody.  
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4.1.3.2 Filactin is part of the Triton-insoluble cytoskeleton and is present in 
soluble and membrane fractions 
 
To investigate biochemically whether filactin co-localizes with F-actin in D. discoideum cells, 
two different assays were carried out: (1) analysis of the Triton-insoluble cytoskeleton and 
(2) analysis of a differential centrifugation. 
The Triton-insoluble cytoskeleton assay was performed according to McRobbie and 
Newell (1983). Filactin, both the GFP-tagged and the endogenous one, could be detected in 
the Triton-insoluble cytoskeleton (figure 36 A, last lane). Furthermore, it was present in 
soluble fractions but also pellets together with membranes in the differential centrifugation 
assays (figure 36 A-C). However, the differential centrifugation assays suggest that filactin 
might be more soluble than associated with F-actin since neither GFP-tagged nor 
endogenous filactin could be detected in the 100,000 g pellets (figures 36 B and C). These 
data indicate that filactin is primarily soluble but also associates with membranes and F-
actin. 
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Figure 36: Filactin is part of the Triton-insoluble cytoskeleton and is present both in 
soluble and membrane fractions. A) Triton-insoluble cytoskeleton of AX2 cells expressing GFP-
filactin full length (7.5 x 105 cells/lane). The western blot was incubated with filactin antibody 3S-55-
4. GFP-filactin is detected at about 130 kDa (arrow head), endogenous filactin at 105 kDa (arrow). 
Filactin is present both in supernatant (spn) and pellet fractions. The bands below 100 kDa most 
probably result from protein degradation. B) Differential centrifugation of AX2 cell lysates (5 x 105 
cells/lane for cell lysates and spn fractions, pellet fractions were concentrated 3-fold). The western 
blot was incubated with filactin antibody 3S-55-4. Endogenous filactin was found both in soluble and 
membrane fractions (arrow head), but could not be detected in the 100,000 g pellet. C) Differential 
centrifugation of filactin KO cells expressing GFP-filactin full length (6.5 x 105 cells/lane for cell lysate 
and spn fractions, the pellet fractions were concentrated 4-fold). The western blot was incubated 
with the GFP antibody K3-184-2. GFP-tagged filactin in a filactin KO background is found both in 
soluble and membrane fractions (arrow), but could not be detected in the 100,000 g pellet. The 
seemingly increased concentration of GFP-filactin in the 100,000 g supernatant most probably is an 
artifact. 
 
4.1.3.3 Filactin is part of stress-induced nuclear actin rods 
Nuclear actin rods are protein bundles that are present in the nucleus of D. discoideum 
spores (Sameshima et al, 2000) and can be induced in vegetative cells under stress 
conditions. In all organisms tested so far, actin can migrate into the nucleus upon treatment 
with dimethyl sulfoxide (DMSO) or increased temperatures and form rod-shaped paracrystals 
(Fukui, 1978; Osborn & Weber, 1984). These rods consist of actin and a set of actin binding 
proteins, including cofilin, actin-interacting protein 1 (Aip1) and coronin (Minamide et al, 
2010; Nishida et al, 1987; Vandebrouck et al, 2010). In our experiments AX2 GFP-cofilin cells 
were used as a reference. In vegetative cells, cofilin co-localizes with actin (figure 37 A). 
Upon treatment with DMSO, not only actin but also cofilin migrates into the nucleus to form 
bundles (figure 37 B). 
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Figure 37: Actin and GFP-cofilin are present in nuclear actin rods. AX2 GFP-cofilin cells were 
fixed and incubated with the act-1 antibody. Scale bar, 5 µm. A) GFP-cofilin co-localizes with actin in 
the cell. B) Cells were incubated with 5 % DMSO for 60 minutes and then fixed. Upon incubation with 
DMSO, both actin and GFP-cofilin migrate into the nucleus and form bundles. 
 
 
To find out whether filactin was also part of the actin-cofilin bundles, AX2 GFP-cofilin 
cells were incubated with DMSO, fixed and then stained with the filactin antibody 3S-55-4. 
Figure 38 A shows the cells before incubation with DMSO, figure 38 B depicts DMSO-treated 
cells. Filactin is clearly co-localizing with the actin-cofilin rods. 
 
 
Figure 38: Filactin is present in nuclear actin rods. AX2 GFP-cofilin cells were fixed and 
incubated with the filactin N-terminal antibody 3S-55-4. Scale bar, 5 µm. A) Filactin co-localizes with 
GFP-cofilin at the cell cortex and is also present in the cytoplasm. B) Cells were incubated with 5 % 
DMSO for 60 minutes and then fixed. Upon incubation with DMSO, the nuclear rods are formed; both 
GFP-cofilin and filactin are part of the bundles in the nucleus.  
 
 
However, when incubating AX2 GFP-filactin cells with DMSO, the GFP-tagged filactin 
cannot be found in the rods (figure 39), it stays in the cytoplasm. The endogenous filactin is 
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still present in the rods (data not shown). Also in a filactin KO background, GFP-filactin is not 
able to enter the nucleus. Additionally, when imaging D. discoideum spores, GFP-cofilin is 
found in the rods in spores, but GFP-filactin is not, both in a wild type and a filactin KO 
background (data not shown). 
 
 
Figure 39: GFP-filactin is not present in nuclear rods. AX2 GFP-filactin full length cells were 
incubated with 5 % DMSO for 60 minutes, fixed and incubated with the act-1 antibody. Note that the 
GFP-filactin is present in the cytoplasm but not in the nucleus. Scale bar, 5 µm. 
 
 
Since the GFP-filactin protein has a mass of ca. 130 kDa it might be just too big to 
cross the nuclear membrane. To analyze whether the GFP-tagged actin domain of filactin is 
able to go into the nucleus and to co-localize with the rods, AX2 cells expressing this fusion 
construct were incubated with DMSO. The GFP-fusion protein is able to cross the nuclear 
membrane and could be found enriched in the nucleus. However, it is not part of the protein 
rods, but localizes around them (figure 40 A). Also immunofluorescence experiments 
confirmed this result. Furthermore, the localization under stress conditions of the filactin N-
terminal domains was analyzed. Upon treatment with DMSO, both GFP-filactin Ist1-like and 
GFP-filactin filamin repeats are found in the nucleus, but not in the rods (figures 40 B and 
C). Since none of the GFP-tagged filactin constructs was found in the rods – neither in the 
wild type nor in the filactin KO background - the GFP-tag probably might hinder an 
integration of filactin into the rods and/or inhibit transport into the nucleus. 
 
Figure 40: GFP-tagged filactin domains are not present in the nuclear rods. The cells were 
incubated with 5 % DMSO for 60 minutes and then imaged live with a confocal microscope. Upon 
incubation with DMSO, the GFP-fusion proteins are enriched in the nucleus, but are not present in the 
rods. Note the dark rod-shaped shadow where the GFP-proteins are not present. Scale bar, 5 µm. A) 
AX2 GFP-filactin actin cells. The first picture shows the rod in a side view, the second picture shows a 
top view. B) AX2 GFP-filactin Ist1 cell. C) AX2 GFP-filactin filamin repeats cells. 
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Even though endogenous filactin is part of the nuclear actin rods, it might not be 
essential for their formation. Time series experiments were carried out with filactin KO cells, 
filactin KO cells expressing GFP-cofilin and AX2 GFP-cofilin cells. The cells were incubated in 
parallel with 5 % DMSO for 0, 5, 15, 30, 60 and 90 minutes. The cells were fixed at the 
respective timepoints and actin was visualized using the act-1 antibody. The rod formation in 
the KO background already started in certain cells already after 15 minutes of incubation 
with DMSO, just as in the control cells. Proper rods were formed after approximately 60 
minutes (data not shown). 
 
 
4.1.3.4 The purified filactin actin domain acts as an actin sequestering 
protein in in vitro assays 
Filactin is notoriously difficult to purify. Since former approaches to purify it from D. 
discoideum cells were not successful, a new purification assay was established in this study. 
The FLAG-tagged filactin full length protein and the filactin actin domain with and without N-
terminal GFP were expressed using the baculovirus system in Sf9 insect cells. Figure 41 
shows the purified and eluted protein constructs. The filactin actin domain could constantly 
be purified in higher amounts than the full length protein. The full length filactin also was 
much more sensitive to degradation, probably due to its PEST-motif. 
 
 
Figure 41: FLAG-filactin constructs purified from 
Sf9 cells. Filactin and GFP-filactin could not be obtained 
in high concentrations and were also very sensitive to 
proteolytic degradation (lane 1 and 2, 105 and 130 kDa). 
The purified filactin actin domain with and without GFP-
tag was very stable (lane 3 and 4, 42 and 70 kDa, 
respectively) and could be obtained in higher 
concentration than the full length constructs. 
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The purified proteins were used in fluorometric studies to investigate their impact on 
actin polymerization. The filactin actin domain acts as an actin sequestering protein in vitro 
as shown in figures 42 A and 43 A. The filactin full length protein was usually limiting since 
the concentration was too low. However, it was obvious that the full length protein did not 
exhibit the same effect as the actin domain only. No significant sequestering activity could be 
observed, neither in the fluorometric nor in the viscometric assays (figures 42 B and 43 B). 
In contrast, the filactin actin domain had an effect on actin polymerization. Besides the 
sequestering activity shown in figure 42 A, it further revealed its sequestering abilities in the 
capping assay depicted in figure 42 C. When the preformed actin seeds were incubated with 
the filactin actin domain and then added to actin and polymerization buffer, the nucleation of 
actin polymerization was inhibited, and the fluorescence signal was even decreased below 
the control’s signal after ca. 30 minutes of polymerization. In addition, the filactin actin 
domain accelerated dilution-induced depolymerization (figure 42 D). The activity observed of 
the filactin actin domain and the filactin full length did not change in presence/absence of 
calcium or EGTA and was not altered by different salt concentrations (up to 100 mM NaCl). 
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Figure 42: Influence of filactin constructs on actin polymerization as measured by 
fluorometric methods. The polymerization and depolymerization of actin (10 % pyrenylated actin) 
was measured in the presence of purified FLAG-filactin full length or FLAG-filactin actin domain. A) 
Filactin actin acts as actin sequestering protein. The fluorescence signal decreases with the increase of 
the filactin actin concentration. B) Filactin full length does not act as actin sequestering protein. The 
fluorescence signal did not decrease significantly with the increase of the filactin concentration. C) 
Filactin actin inhibits seeded nucleation of actin polymerization. The addition of preformed actin seeds 
lead to a quicker actin polymerization (red graph) compared to the control (blue dashed graph). Pre-
incubation of filactin actin with the actin seeds resulted in inhibition of the nucleation (green graph) 
and a decrease of fluorescence signal even below the control on the long term. D) Filactin actin 
accelerates dilution-induced depolymerization. The depolymerization of actin just below the critical 
concentration of the barbed end was monitored with the addition of increasing amounts of filactin 
actin which accelerated depolymerization. 
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Figure 43: Influence of filactin constructs on actin polymerization as measured by low 
shear viscometry. 15 µM actin was incubated with the indicated, increasing amounts of purified 
FLAG-filactin full length or FLAG-filactin actin domain and the viscosity of the solution was measured 
with a falling ball viscometer. The error bars indicate the standard error. A) The filactin actin domain 
reduces the viscosity of the actin solution. Already when added in a molar ratio of 1/20 (filactin actin 
domain/actin), the viscosity was reduced by ca. 85 %. B) Filactin full length slightly increases the 
viscosity of the actin solution. When filactin was added to actin in a molar ratio of 1/20 (filactin/actin) 
the viscosity was increased by about 40 %. 
 
 
Since it was still unclear from the conducted fluorometric and viscometric experiments 
whether the filactin actin domain acts as G-actin sequestering or probably as F-actin capping 
protein, a spindown experiment was carried out. F-actin and G-actin can be separated by 
centrifugation at 120,000 g. The F-actin is pelletable whereas the soluble G-actin stays in the 
supernatant. After co-polymerization of actin with the GFP-tagged filactin actin domain which 
was monitored on the fluorometer (figure 44 A), the F-actin fraction and soluble fraction 
were separated by centrifugation of the sample. The GFP-filactin actin domain was mostly 
found in the supernatant (figure 44 B, lane 3, 70 kDa), but also to a lesser extent in the 
pellet fraction (figure 44 B, lane 4, 70 kDa). It is remarkable that in the sample in which the 
filactin actin domain was added to the actin polymerization, the amount of soluble actin 
increased (figure 44 B, lane 1 and lane 3 at 42 kDa). These data indicate that filactin by 
sequestering actin monomers increased the concentration of actin in the supernatant, which 
is in accordance with the fluorometer data. Thus, the filactin actin domain is most probably a 
sequestering protein but might still be able to bind to filamentous actin. 
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Figure 44: The filactin actin domain acts as an actin sequestering protein but can be 
detected together with F-actin as well. A) 2 µM actin (10 % pyrenylated) was polymerized in the 
presence and the absence of 1.2 µM FLAG-GFP-filactin actin. B) The samples from (A) were 
ultracentrifuged, pellet and soluble fraction were separated and analyzed on a SDS-gel. Pellet 
fractions are concentrated 2-fold. In the actin control (lane 1 and 2), most of the actin is found in the 
pellet. In the sample with filactin actin most of the added protein is detected in the supernatant, and 
along with it also the concentration of soluble actin increased (lane 3). However, the FLAG-GFP-filactin 
actin domain can also be centrifuged together with F-actin (lane 4). 
 
 
4.1.4 Filactin might be associated with the ESCRT pathway 
4.1.4.1 Filactin interacts with ESCRT-related proteins vta1, vps4 and vps46  
To identify potential interaction partners of filactin, GFP-Traps (Chromotek) were performed 
with cell lines expressing the GFP-tagged full length filactin, the Ist1-like domain, filamin 
repeats and the actin domain. The GFP-fusion proteins bind to the beads coated with GFP 
antibody and can be pulled down together with their interaction partners. Figure 45 A shows 
a Coomassie Blue stained SDS-gel of a GFP-Trap with GFP-filactin and GFP-filactin filamin 
repeats. In mass spectrometry analyses, the protein vta1 (vacuolar protein sorting twenty-
associated 1) was reproducibly detected to interact with filactin, in particular with the filamin 
repeats. Hence, a GST-vta1 construct was created as well as a GFP-vta1 overexpressing D. 
discoideum cell line. GST-vta1 could pull down endogenous filactin from a AX2 cell lysate 
(figure 45 B) and GFP-vta1 could pull down endogenous and additional purified FLAG-filactin 
(figure 45 C). Thus, vta1 is associated with filactin in D. discoideum. 
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Figure 45: Filactin interacts with the 
ESCRT-related protein vta1. A) 
Coomassie Blue stained SDS-gel. Vta1 
(indicated by red arrow head) was 
reproducibly identified in GFP-Traps to be 
associated with filactin, in particular with 
its filamin repeats (lane 2). B) GST-vta1 
pulls down endogenous filactin. GST only 
and GST-vta1 were incubated with AX2 
lysate, centrifuged, washed and analyzed 
on a SDS-gel. The left side shows a 
Coomassie Blue stained gel, the right side 
shows a western blot incubated with the 
filactin antibody 3S-55-4. C) GFP-vta1 
pulls down purified FLAG-filactin. The left 
side shows a Coomassie Blue stained gel, 
the right side shows a western blot 
incubated with the filactin antibody 3S-55-
4. Purified FLAG-filactin (lane 1) was 
incubated with GFP beads and GFP-vta1  
beads obtained in a GFP-Trap. The beads 
were subsequently centrifuged, washed 
and boiled in SDS-sample buffer. The 
FLAG-filactin pulled down by GFP-vta1 is  
                                                                                 already visible on the Coomassie Blue         
                                                                                 stained gel (lane 3, red arrow head).  
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Since the identified filactin interacting protein vta1 interacts with the AAA ATPase 
vps4 (vacuolar protein sorting 4) in the context of the ESCRT machinery in yeast and 
humans, a GST-vps4 construct and a GFP-vps4 overexpressing D. discoideum cell line were 
generated. Furthermore, in yeast Ist1 interacts with Did2, namely vps46 (vacuolar protein 
sorting 46) in D. discoideum. Therefore, constructs were also generated for the Did2 
homolog vps46. The interaction of vta1 and vps4 described in yeast and humans could be 
confirmed to be also conserved in D. discoideum (figure 46 C). In addition, vps4 and vps46 
seem to interact with filactin as well (figures 46 A and B), but this interaction was not always 
reproducible and mostly rather weak. Probably vps4 interacts with filactin indirectly via vta1. 
 
 
 
Figure 46: Filactin might interact with the ESCRT-
related proteins vps4 and vps46, while vps4 is 
associated with vta1. The left side in each picture shows a 
SDS-gel stained with Coomassie Blue, the right side shows a 
western blot incubated with the filactin antibody 3S-55-4. A) 
Endogenous filactin can be pulled down with GST-vps46. GST 
only and GST-vps46 were incubated with AX2 lysate, 
centrifuged, washed and analyzed on a SDS-gel. Filactin full 
length could be detected weakly in the western blot (lane 4, 
red arrow head). B) Purified GFP-filactin can be pulled down 
with GFP-vps4. GFP-filactin was incubated with GFP beads and 
GFP-vps4 beads obtained in a GFP-trap. The beads were 
centrifuged, washed and analyzed on a SDS-gel. GFP-filactin 
and endogenous filactin could be detected in the western blot 
(lane 5, red arrow heads). C) GFP-vta1 can be pulled down 
with GST-vps4. GST-vps4 beads before and after incubation 
with AX2 GFP-vta1 lysate (lane 1 and 2, respectively). In the 
western blot incubated with GFP antibody, GFP-vta1 could be 
detected in the pulldown (lane 4, red arrow head). 
 
Results II: Actin variants in Dictyostelium amoebae 
 
72 
 
4.1.4.2 Localization of GFP-ESCRT related proteins in D. discoideum 
Since the interaction of the ESCRT-related proteins and filactin was determined on a 
biochemical basis, a putative co-localization in D. discoideum cells was analyzed via 
immunofluorescence. AX2 GFP-vta1, AX2 GFP-vps4 and AX2 GFP-vps46 cells were fixed and 
filactin was stained with either the N-terminal filactin antibody 3S-55-4 or the C-terminal 
filactin antibody 4S-59-4. GFP-vta1, GFP-vps4, GFP-vps46 and filactin co-localize 
occasionally, but not always (figures 47, 48, 49). Both filactin and the GFP-tagged ESCRT-
related proteins vta1, vps4 and vps46 localize in vesicle-like structures but do not overlap in 
every case. GFP-vps4 vesicle-like structures were co-localizing with filactin most frequently 
(figure 48). The localization of GFP-vta1, GFP-vps4 and GFP-vps46 in a filactin KO 
background did not clearly alter (data not shown); vesicle-like structures were still present. 
Additionally, GFP-vta1 was pelletable together with filactin in the Triton-insoluble 
cytoskeleton (data not shown).  
 
 
Figure 47: GFP-vta1 and filactin occasionally co-localize in D. discoideum. AX2 GFP-vta1 
cells were fixed and filactin was labeled with the respective antibodies. GFP-vta1 structures co-
localizing with filactin are indicated by white arrow heads. Scale bar, 5 µm. A) GFP-vta1 cells were 
incubated with the filactin antibody 3S-55-4. B) GFP-vta1 cells were incubated with the filactin 
antibody 4S-59-4, which shows a slight cross-reaction with conventional actin. 
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Figure 48: GFP-vps4 and filactin co-localize in D. discoideum. AX2 GFP-vps4 cells were fixed 
and filactin was labeled with the respective antibodies. GFP-vps4 structures co-localizing with filactin 
are indicated by white arrow heads. Scale bar, 5 µm. A) GFP-vps4 cells were incubated with the 
filactin antibody 3S-55-4. B) GFP-vps4 cells were incubated with the filactin antibody 4S-59-4. 
 
 
Figure 49: GFP-vps46 and filactin occasionally co-localize in D. discoideum. AX2 GFP-vps46 
cells were fixed and filactin was labeled with the respective antibodies. GFP-vps46 structures co-
localizing with filactin are indicated by white arrow heads. Scale bar, 5 µm. A) GFP-vps46 cells were 
incubated with the filactin antibody 3S-55-4. B) GFP-vps46 cells were incubated with the filactin 
antibody 4S-59-4. 
 
 
4.1.4.3 Generation of a vps4 knock out construct 
To properly analyze and possibly prove the involvement of filactin in the ESCRT pathway, a 
vps4 knock out strain was attempted. With a non-functional vps4 protein, the ESCRT-III 
complex cannot be recycled into the cytoplasm and accumulates on the multivesicular body. 
In yeast, a vps4 mutant accumulates vacuolar, endocytic and late-Golgi markers in an 
aberrant multilamellar pre-vacuolar compartment (Babst et al, 1997). Thus, hypothetically, 
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the distribution of filactin in a vps4 KO cell should alter significantly compared to the 
localization in a wild type cell if filactin is actually implicated in the ESCRT pathway. A 
construct was generated that should replace the endogenous vps4 gene in the genomic DNA 
of the D. discoideum wild type strain AX2 with a vps4 genomic sequence in which the 
ATPase domain is interrupted by a blasticidin resistance cassette. The construct was 
successfully generated and transformed in D. discoideum cells. Despite many attempts, no 
vps4 KO strain could be obtained. Verification of successful homologous recombination by 
PCR lead to the result that the surviving cells – if there were any – had the blasticidin 
resistance cassette inserted at a different region within the genome, but the vps4 sequence 
could not be inactivated. It seemed very unlikely that a KO of vps4 would be lethal for D. 
discoideum since vps4 KOs in yeast are viable (Babst et al, 1997) as well as dominant 
negative VPS4 mutants in human cells (Fujita et al, 2003; Kieffer et al, 2008; Xia et al, 
2012). However, attempts to knock out vps4 by homologous recombination or down-regulate 
vps4 by antisense inhibition in D. discoideum were unsuccessful in other research groups as 
well (personal communication, Laurence Aubry and Paul R. Fisher). Consequently, for now, 
vps4 function appears to be crucial for the viability of D. discoideum cells and therefore, 
filactin could unfortunately not be analyzed in a vps4 KO background in this study. 
 
 
4.1.4.4 Filactin might be involved in the autophagic pathway 
Autophagy is responsible for the clearance of damaged organelles and protein aggregates as 
well as bulk consumption of cytoplasmic proteins during starvation. Even though there is no 
clear evidence yet for the implication of the ESCRT pathway in autophagy processes, several 
studies show that an impaired ESCRT machinery leads to the accumulation of 
autophagosomes in the cell (Filimonenko et al, 2007; Lee et al, 2007; Nara et al, 2002; 
Rusten et al, 2007). Therefore, the number of autophagosomes was analyzed in the AX2 wild 
type strain in comparison with the filactin KO strain. The autophagosome marker construct 
mRFP-ATG8 (generously supplied by Ludwig Eichinger, Universität zu Köln) was transformed 
into selected strains and the phenotype of the transformants was analyzed. Interestingly, an 
accumulation of autophagosomes was observed in the filactin KO strain compared to wild 
type AX2 cells (figures 50 A and B). An analysis of the autophagosome number per cell is 
displayed in figure 50 C. Many cells, both in AX2 and in filactin KO background, do not 
possess a RFP-ATG8 positive autophagosome: 37 % of the AX2 cells and 29 % of the 
analyzed cells of the filactin KO strain did not contain any RFP-ATG8 positive 
autophagosomes. On average, AX2 RFP-ATG8 and filactin KO RFP-ATG8 cells comprised 1.2 
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and 2.1 autophagosomes per cell, respectively. In AX2 cells, most of the cells contain none 
or one autophagosome (a representative cell is shown in figure 50 A). In filactin KO cells, 
most of the autophagosomes are present in cells with four or more autophagosomes (a 
representative cell is shown in figure 50 B). 
A co-localization of the autophagosomes with the filactin vesicle-like structures could 
not be observed, neither in D. discoideum strains expressing both RFP-ATG8 and GFP-filactin 
full length, nor in immunofluorescence experiments with a polyclonal ATG8 antibody 
(generously supplied by Ludwig Eichinger, Universität zu Köln). 
 
 
Figure 50: Autophagosomes accumulate in filactin KO cells. A) Confocal image of a living AX2 
RFP-ATG8 cell which contains only one autophagosome. Autophagosomes in wild type cells usually 
have a diameter of 200 nm – 2 µm. Scale bar, 5 µm. B) Stack projection of confocal images of a living 
filactin KO RFP-ATG8 cell which contains many autophagosomes of different sizes. Scale bar, 5 µm. C) 
Analysis of the number of autophagosomes present in cells with 0-1, 2, 3, and not less than 4 
autophagosomes in percent. Cells were fixed and the fluorescence of RFP-ATG8 was enhanced with 
the RFP antibody K64-372-1. For evaluation, confocal stacks were superposed and the 
autophagosomes in the cells were counted. The number of cells counted (n) is displayed in the upper 
right corner. Most of the autophagosomes in filactin KO cells are present in cells with 4 and more 
autophagosomes. 
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4.1.5 Filactin might form a tetramer via its filamin-like Ig repeat domain 
The purified FLAG-filactin full length was run on a ÄKTA superose 6 gel filtration column to 
check the size of the protein. Filactin has a size of 105 kDa. Surprisingly, FLAG-filactin full 
length reproducibly elutes at a molecular weight of 400,000 (figure 51 A), suggesting a 
tetrameric structure. When applying a whole D. discoideum lysate (soluble lysate of 5 x 106 
frozen and thawed AX2 GFP-filactin cells) on the gel filtration column, endogenous and GFP-
filactin can be detected at a molecular weight between 400,000 and 40,000, indicating that 
in the cell, filactin is present as a tetramer, but also as monomer and even maybe as dimer 
or trimer. 
To define more precisely which part of the protein is responsible for the 
tetramerization, the elution profiles of the FLAG-actin domain, the GST-Ist1-like domain and 
the GST-filamin repeats were analyzed on a gel filtration column. The filactin actin domain 
and the Ist1-like domain elute at their monomeric size, at ca. 42,000 and 50,000, 
respectively. In contrast, the GST-filactin filamin repeats do not elute at the expected 52,000 
but at ca. 200,000 – 220,000, suggesting that this domain is responsible for the 
tetramerization of filactin (figure 51 B). 
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Figure 51: Filactin might form a tetramer via its filamin-like Ig repeats. Purified FLAG-filactin 
and GST-filactin filamin repeats were analyzed using ÄKTA superose 6 and superose 12 gel filtration 
columns. The upper panel shows the elution profiles (measured at 280 nm). 500 µl-fractions were 
collected and analyzed on a SDS-gel (middle panel). The lower panel shows the calibration curves of 
the columns and the measured molecular mass of the protein indicated with the red arrow. A) The 
peak of filactin full length appears at ca. 13.5 ml which corresponds to a partition coefficient of 
0.34375, meaning that it elutes at a molecular weight of about 400,000. B) The peak of the filamin 
repeats appears at ca. 10.7 ml which corresponds to a partition coefficient of 0.16139, meaning that it 
elutes at a molecular weight of ca. 200,000-220,000. 
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4.1.6 Purified filactin imaged using a transmission electron microscope 
To visualize the presumptive filactin tetramer, imaging of the protein with the transmission 
electron microscope was attempted. These experiments were carried out in the Baumeister 
laboratory (Max-Planck-Institut für Biochemie, Martinsried). In a negative stain, proteins and 
protein complexes from 100 kDa on should be visible. Filactin has a size of 105 kDa, and the 
tetramer would be 420 kDa. Smaller proteins only appear as a background noise. The FLAG-
tagged full length filactin and the FLAG-tagged filactin actin domain were purified from Sf9 
cells. Since the filactin full length protein always was contaminated by many degradation 
products after the purification, it was run on a ÄKTA superose 6 gel filtration column and 
only the fraction of a molecular weight of ca. 400,000 was kept. It was prepared for the 
negative stain just in G-Buffer containing 50 mM NaCl (figure 52 B), then under polymerizing 
conditions (figure 52 C) and together with actin under polymerizing conditions (figure 52 D). 
As a control, rabbit actin only was polymerized (figure 52 A). In the control, actin filaments 
were visible. In the sample with filactin, no distinct molecular structure could be detected. 
Proteins of different sizes were present, suggesting that there still occurred degradation after 
the purification over the gel filtration column. Also, no distinct tetrameric conformation of the 
protein could be assessed. When incubated in polymerization buffer, filactin seems to form 
aggregates (figure 52 C), more than under non-polymerizing conditions. These aggregates 
also remained to a lower extent when filactin was incubated with actin under polymerizing 
conditions, but no actin filaments were visible anymore (figure 52 D). 
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Figure 52: Purified FLAG-filactin imaged using a transmission electron microscope. Purified 
FLAG-filactin was fractioned on a ÄKTA superose 6 gel filtration column and the 400,000 fraction was 
imaged by negative stain with and without actin and under polymerizing conditions. Scale bar, 200 
nm. A) Polymerized purified rabbit actin under polymerizing conditions (control). Note the two actin 
filaments. In the image section magnification, three helices within the filament are visible, indicated 
by white brackets. Scale bar in the blow-up section, 40 nm. B) Purified FLAG-filactin. Proteins of 
different sizes were visible, but no evident tetramer could be detected. C) Purified FLAG-filactin under 
polymerizing conditions. Upon addition of polymerization buffer, filactin seems to form aggregates. D) 
Purified FLAG-filactin with rabbit actin under polymerizing conditions. The proteins seem to form 
aggregates, but no filaments could be found. 
 
 
Also the filactin actin domain only was imaged (figure 53). The filactin actin domain 
has a size of ca. 42 kDa and seems to be present as a monomer. As expected, when imaging 
the protein in a negative stain, only small proteins are visible that appear rather as a 
background noise. When incubating the protein under polymerizing conditions, it seemed to 
form aggregates (figure 53 B), just as it was observed for the full length protein as well 
(figure 52 C). When incubating the filactin actin domain together with rabbit actin, these 
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aggregates still were present, but apparently in a lower concentration than without actin, 
which is consistent with the observations for the full length filactin. Also, no actin filaments 
were present under that condition (figure 53 C). 
 
 
 
Figure 53: Purified FLAG-filactin actin 
domain imaged using a transmission 
electron microscope. Purified FLAG-filactin 
actin was imaged as a negative stain with and 
without actin and under polymerizing conditions. 
Scale bar, 200 nm. A) Purified filactin actin 
domain. Small proteins are visible B) Purified 
filactin actin domain under polymerizing 
conditions. Upon addition of polymerization 
buffer, the filactin actin domain seems to form 
aggregates. C) Purified filactin actin domain with 
rabbit actin under polymerizing conditions. The 
proteins seem to form aggregates, but no 
filaments could be detected. 
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4.2 Other actin variants in D. discoideum 
Besides filactin, preliminary studies of few other D. discoideum actin variants were 
conducted. Act24 and act25 were chosen since they are divergent from the conventional 
act8 group, but not as much as e.g. filactin. The D. discoideum cell lines expressing GFP-
act24 and GFP-act25 were provided by Annette Müller-Taubenberger. Since act24 and act25 
are 82 % and 78 % identical with conventional actin, respectively, it was tested whether the 
act-1 antibody recognizing D. discoideum conventional actin (Simpson et al, 1984) would 
also bind to these actin variants. Western blot analysis revealed that the GFP-tagged actin 
variants act24 and act25 cannot be detected by the act-1 antibody (figure 54 C) even though 
most of the residues described to be required for the formation of the act-1 antigenic site are 
present (figure 55).  
 
 
Figure 54: SDS-Page Analysis of GFP-tagged actin variants 24 and 25. Total cell lysate was 
applied on a SDS-gel in a concentration of 2 x 105 cells/lane. A) Coomassie Blue stained SDS-gel. B) 
Western blot incubated with the GFP antibody K3-184-2. GFP-act24 and GFP-act24 were detected at 
approximately 70 kDa. Note the two bands just below each other for both GFP-act24 and GFP-act25. 
C) Western blot incubated with the actin antibody act-1. Endogenous actin in the mutant strains is 
present as in the wild type strain AX2. The act-1 antibody did not recognize GFP-act24 and GFP-act25. 
 
Simpson et al (1984) appoint amino acid 13 – 50 of D. discoideum actin8 to be 
important for act-1 binding, especially Thr42 seems to be critical. The actin variants show 
high homology to the act8 protein in this region (figure 55), but are still not recognized by 
the antibody. 
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Figure 55: The binding epitope of the act-1 actin antibody is conserved in the analyzed 
actin variants but apparently not enough to allow act-1 binding. Alignments of aa 1-60 for 
act8, act24 and act25 are displayed as well as aa 574-634 for filactin. Simpson et al (1984) 
described amino acids 13-50 of D. discoideum conventional actin (act8-group) to be required for 
act-1 binding (red box), especially the threonine at position 42 (red arrow) should be critical for 
the formation of the act-1 antigenic site. Particularly act24 is highly conserved in this region and 
differs only in two amino acids from the act8 sequence. However, the act-1 antibody can neither 
detect GFP-act24 nor GFP-act25 and filactin.  
 
Another actin antibody, namely 224-236-1 (Westphal et al, 1997), was also unable to 
bind to GFP-act24 and GFP-act25 (figure 56 C). Furthermore, the filactin antibody which 
recognizes the actin domain of filactin (4S-59-4), does not bind to the actin variants act24 
and act25 (data not shown). 
 
 
Figure 56: The actin antibodies act-1 and 224-236-1 do not recognize GFP-act24 and 
GFP-act25. Total cell lysate was applied on a SDS-gel in a concentration of 2 x 105 cells/lane. After 
protein transfer onto the nitrocellulose membrane, the bands of the size 42 kDa (conventional actin) 
were removed, so that the excess of conventional actin would not exhaust the actin antibody in 
solution during incubation of the membrane. A) Coomassie Blue stained SDS-gel. B) Western blot 
incubated with the actin antibody act-1. C) Western blot incubated with the anti-actin antibody 224-
236-1. 
 
Live-Imaging and immunofluorescence imaging showed that GFP-act24 and GFP-
act25 localize to the cytoplasm and seem not to co-localize with the conventional F-actin at 
the cell cortex in vegetative D. discoideum cells (data not shown). The cell lines expressing 
the GFP-tagged variants did not exhibit an altered phenotype.  
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5. Discussion 
The major goal of this work was to analyze the functions in actin dynamics of WH2 domains 
and selected actin variants. Analysis of the studied proteins revealed that they influence the 
microfilament system. The multifunctional WH2 domains in tandem can both enhance actin 
filament formation and disrupt F-actin in a concentration dependent manner. Filactin, an 
actin variant in D. discoideum seems to be an actin sequestering protein and to be 
associated with the ESCRT pathway. The first part of the discussion will elaborate the 
functions of WH2 domains in proteins and the second part will outline the possible functions 
of filactin and other actin variants. 
 
5.1 WH2 domains are versatile regulators of actin dynamics 
WH2 domains in proteins can nucleate actin polymerization, sequester actin molecules, 
disrupt and depolymerize actin filaments in vitro. These partially new findings show the 
intrinsic multifunctionality and versatility of that domain. In this study, WH2 domains of fly 
Spire and mouse CAP2 were analyzed and the WH2 domain(s) of both of these proteins 
showed similar characteristics. Thus, the work on these two proteins can be seen as an 
exemplary study for other proteins containing WH2 domains. The WH2 domain in tandem is 
also present in other eukaryotic proteins, such as N-WASP (two WH2 domains) and Cordon-
Bleu (three WH2 domains) (Ahuja et al, 2007) but also in prokaryotic virulence factors like 
VopF and VopL (three WH2 domains) (Liverman et al, 2007; Tam et al, 2007). 
 
5.1.1 Nucleation of actin polymerization and G-actin sequestering by WH2 
domains 
Spire nucleates actin filament formation only at substoichiometric concentrations and 
sequesters G-actin at stoichiometric concentrations; therefore, nucleation and sequestration 
by WH2 domains go hand in hand and both characteristics must be taken into account for 
the functions of these proteins in vitro and in vivo. First of all, for nucleation of actin 
polymerization by WH2 domains at least two WH2 domains in tandem are required. Single 
WH2 domains as present in the constructs SpireL3+D, SpireD and CAP2-WH2 show the 
sequestering activity only. The linker 3 situated between Spire WH2 domains C and D was 
previously described as an actin binding element with weak actin nucleating activity (Zuchero 
et al, 2009). Thus, the construct SpireL3+D should possibly be able to nucleate actin 
filament formation. However, in this study, the construct SpireL3+D did not exhibit any 
nucleating activity. Additionally, the Isothermal Titration Calorimetry (ITC) measurements 
Discussion 
 
84 
 
performed by Sitar et al (2011) did not identify any interaction between linker 3 and actin 
molecules. Two, three and four WH2 domains in series effect nucleation of actin filament 
formation as shown in this thesis. These data appear logical since at least two G-actin 
molecules need to be positioned in close proximity to act as a nucleus to which a third actin 
molecule can be added easily to start polymerization. It could not be concluded from our 
assays that a construct with three or four WH2 domains nucleates more efficiently than a 
construct with two WH2 domains. Theoretically, three actin molecules should act as better 
nucleus than two actin molecules. However, the actin bound to the WH2 domains does not 
adopt the F-actin conformation. WH2 domains are G-actin binding motifs. The small-angle X-
ray scattering and crystallography studies performed by Sitar et al (2011) show that Spire-
actin complexes form stable, straight-longitudinal configurations in which actin is loosely 
positioned along the WH2 domain stretch. The longitudinal architecture of the Spire–actin 
interaction is dominant in solution under non-polymerizing conditions (Sitar et al, 2011). The 
in vitro experiments presented by Sitar et al (2011) as well as other previous studies (Bosch 
et al, 2007; Ducka et al, 2010) suggest that under non-polymerizing conditions, Spire binds 
actin to form the sequestering/nucleating complex which remains inactive in a G-actin 
solution. Upon addition of polymerization buffer, the WH2 domains in tandem permit the 
formation of longitudinal interacting bonds, resulting in a rearrangement of the actin 
conformation to the filamentous form of one strand of the filament (Ducka et al, 2010). 
Further actin molecules are added and a two-start actin filament is generated. The WH2 
domains, being G-actin binding motifs, will reduce the affinity to the emerging filament and 
finally release it into the solution where it acts as a nucleus for further actin polymerization. 
It is tempting to assume that the tandemly organized WH2 domains release, due to a 
decreased binding affinity, the emerging filament as soon as the ATP moieties in the 
nucleotide binding cleft of the individual F-actin subunit are hydrolyzed. The WH2 domains 
will subsequently bind de novo to G-actin molecules to repeat the process, leading to 
enhanced nucleation of actin polymerization (compare nucleation model shown in figure 57). 
The polymerization assays conducted with prepurified Spire-actin complexes clearly show 
that these are the intermediates that lead to enhanced nucleation. WH2 domains not in 
complex with actin would exhibit the sequestering activity at these concentrations.  
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Intriguingly, the samples in which actin polymerization was triggered by WH2 
domains always show a decrease of fluorescence at steady state compared to the control. 
The G-actin solutions used for the in vitro polymerization assays usually contain about 10 % 
pyrenylated actin. At steady state, almost all available G-actin is polymerized, suggesting 
that in the other samples, some of the available monomeric actin is prevented from 
integration into the actin filaments. This supports the idea that the WH2 domains in tandem 
are dynamic nuclei that release from emerging filaments and bind available G-actin in 
solution. The WH2 domains have such a high affinity to actin molecules that an ‘empty’ WH2 
stretch will immediately fill its binding sites with available G-actin and thus the WH2 domains 
almost only occur in complex with actin in such an assay. Once the pool of available free G-
actin is exhausted in polymerization, the WH2-actin complexes will not nucleate filaments 
anymore but will remain bound to G-actin conformation molecules. Thus the presence of 
pyrenylated G-actin in solution available for polymerization is decreased which finally leads to 
the formation of less F-actin than in the control. 
 It is consistent with these assumptions that at stoichiometric concentrations of WH2 
domains over actin, actin polymerization cannot be nucleated since the G-actin molecules are 
sequestered in the WH2-actin complex (compare model for sequestration shown in figure 
58).  
 
 
 
 
 
 
Figure 57: Working model of nucleation of actin polymerization by WH2 domains in 
tandem (at substoichiometric concentrations of WH2 domain constructs). WH2 domains in 
tandem bind to G-actin molecules forming a longitudinal sequestering/nucleating complex which 
remains inactive under non-polymerizing conditions. Under polymerizing conditions, the WH2-actin 
complex rearranges its longitudinal conformation to the filamentous form and actin filaments can be 
formed. The WH2 domains reduce the affinity to F-actin and release the short filament thus favoring 
elongation. The now ‘empty’ WH2 domains immediately bind to free available G-actin in solution. 
When all available G-actin molecules are consumed, the WH2 domains stay in complex with the 
remaining G-actin thus also decreasing the fluorescence at steady state. 
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The hypothesis that WH2 domains in tandem are dynamic actin nuclei that release 
from the filaments and are not ‘dead-end’ WH2-actin complexes as it was suggested earlier 
(Bosch et al, 2007) is supported by the experiment of actin polymerization nucleation by 
prepurified WH2-actin complexes. In these assays, the prepurified Spire-actin complexes 
were generated by the use of unlabeled actin. After effected nucleation of actin 
polymerization by these complexes, a decrease of fluorescence at steady state is observed as 
well, suggesting that the unlabeled actin was released and replaced by pyrenylated actin 
from the solution. In case the WH2 domains would remain on the actin filaments, no 
decrease of fluorescence at steady state should be observed. 
In conclusion, the nucleating activity by WH2 domains in tandem and the decrease of 
fluorescence at steady state are closely associated. The finding of this molecular mechanism 
of this intrinsic versatile function of WH2 domains in tandem might alter the view on WH2 
domain containing proteins in general. The in vitro analysis of the function of WH2 domains 
is important and necessary, but might be insufficient to elucidate its function in living cells. 
In vivo, nucleation and sequestration by WH2 domains seem to be much more complex than 
observed in this study. It was shown previously that nucleation of actin polymerization by 
Spire depends also on cooperation with formins and profilins (Pfender et al, 2011; Quinlan et 
al, 2007). The nucleation of filament formation thus is regulated by other nucleating, 
sequestration factors and maybe unknown proteins. Sitar et al (2011) propose a model in 
which one formin dimer binds two molecules of Spire, and each Spire protein binds to four 
actin molecules thereby bringing together eight actin molecules in vivo. This short filament 
seed can then act as a nucleating complex from which Spire dissociates to allow formin-
promoted actin filament elongation at the barbed end. Nevertheless, the final concentration 
of WH2 domain constructs in subcellular regions is not known and it is not completely clear 
 
Figure 58: Working model of sequestration of actin by WH2 domains (at high 
concentrations of WH2 domain constructs). Substantial concentrations of WH2 domains 
sequester substantial concentrations of available G-actin. This reduces the amount of polymerizable 
G-actin and leads to a large delay of polymerization.  
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under which trigger a protein containing at least two WH2 domains in tandem would 
nucleate actin filament formation or would sequester actin molecules. Hence, the set of 
players required for in vivo function of WH2 domain containing proteins needs to be 
identified to understand the complexity and dynamics of these proteins. 
 
5.1.2 Disruption of actin filaments by WH2 domains 
In contrast to nucleation, the sequestering activity as well as the filament disrupting activity 
are attributes of all constructs, including a single WH2 domain, e.g. the SpireD construct with 
a sequence of only 22 amino acids. This indicates that the disintegration of actin filaments is 
not dependent on a concerted action of two actin binding domains as it is characteristical for 
the F-actin severing proteins from the gelsolin protein family (Eichinger et al, 1991; 
Schnuchel et al, 1995). It is intriguing that the WH2 domains being G-actin binding motifs 
have nonetheless such a high affinity to actin that they are able to bind the filamentous form 
and forcefully rip off subunits from the filament, thereby destroying the whole structure 
(compare model filament disruption shown in figure 59). Subsequently, the WH2 domains 
remain soluble with their bound actin in monomeric globular conformation. Thus, the binding 
affinity of single WH2 domains to actin seems to win over the process of actin filament 
formation. 
 
Figure 59: Working model for the 
disruption of actin filaments by WH2 
domains. When adding WH2 domain 
constructs to fully polymerized actin filaments, 
either single WH2 domains or perhaps only a 
single domain arranged in a tandem, they seem 
to have such a high affinity to actin that they 
are able to bind to the filamentous form and 
forcefully sequester actin monomers from the 
filament, thereby destroying the whole 
structure and chopping up the filament. The 
actin bound to the WH2 domains most 
probably rearranges its conformation to the G-
actin form. 
 
 
The high potential of F-actin disrupting activity by 1-4 WH2 domains was shown in 
fluorometric assays. It is surprising how quickly the actin filaments are disrupted, resulting in 
drops of fluorescence to stable plateaus within seconds. In contrast to recent findings by 
Chen et al (2012), it could not be confirmed that SpireABCD severs more efficiently than a 
construct containing only two or three WH2 domains. In the assays performed in this work, 
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the artificial construct SpireDDD seems to chop up actin filaments most efficiently compared 
to the other constructs. This might be due to the high binding affinity of this domain to actin 
with a Kd of 0.17 µM (Sitar et al, 2011). Three domains with a strong actin binding affinity 
might chop up filaments more efficiently than the SpireABCD construct in which cooperative 
binding might play a role. Nonetheless, the single WH2 domain SpireL3D needs to be applied 
in much higher concentrations (about 20-fold) to reach the same effect than SpireDDD 
containing three WH2 domains. WH2 domains in tandem are possibly more efficient in 
disrupting the actin filaments because they have an entropic advantage over single domains. 
The force that needs to be raised to disrupt the F-actin conformation might be more 
efficiently established when the binding surface is bigger. The disruption of actin filaments 
and actin-fascin filament bundles was visualized by TIRF microscopy for the Spire constructs 
and on a confocal microscope for CAP2-WH2. Both constructs disrupt filaments and filament 
bundles until they completely disappear. Thus the affinity of WH2 domains to actin is even 
so high that they can disrupt cross-linked filament bundles.  
WH2 domains saturated with actin do not exhibit the same F-actin disrupting activity 
as ‘empty’ WH2 domains. In fluorometric experiments, the Spire-actin complexes could not 
disrupt actin filaments like free WH2 domains and thus the fluorescence did not drop 
immediately upon addition of these constructs. However, when the fluorescence of the F-
actin solution to which the Spire-actin complexes were added was measured again after 
some incubation time, a drop of fluorescence could be recorded. Hence, the unlabeled actin 
was released by the complex over time and was replaced by pyrenylated actin. These data 
confirm the previous finding of this study that Spire-actin complexes are dynamic nuclei for 
actin polymerization and do not sequester their bound actin in a ‘dead-end’-manner.  
 The single WH2 domain of CAP2 was shown to sequester G-actin and disrupt actin 
filaments in this study (Peche et al, 2013). This is in agreement with earlier findings that CAP 
from lower eukaryotes and the other mammalian CAP - CAP1 - exert an inhibitory effect on 
actin polymerization (Bertling et al, 2004; Gottwald et al, 1996). CAP2 is a protein that plays 
a role in cardiac muscle where it localizes to the M-band and to adjacent regions of the 
sarcomere. Ablation of CAP2 leads to ventricular dilated cardiomyopathy in mice providing 
strong evidence how important this protein is for M-band and sarcomere organization. 
Myofibrillar organization is essential for the physiological activity of the cardiac system. To 
date, the turnover process of entire actin filaments in myofibrils is not entirely understood 
and was described to be slow (Littlefield & Fowler, 2008). In non-contractile cardiomyocytes 
actin filaments are very stable, whereas contractility induces rapid depolymerization of actin 
filaments which are not contributing to contractility (Skwarek-Maruszewska et al, 2009). 
These filaments might be replaced by new ones subsequently (Littlefield & Fowler, 2008; 
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Skwarek-Maruszewska et al, 2009). CAP2 was shown to regulate filament formation 
previously (Peche et al, 2007) and most probably, the lack of CAP2 leads to the disarray of 
the sarcomere due to the loss of its WH2 domain dependent G-actin sequestering and 
filament disrupting activity. CAP2 might be responsible for maintaining the length of 
sarcomeric actin filaments by severing them in the M-band region. 
 
5.1.3 D. discoideum amoebae respond to treatment with SpireWH2 
constructs 
A most surprising finding of this work is the behavior of living D. discoideum amoebae to 
treatment with SpireDDD protein. The addition of SpireWH2 domains seems to exert a 
certain stress to the cells since the cells round up and show a disintegration of the actin 
cytoskeleton, a similar reaction compared to the treatment with Latrunculin A. At higher 
concentrations, the cells even form cytoplasmic rods which usually takes place when the cells 
are exposed to ATP-depletion, e.g. during the treatment with NaN3. Interestingly, the 
response of the cells occurs exclusively when they encounter the ‘empty’ WH2 domain 
constructs. SpireDDD saturated with actin does not affect the amoebae. Possibly, the 
SpireWH2 constructs might pass the membrane of D. discoideum cells and disrupt the 
filamentous actin network. If this is a true finding, it would contradict the old dogma that 
proteins are not able to simply pass the membrane of cells. Even more intriguing would be 
the identification of a membrane receptor that would bind the WH2 domains on the surface 
of the D. discoideum membrane and trigger an intracellular response. When analyzing 
whether TMR-labeled SpireBCD would be able to enter AX2 GFP-cofilin overexpressing cells 
in preliminary experiments on a confocal microscope, no TMR-fluorescence could be 
detected within the treated cells (data not shown). However, the TMR-SpireBCD contains 
only 15 % labeled SpireBCD constructs. Thus, an investigation of the presence of WH2 
domain constructs within the cells requires the generation of antibodies against these 
proteins. 
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5.2 Filactin and other actin variants 
The D. discoideum conventional actin (act8-group) represents a nearly perfect cytoplasmic 
actin which is highly conserved throughout evolution (Joseph et al, 2008). The presence of 
the large number of actin variants in D. discoideum is very intriguing and raises the question 
whether these variants share similar activities. One could conclude that some of them have 
structural cytoskeletal functions, some rather have regulatory functions, some are important 
in a subcellular compartment or at a specific time during development in the life cycle of D. 
discoideum. Posttranslational modifications of these proteins might also play a role. 
Interestingly, there seem to be at least two different forms of both the GFP-act24 and GFP-
act25 fusion protein in transformed D. discoideum cells. Possibly, more than one ‘species’ of 
a distinct actin variant (e.g. phosphorylated and unphosphorylated) are present in the cell. 
The investigation of actin variants on the cellular level is rather difficult because of the high 
similarity of the protein sequences and therefore, generating specific antibodies or KO cell 
lines seems to be quite a challenge. However, in this study it was discovered that two actin 
antibodies recognizing conventional act8-group D. discoideum actin (Simpson et al, 1984; 
Westphal et al, 1997) do not bind to at least the three tested actin variants act24, act25 and 
filactin. Consequently, the described binding epitope is probably too divergent in the actin 
variants or possibly, the different amino acids in the actin variants cause a conformational 
and probably antigenic change at a topologically different site within the protein. It will be 
interesting to analyze the many D. discoideum actin variants and their functions in more 
detail in biochemical and cell biological assays, e.g. conducting in vitro (polymerization) 
assays, generating antibodies and analyzing KO cell lines. 
Filactin is the most extraordinary actin variant of D. discoideum with a conserved C-
terminal actin domain and an extended N-terminus with a distinct domain organization. Since 
the actin domain of the protein has a higher homology to bona fide actins than to actin-
related proteins (ARPs), it is classified as an actin variant.  
At the beginning of this thesis, the major question was whether filactin co-
polymerizes with conventional actin and whether it is able to self-polymerize as well, since 
the filactin actin is so similar to conventional actin. Now, with the data obtained during this 
work, the model changed into a different direction. Filactin, or rather the filactin actin 
domain seems to act as a G-actin sequestering protein, and is not integrated into filaments 
(figure 60 D). Furthermore, filactin probably might cap F-actin (figure 60 E). The N-terminal 
extension of filactin could serve as a regulator of filactins’ function within the microfilament 
system and inhibit or activate its interaction with the actin cytoskeleton (figure 60 B). In 
addition, filactin seems to be present especially as a tetramer (figure 60 C) and as a 
monomer, and maybe as a trimer and dimer as well. In a cell, filactin co-localizes with F-
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actin but is also present in the cytoplasm on vesicle-like structures. Through its N-terminal 
domains, filactin is associated with the ESCRT pathway (figures 60 F and G).  
 
 
Figure 60: Working model of filactin conformation and function within the microfilament 
system in the cell. All the models are simple, hypothetic and undetailed depictions of possible 
conformations and functions of filactin. A) Depiction of G-actin and filactin as used in the following 
models. In filactin, the N-terminal Ist1-like domain is displayed as yellow oval, the filamin-like Ig-
repeats as two small green ovals and the actin-like domain as a red circle. B) There might be an 
autoinhibited filactin conformation in which the access to the actin domain might be inhibited by a 
certain fold of the N-terminal domains. C) Filactin might be a tetramer. The tetramerization domain is 
located at the filamin-like Ig repeats. D) Filactin seems to act as a G-actin sequestering protein. E) 
Filactin possibly might act as a capping protein. However, it is unlikely that it caps the fast growing 
end. F) and G) Filactin is associated with the ESCRT pathway by interacting with vta1. It might 
sequester actin at sites of membrane scissons (F) or it might connect the ESCRT machinery to the 
microfilament system by capping F-actin (G).  
 
5.2.1 The function of the filactin actin domain 
In this work, the localization of filactin was analyzed with regard to the actin cytoskeleton, as 
well as its function in actin dynamics. The actin domain of filactin shares 64 % identity with 
D. discoideum conventional actin and 67 % identity with human β-actin. Studies prior to this 
thesis found filactin to co-localize with conventional actin in D. discoideum (Israel, 2002). 
Indeed, the co-localization of the 105 kDa protein with actin in the cell could be confirmed in 
immunofluorescence studies. Moreover, the fact that the generated antibody specific for the 
filactin actin domain (4S-59-4) cross-reacts with conventional actin in western blot analysis 
as well as in immunofluorescence studies confirms the high similarity of filactin to 
conventional actin. 
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Additionally, this study specified the actin domain of filactin to be responsible for the 
observed co-localization with conventional actin. The GFP-fusion constructs of the N-terminal 
domains do not co-localize with conventional actin but are enriched in the nucleus, even 
without showing the vesicle-like distribution of the full length construct. Most probably, a 
cooperation of the different filactin domains is necessary for localization and function of the 
full length protein. Interestingly, filactin is part of the stress-induced, nuclear actin rods. This 
is another clear indication that filactin is part of the actin cytoskeleton. Until now, only 
cytoskeletal proteins were identified in the rods besides actin, such as cofilin, Aip1 and 
coronin (Minamide et al, 2010; Nishida et al, 1987; Vandebrouck et al, 2010). All of these 
proteins seem to be able to pass the nuclear membrane. Small molecules and proteins of a 
size up to about 50 kDa can pass freely through the nuclear envelope across aqueous 
channels of a diameter of about 9 nm. The nuclear pores usually have a maximum diameter 
of about 25 nm and proteins bigger than 50 kDa need to be imported or exported in a 
regulated fashion. The proteins known to be implicated in the nuclear actin rods are not 
bigger than 65 kDa. In contrast, monomeric filactin has a molecular weight of 105 kDa. It is 
very intriguing that this protein can pass the nuclear membrane upon stress treatment very 
quickly (within 5-10 minutes) to finally be found within the rods. When treating GFP-filactin 
overexpressing cells with DMSO, the GFP-tagged filactin - now a protein of 130 kDa - seems 
to be unable to cross the nuclear envelope. The protein is found in the cytoplasm only, but 
the rods are still formed. Consequently, the GFP-tagged filactin might be too big to get into 
the nucleus. All smaller GFP-tagged filactin domain constructs used in this study were found 
enriched in the nucleus upon treatment with DMSO, but were clearly not part of the rods. 
Thus, the GFP-tag might hinder integration of the fusion protein into the rods. How filactin 
passes the nuclear membrane, how it influences the rod formation, how it is integrated into 
the actin rods and how important it is for the spatial and temporal formation, stability and 
biophysics of the rod remain to be elucidated. 
For the first time, recombinant filactin was successfully expressed and purified in this 
study using the baculovirus expression system. This allowed investigation of filactin’s 
function in actin dynamics in in vitro assays. The actin domain of filactin shows the 
characteristics of an actin sequestering protein in fluorometric, viscometric and spindown 
assays. However, the actin domain of filactin could also act as a minus end capping protein. 
It seems unlikely that the actin domain acts as a plus end capping protein, because in the 
dilution-induced depolymerization assay it would have slowed down the depolymerization 
instead of accelerating it. Possibly emerging filaments are capped at the minus end and 
thereby both the fluorescence signal in fluorometric assays and the viscosity of the actin 
solution in viscometric assays were reduced. It needs to be assessed exactly whether the 
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actin domain really acts as a capping protein e.g. by capping emerging filaments by known 
capping proteins at the minus end of the filament and subsequently investigating the 
influence of added filactin actin. Furthermore, a recombinant FLAG-GFP-filactin actin 
construct was generated in this study. The interaction of fluorescently labeled actin and 
filactin actin could be investigated at a TIRF microscope. 
Surprisingly, the full length filactin protein does not exhibit the same characteristics 
as the filactin actin domain. Although the actin domain is present in this construct as well, it 
does not act as an actin sequestering protein in the conducted in vitro assays. There are 
several possible explanations for this phenomenon. First, the protein might not be functional 
after the purification since it is very sensitive to proteolytic cleavage. Second, probably the 
full length protein is self-inhibited but needs to be activated by certain conditions or factors. 
Possibly the N-terminal domains inhibit the function of the actin domain by a hairpin 
conformation in which the N-terminus is folded over the active sites of the actin domain. 
Third, the interactions of filactin with the actin cytoskeleton in D. discoideum are so specific 
that the use of rabbit muscle actin for the in vitro actin polymerization assays was 
unfavorable and the assays need to be repeated with purified D. discoideum actin. To further 
analyze the localization of full length filactin in respect to actin filaments in vitro, the 
recombinant FLAG-GFP-filactin construct generated in this work could be used in TIRF 
assays. 
 
5.2.2 The function of the filactin amino-terminal domains 
In this thesis, the very N-terminal domain of filactin was identified as Ist1-like domain via 
sequence analysis. The filactin Ist1-like domain is only homologous to amino acid 1-196 of 
human IST1 (366 amino acids) and supposedly has a similar fold. In human and yeast, Ist1 
was described to be implicated in the ESCRT pathway, especially in the regulation of 
membrane scission and ESCRT-III disassembly (Dimaano et al, 2008; Entian et al, 1999). In 
both organisms, the Ist1 protein interacts with other proteins of the ESCRT machinery, 
namely CHMP1/Did2, VPS4/vps4 and LIP5/vta1 via its different domains (figure 61; Bajorek 
et al, 2009a; Dimaano et al, 2008; Rue et al, 2008).  
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Figure 61: The proteins filactin and Hs IST1 / Sc Ist1 and their interaction partners. The 
Ist1-like domain of filactin is homologous to the N-terminal domain of human or yeast Ist1 (blue 
dashed line). H. sapiens IST1 and S. cerevisiae Ist1 have the same domain organization. The 
interacting proteins for human IST1 (Hs IST1) are displayed in capital letters below the both way 
arrows, the corresponding homologs and interacting proteins of yeast Ist1 (Sc Ist1) follow in brackets. 
Filactin possibly interacts with vps46, the D. discoideum homolog of CHMP1/Did2, via its Ist1-like 
domain. Filactin was clearly identified to interact with vta1 via its filamin repeats. These filamin repeats 
lack the MIM motifs present in ESCRT-III proteins responsible for interaction with VPS4/Vps4 and 
LIP5/Vta1 in human or yeast. A co-localization of vps4 and filactin was observed in this study, but the 
interaction domain of vps4 to filactin remains to be identified. Furthermore, filactin interacts with actin 
via its C-terminal actin domain. 
 
Interestingly, even though in filactin only the N-terminal domain is present that 
theoretically could interact with vps46, filactin was identified to interact with vta1 in different 
biochemical assays. More precisely, vta1 binds to the filamin-like Ig repeats of filactin which 
do not show any homology to the MIM motif (MIM, MIT-interacting motif; MIT, microtubule-
interacting and transport) responsible for Ist1-vta1 interaction in human and yeast. Also a 
co-localization of filactin and vps4 could be observed, and possibly, filactin interacts with 
vps46 via its Ist1-like domain. 
 Taken together, according to what is known about the ESCRT-III machinery in yeast 
and human (Azmi et al, 2006; Azmi et al, 2008; Nickerson et al, 2006; Dimaano et al, 2008; 
Rue et al, 2008; Yu et al, 2008), the ESCRT-III disassembly model depicted in figure 61 can 
be proposed in which filactin influences vps4 recruitment and assembly. This helps to trigger 
the last step of the ESCRT machinery in which the ESCRT-III complex after successful 
membrane scission is recycled back into the cytoplasm. In this model, the relation of filactin 
to the microfilament system is neglected for simplicity reasons. Filactin probably interacts via 
its Ist1-like domain with vps46 in the cytoplasm. The filactin-vps46 complex might recruit 
dimeric vps4 to the ESCRT-III complex. This recruitment is not crucial for vps4 function but 
might influence the kinetics and proper timing of vps4 recruitment to ESCRT-III, while 
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simultaneously inhibiting premature vps4 oligomerization into the active form until the 
membrane scission effected by the ESCRT-III complex is terminated. Then probably vps46 
dissociates and vta1 binds to filactin and vps4. Possibly, vps46 also stays associated to 
filactin and the vps4-vta1 complex, since it has the potential to bind to vta1 and vps4 as 
well. Vta1, an assembly catalyzer of vps4, triggers the oligomerization of vps4 into the 
functional, dodecameric AAA ATPase. In an ATP-dependent step, vps4 disassembles the 
ESCRT-III complex to recycle it back into the cytoplasm. In this model, filactin triggers the 
vta1-vps4 interaction and therefore regulates vps4 function in D. discoideum. To further 
assess a co-localization of filactin and vta1, vps46 and vps4 in vivo, strains expressing GFP-
filactin and RFP-vta1/RFP-vps46/RFP-vps4 should be generated.  
 
 
Figure 62: Working model of the implication of filactin in the ESCRT-III complex 
disassembly. Displayed is the hypothetical process of ESCRT-III complex disassembly from the 
membrane of a multivesicular body. A legend for the different components is depicted below the 
model. The ESCRT-III complex effects the scission of the membrane neck at the end of the ESCRT-
pathway. Afterwards, it remains bound to the membrane. Filactin possibly binds with its Ist1-like 
domain to vps46 and recruits dimeric vps4 to the ESCRT-III complex. Once membrane scission is 
completed, vps46 is possibly released and vta1 recruited to the vps4 dimer. Vta1 catalyzes the 
assembly of the dodecameric AAA-ATPase vps4 into its active form. In an ATP-dependent step the 
vps4-vta1 complex disassembles the ESCRT-III complex, thereby recycling it back into the cytoplasm 
for another round of the ESCRT pathway. 
 
To explore further the possible part of filactin in the ESCRT pathway, autophagy in in 
D. discoideum wild type AX2 and filactin KO cells was investigated. D. discoideum prove to 
be a suitable model to investigate autophagy processes in eukaryotic cells (Calvo-Garrido et 
al, 2010). Defects in the autophagic pathway are associated with a range of 
neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s disease. 
Previous studies report that a defective ESCRT machinery leads to the accumulation of 
autophagosomes in the cell (Filimonenko et al, 2007; Lee et al, 2007; Nara et al, 2002; 
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Rusten et al, 2007). In this study, an accumulation of autophagosomes was indeed observed 
in the filactin KO strain compared to wildtype AX2 cells in preliminary experiments, indicating 
that filactin might interfere with the ESCRT machinery. Until now, there is no clear evidence 
of the implication of the ESCRT pathway in autophagy processes, but there are indications 
that have been discussed recently (Metcalf & Isaacs, 2010; Rusten & Stenmark, 2009). 
There are a series of hypothesis how impairing the ESCRT machinery results in the 
accumulation of autophagosomes. One explanation is that the ESCRT machinery is required 
for the closure of the phagophore neck. An autophagosome is topologically equivalent to a 
multivesicular body, except that it only contains a single, large intraluminal vesicle filling up 
the whole organelle. The closure of the phagophore neck is practically equivalent to the 
scission of intraluminal vesicles into the multivesicular body. Thus, it can be speculated that 
disruption of the ESCRT machinery leads to incomplete phagophore closure and results in 
multiple unsealed abnormal autophagosomes. However, according to Rusten and Stenmark 
(2009) the most plausible discussed model is the following: The accumulation of 
autophagosomes in the cell might be due to inhibition of fusion events of autophagosomes 
with endosomes and lysosomes. The fusion of the autophagosome with endosomes and 
lysosomes is a key event in the autophagic flux. The fusion of the autophagosome with a 
multivesicular body results in a so called amphisome, which then fuses with the lysososome 
in which the cargo is finally degraded. Possibly, the fusion of multivesicular bodies and the 
autophagosome is impaired in filactin KO cells, meaning that filactin’s function might be 
associated with the fusion of these organelles. 
How filactin connects the microfilament system with the ESCRT machinery is 
unknown. If filactin acts as a capping protein, it might connect F-actin to sites of membrane 
scission and may serve as a track for transport and ‘outlet belt’ of the ESCRT-III subunits 
back into the cytoplasm. If filactin is rather a G-actin sequestering protein, it probably might 
clear membrane scission sites from F-actin, as it is observed for ESCRT-mediated abscission 
in cytokinesis (Dambournet et al, 2011; Guizetti et al, 2011). There, actin is required for 
preparatory steps, but not the scission itself. A presence of F-actin at the intercellular bridge 
can perturb and delay cytokinesis abscission like it is the case in Lowe syndrome patients 
(Dambournet et al, 2011). The exact function of filactin in the ESCRT pathway needs to be 
investigated in more detail, as well as the connection between the microfilament system and 
the ESCRT pathway. Nonetheless, with the protein filactin, for the first time there is a hint 
that a connection exists between the actin cytoskeleton and the ESCRT pathway. Thus, actin 
variants might have highly specific and maybe cytoskeleton-independent subcellular 
functions within the cell.  
References 
 
97 
 
References 
 
Ahuja R, Pinyol R, Reichenbach N, Custer L, Klingensmith J, Kessels MM, Qualmann B (2007) Cordon-
bleu is an actin nucleation factor and controls neuronal morphology. Cell 131: 337-350 
 
Ali MY, Krementsova EB, Kennedy GG, Mahaffy R, Pollard TD, Trybus KM, Warshaw DM (2007) Myosin 
Va maneuvers through actin intersections and diffuses along microtubules. Proceedings of the 
National Academy of Sciences of the United States of America 104: 4332-4336 
 
Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based 
environment for protein structure homology modelling. Bioinformatics 22: 195-201 
 
Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD (2002a) Escrt-III: an endosome-
associated heterooligomeric protein complex required for mvb sorting. Developmental cell 3: 271-282 
 
Babst M, Katzmann DJ, Snyder WB, Wendland B, Emr SD (2002b) Endosome-associated complex, 
ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Developmental 
cell 3: 283-289 
 
Babst M, Sato TK, Banta LM, Emr SD (1997) Endosomal transport function in yeast requires a novel 
AAA-type ATPase, Vps4p. The EMBO journal 16: 1820-1831 
 
Babst M, Wendland B, Estepa EJ, Emr SD (1998) The Vps4p AAA ATPase regulates membrane 
association of a Vps protein complex required for normal endosome function. The EMBO journal 17: 
2982-2993 
 
Bajorek M, Morita E, Skalicky JJ, Morham SG, Babst M, Sundquist WI (2009a) Biochemical analyses of 
human IST1 and its function in cytokinesis. Molecular biology of the cell 20: 1360-1373 
 
Bajorek M, Schubert HL, McCullough J, Langelier C, Eckert DM, Stubblefield WM, Uter NT, Myszka DG, 
Hill CP, Sundquist WI (2009b) Structural basis for ESCRT-III protein autoinhibition. Nature structural & 
molecular biology 16: 754-762 
 
Bertling E, Hotulainen P, Mattila PK, Matilainen T, Salminen M, Lappalainen P (2004) Cyclase-
associated protein 1 (CAP1) promotes cofilin-induced actin dynamics in mammalian nonmuscle cells. 
Molecular biology of the cell 15: 2324-2334 
 
Blanc C, Charette SJ, Mattei S, Aubry L, Smith EW, Cosson P, Letourneur F (2009) Dictyostelium Tom1 
participates to an ancestral ESCRT-0 complex. Traffic 10: 161-171 
 
Bosch M, Le KH, Bugyi B, Correia JJ, Renault L, Carlier MF (2007) Analysis of the function of Spire in 
actin assembly and its synergy with formin and profilin. Molecular cell 28: 555-568 
 
Calvo-Garrido J, Carilla-Latorre S, Kubohara Y, Santos-Rodrigo N, Mesquita A, Soldati T, Golstein P, 
Escalante R (2010) Autophagy in Dictyostelium: genes and pathways, cell death and infection. 
Autophagy 6: 686-701 
 
Campellone KG, Welch MD (2010) A nucleator arms race: cellular control of actin assembly. Nature 
reviews Molecular cell biology 11: 237-251 
 
Charette SJ, Cosson P (2004) Preparation of genomic DNA from Dictyostelium discoideum for PCR 
analysis. BioTechniques 36: 574-575 
 
Chen CK, Sawaya MR, Phillips ML, Reisler E, Quinlan ME (2012) Multiple forms of Spire-actin 
complexes and their functional consequences. The Journal of biological chemistry 287: 10684-10692 
 
References 
 
98 
 
Chereau D, Kerff F, Graceffa P, Grabarek Z, Langsetmo K, Dominguez R (2005) Actin-bound structures 
of Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament 
assembly. Proceedings of the National Academy of Sciences of the United States of America 102: 
16644-16649 
 
Chisholm RL, Firtel RA (2004) Insights into morphogenesis from a simple developmental system. 
Nature reviews Molecular cell biology 5: 531-541 
 
Ciccarelli FD, Proukakis C, Patel H, Cross H, Azam S, Patton MA, Bork P, Crosby AH (2003) The 
identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic 
paraplegia. Genomics 81: 437-441 
 
Claessens MM, Semmrich C, Ramos L, Bausch AR (2008) Helical twist controls the thickness of F-actin 
bundles. Proceedings of the National Academy of Sciences of the United States of America 105: 8819-
8822 
 
Cleuren YT, Boonstra J (2012) Actin: Structure, Functions and Disease. In Actin: Structure, Functions 
and Disease, Consuelas VA, Minas DJ (eds), Chapter 2, pp 61 - 96. Nova Publishers 
 
Cooper JA, Walker SB, Pollard TD (1983) Pyrene actin: documentation of the validity of a sensitive 
assay for actin polymerization. Journal of muscle research and cell motility 4: 253-262 
 
Czisch M, Schleicher M, Horger S, Voelter W, Holak TA (1993) Conformation of thymosin beta 4 in 
water determined by NMR spectroscopy. European journal of biochemistry / FEBS 218: 335-344 
 
Dagert M, Ehrlich SD (1979) Prolonged incubation in calcium chloride improves the competence of 
Escherichia coli cells. Gene 6: 23-28 
 
Dambournet D, Machicoane M, Chesneau L, Sachse M, Rocancourt M, El Marjou A, Formstecher E, 
Salomon R, Goud B, Echard A (2011) Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin 
for successful cytokinesis. Nature cell biology 13: 981-988 
 
Devreotes PN, Zigmond SH (1988) Chemotaxis in eukaryotic cells: a focus on leukocytes and 
Dictyostelium. Annual review of cell biology 4: 649-686 
 
Dimaano C, Jones CB, Hanono A, Curtiss M, Babst M (2008) Ist1 regulates Vps4 localization and 
assembly. Molecular biology of the cell 19: 465-474 
 
Domazetovska A, Ilkovski B, Kumar V, Valova VA, Vandebrouck A, Hutchinson DO, Robinson PJ, 
Cooper ST, Sparrow JC, Peckham M, North KN (2007) Intranuclear rod myopathy: molecular 
pathogenesis and mechanisms of weakness. Annals of neurology 62: 597-608 
 
Ducka AM (2011) Molecular architecture of Spire-actin complexes and its implication for actin filament 
assembly. Dr. rer. nat Thesis, Abteilung Strukturforschung Biologische NMR-Arbeitsgruppe, Max-
Planck-Institut für Biochemie  
 
Ducka AM, Joel P, Popowicz GM, Trybus KM, Schleicher M, Noegel AA, Huber R, Holak TA, Sitar T 
(2010) Structures of actin-bound Wiskott-Aldrich syndrome protein homology 2 (WH2) domains of 
Spire and the implication for filament nucleation. Proceedings of the National Academy of Sciences of 
the United States of America 107: 11757-11762 
 
Eichinger L, Noegel AA, Schleicher M (1991) Domain structure in actin-binding proteins: expression 
and functional characterization of truncated severin. The Journal of cell biology 112: 665-676 
 
Eichinger L, Pachebat JA, Glockner G, Rajandream MA, Sucgang R, Berriman M, Song J, Olsen R, 
Szafranski K, Xu Q, Tunggal B, Kummerfeld S, Madera M, Konfortov BA, Rivero F, Bankier AT, 
Lehmann R, Hamlin N, Davies R, Gaudet P, Fey P, Pilcher K, Chen G, Saunders D, Sodergren E, Davis 
P, Kerhornou A, Nie X, Hall N, Anjard C, Hemphill L, Bason N, Farbrother P, Desany B, Just E, Morio T, 
Rost R, Churcher C, Cooper J, Haydock S, van Driessche N, Cronin A, Goodhead I, Muzny D, Mourier 
References 
 
99 
 
T, Pain A, Lu M, Harper D, Lindsay R, Hauser H, James K, Quiles M, Madan Babu M, Saito T, 
Buchrieser C, Wardroper A, Felder M, Thangavelu M, Johnson D, Knights A, Loulseged H, Mungall K, 
Oliver K, Price C, Quail MA, Urushihara H, Hernandez J, Rabbinowitsch E, Steffen D, Sanders M, Ma J, 
Kohara Y, Sharp S, Simmonds M, Spiegler S, Tivey A, Sugano S, White B, Walker D, Woodward J, 
Winckler T, Tanaka Y, Shaulsky G, Schleicher M, Weinstock G, Rosenthal A, Cox EC, Chisholm RL, 
Gibbs R, Loomis WF, Platzer M, Kay RR, Williams J, Dear PH, Noegel AA, Barrell B, Kuspa A (2005) 
The genome of the social amoeba Dictyostelium discoideum. Nature 435: 43-57 
 
Entian KD, Schuster T, Hegemann JH, Becher D, Feldmann H, Guldener U, Gotz R, Hansen M, 
Hollenberg CP, Jansen G, Kramer W, Klein S, Kotter P, Kricke J, Launhardt H, Mannhaupt G, Maierl A, 
Meyer P, Mewes W, Munder T, Niedenthal RK, Ramezani Rad M, Rohmer A, Romer A, Hinnen A, et al. 
(1999) Functional analysis of 150 deletion mutants in Saccharomyces cerevisiae by a systematic 
approach. Molecular & general genetics : MGG 262: 683-702 
 
Faix J, Clougherty C, Konzok A, Mintert U, Murphy J, Albrecht R, Muhlbauer B, Kuhlmann J (1998) The 
IQGAP-related protein DGAP1 interacts with Rac and is involved in the modulation of the F-actin 
cytoskeleton and control of cell motility. Journal of cell science 111 ( Pt 20): 3059-3071 
 
Faix J, Kreppel L, Shaulsky G, Schleicher M, Kimmel AR (2004) A rapid and efficient method to 
generate multiple gene disruptions in Dictyostelium discoideum using a single selectable marker and 
the Cre-loxP system. Nucleic acids research 32: e143 
 
Field J, Nikawa J, Broek D, MacDonald B, Rodgers L, Wilson IA, Lerner RA, Wigler M (1988) 
Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an 
epitope addition method. Molecular and cellular biology 8: 2159-2165 
 
Field J, Vojtek A, Ballester R, Bolger G, Colicelli J, Ferguson K, Gerst J, Kataoka T, Michaeli T, Powers 
S, et al. (1990) Cloning and characterization of CAP, the S. cerevisiae gene encoding the 70 kd 
adenylyl cyclase-associated protein. Cell 61: 319-327 
 
Filimonenko M, Stuffers S, Raiborg C, Yamamoto A, Malerod L, Fisher EM, Isaacs A, Brech A, 
Stenmark H, Simonsen A (2007) Functional multivesicular bodies are required for autophagic 
clearance of protein aggregates associated with neurodegenerative disease. The Journal of cell 
biology 179: 485-500 
 
Fujita H, Yamanaka M, Imamura K, Tanaka Y, Nara A, Yoshimori T, Yokota S, Himeno M (2003) A 
dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane trafficking out of 
endosomal/lysosomal compartments: class E vps phenotype in mammalian cells. Journal of cell 
science 116: 401-414 
 
Fukui Y (1978) Intranuclear actin bundles induced by dimethyl sulfoxide in interphase nucleus of 
Dictyostelium. The Journal of cell biology 76: 146-157 
 
Ghazi-Tabatabai S, Saksena S, Short JM, Pobbati AV, Veprintsev DB, Crowther RA, Emr SD, Egelman 
EH, Williams RL (2008) Structure and disassembly of filaments formed by the ESCRT-III subunit 
Vps24. Structure 16: 1345-1356 
 
Glockner G, Eichinger L, Szafranski K, Pachebat JA, Bankier AT, Dear PH, Lehmann R, Baumgart C, 
Parra G, Abril JF, Guigo R, Kumpf K, Tunggal B, Cox E, Quail MA, Platzer M, Rosenthal A, Noegel AA 
(2002) Sequence and analysis of chromosome 2 of Dictyostelium discoideum. Nature 418: 79-85 
 
Gottwald U, Brokamp R, Karakesisoglou I, Schleicher M, Noegel AA (1996) Identification of a cyclase-
associated protein (CAP) homologue in Dictyostelium discoideum and characterization of its interaction 
with actin. Molecular biology of the cell 7: 261-272 
 
Gruenberg J, Stenmark H (2004) The biogenesis of multivesicular endosomes. Nature reviews 
Molecular cell biology 5: 317-323 
 
References 
 
100 
 
Guizetti J, Schermelleh L, Mantler J, Maar S, Poser I, Leonhardt H, Muller-Reichert T, Gerlich DW 
(2011) Cortical constriction during abscission involves helices of ESCRT-III-dependent filaments. 
Science 331: 1616-1620 
 
Halliburton WD (1887) On Muscle-Plasma. The Journal of physiology 8: 133-202 
 
Hanson PI, Roth R, Lin Y, Heuser JE (2008) Plasma membrane deformation by circular arrays of 
ESCRT-III protein filaments. The Journal of cell biology 180: 389-402 
 
Hurley JH, Hanson PI (2010) Membrane budding and scission by the ESCRT machinery: it's all in the 
neck. Nature reviews Molecular cell biology 11: 556-566 
 
Hutchinson DO, Charlton A, Laing NG, Ilkovski B, North KN (2006) Autosomal dominant nemaline 
myopathy with intranuclear rods due to mutation of the skeletal muscle ACTA1 gene: clinical and 
pathological variability within a kindred. Neuromuscular disorders : NMD 16: 113-121 
 
Israel L (2002) Domänenanalyse des Cyclase-assoziierten Proteins (CAP) und Charakterisierung von 
Filactin, einem neuartigen actinähnlichen Protein aus Dictyostelium discoideum. Dr. rer. nat Thesis, 
Institut für Zellbiologie, Ludwig-Maximilians-Universität, Munich 
 
Janssen KP, Eichinger L, Janmey PA, Noegel AA, Schliwa M, Witke W, Schleicher M (1996) Viscoelastic 
properties of F-actin solutions in the presence of normal and mutated actin-binding proteins. Archives 
of biochemistry and biophysics 325: 183-189 
 
Joseph JM, Fey P, Ramalingam N, Liu XI, Rohlfs M, Noegel AA, Muller-Taubenberger A, Glockner G, 
Schleicher M (2008) The actinome of Dictyostelium discoideum in comparison to actins and actin-
related proteins from other organisms. PloS one 3: e2654 
 
Kaimaktchiev V, Goebel H, Laing N, Narus M, Weeks D, Nixon R (2006) Intranuclear nemaline rod 
myopathy. Muscle & nerve 34: 369-372 
 
Katzmann DJ, Babst M, Emr SD (2001) Ubiquitin-dependent sorting into the multivesicular body 
pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106: 
145-155 
 
Kerkhoff E (2006) Cellular functions of the Spir actin-nucleation factors. Trends in cell biology 16: 
477-483 
 
Kerkhoff E, Simpson JC, Leberfinger CB, Otto IM, Doerks T, Bork P, Rapp UR, Raabe T, Pepperkok R 
(2001) The Spir actin organizers are involved in vesicle transport processes. Current biology : CB 11: 
1963-1968 
 
Kieffer C, Skalicky JJ, Morita E, De Domenico I, Ward DM, Kaplan J, Sundquist WI (2008) Two distinct 
modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and 
HIV-1 budding. Developmental cell 15: 62-73 
 
Kouyama T, Mihashi K (1981) Fluorimetry study of N-(1-pyrenyl)iodoacetamide-labelled F-actin. Local 
structural change of actin protomer both on polymerization and on binding of heavy meromyosin. 
European journal of biochemistry / FEBS 114: 33-38 
 
Ksiazek D, Brandstetter H, Israel L, Bourenkov GP, Katchalova G, Janssen KP, Bartunik HD, Noegel AA, 
Schleicher M, Holak TA (2003) Structure of the N-terminal domain of the adenylyl cyclase-associated 
protein (CAP) from Dictyostelium discoideum. Structure 11: 1171-1178 
 
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage 
T4. Nature 227: 680-685 
 
References 
 
101 
 
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, 
Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG (2007) Clustal W and Clustal X version 2.0. 
Bioinformatics 23: 2947-2948 
 
Lata S, Schoehn G, Jain A, Pires R, Piehler J, Gottlinger HG, Weissenhorn W (2008) Helical structures 
of ESCRT-III are disassembled by VPS4. Science 321: 1354-1357 
 
Lee JA, Beigneux A, Ahmad ST, Young SG, Gao FB (2007) ESCRT-III dysfunction causes 
autophagosome accumulation and neurodegeneration. Current biology : CB 17: 1561-1567 
 
Littlefield RS, Fowler VM (2008) Thin filament length regulation in striated muscle sarcomeres: 
pointed-end dynamics go beyond a nebulin ruler. Seminars in cell & developmental biology 19: 511-
519 
 
Liverman AD, Cheng HC, Trosky JE, Leung DW, Yarbrough ML, Burdette DL, Rosen MK, Orth K (2007) 
Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proceedings of the National 
Academy of Sciences of the United States of America 104: 17117-17122 
 
MacLean-Fletcher SD, Pollard TD (1980) Viscometric analysis of the gelation of Acanthamoeba 
extracts and purification of two gelation factors. The Journal of cell biology 85: 414-428 
 
Makkonen M, Bertling E, Chebotareva NA, Baum J, Lappalainen P (2013) Mammalian and malaria 
parasite cyclase-associated proteins catalyze nucleotide exchange on G-actin through a conserved 
mechanism. The Journal of biological chemistry 288: 984-994 
 
Manseau LJ, Schupbach T (1989) cappuccino and spire: two unique maternal-effect loci required for 
both the anteroposterior and dorsoventral patterns of the Drosophila embryo. Genes & development 
3: 1437-1452 
 
Mattei S, Klein G, Satre M, Aubry L (2006) Trafficking and developmental signaling: Alix at the 
crossroads. European journal of cell biology 85: 925-936 
 
McCoy AJ, Fucini P, Noegel AA, Stewart M (1999) Structural basis for dimerization of the Dictyostelium 
gelation factor (ABP120) rod. Nature structural biology 6: 836-841 
 
McHugh KM, Crawford K, Lessard JL (1991) A comprehensive analysis of the developmental and 
tissue-specific expression of the isoactin multigene family in the rat. Developmental biology 148: 442-
458 
 
McKinney EC, Meagher RB (1998) Members of the Arabidopsis actin gene family are widely dispersed 
in the genome. Genetics 149: 663-675 
 
McRobbie SJ, Newell PC (1983) Changes in actin associated with the cytoskeleton following 
chemotactic stimulation of dictyostelium discoideum. Biochemical and biophysical research 
communications 115: 351-359 
 
Metcalf D, Isaacs AM (2010) The role of ESCRT proteins in fusion events involving lysosomes, 
endosomes and autophagosomes. Biochemical Society transactions 38: 1469-1473 
 
Minamide LS, Maiti S, Boyle JA, Davis RC, Coppinger JA, Bao Y, Huang TY, Yates J, Bokoch GM, 
Bamburg JR (2010) Isolation and characterization of cytoplasmic cofilin-actin rods. The Journal of 
biological chemistry 285: 5450-5460 
 
Moriyama K, Yahara I (2002) Human CAP1 is a key factor in the recycling of cofilin and actin for rapid 
actin turnover. Journal of cell science 115: 1591-1601 
 
Muziol T, Pineda-Molina E, Ravelli RB, Zamborlini A, Usami Y, Gottlinger H, Weissenhorn W (2006) 
Structural basis for budding by the ESCRT-III factor CHMP3. Developmental cell 10: 821-830 
 
References 
 
102 
 
Nara A, Mizushima N, Yamamoto A, Kabeya Y, Ohsumi Y, Yoshimori T (2002) SKD1 AAA ATPase-
dependent endosomal transport is involved in autolysosome formation. Cell structure and function 27: 
29-37 
 
Nishida E, Iida K, Yonezawa N, Koyasu S, Yahara I, Sakai H (1987) Cofilin is a component of 
intranuclear and cytoplasmic actin rods induced in cultured cells. Proceedings of the National Academy 
of Sciences of the United States of America 84: 5262-5266 
 
Noegel AA, Blau-Wasser R, Sultana H, Muller R, Israel L, Schleicher M, Patel H, Weijer CJ (2004) The 
cyclase-associated protein CAP as regulator of cell polarity and cAMP signaling in Dictyostelium. 
Molecular biology of the cell 15: 934-945 
 
Noegel AA, Rivero F, Albrecht R, Janssen KP, Kohler J, Parent CA, Schleicher M (1999) Assessing the 
role of the ASP56/CAP homologue of Dictyostelium discoideum and the requirements for subcellular 
localization. Journal of cell science 112 ( Pt 19): 3195-3203 
 
Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, Jacob RL, Hubner C, Oexle 
K, Anderson JR, Verity CM, North KN, Iannaccone ST, Muller CR, Nurnberg P, Muntoni F, Sewry C, 
Hughes I, Sutphen R, Lacson AG, Swoboda KJ, Vigneron J, Wallgren-Pettersson C, Beggs AH, Laing 
NG (1999) Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and 
nemaline myopathy. Nature genetics 23: 208-212 
 
O'Connell KL, Stults JT (1997) Identification of mouse liver proteins on two-dimensional 
electrophoresis gels by matrix-assisted laser desorption/ionization mass spectrometry of in situ 
enzymatic digests. Electrophoresis 18: 349-359 
 
Osborn M, Weber K (1984) Actin paracrystal induction by forskolin and by db-cAMP in CHO cells. 
Experimental cell research 150: 408-418 
 
Ostermeier C, Brunger AT (1999) Structural basis of Rab effector specificity: crystal structure of the 
small G protein Rab3A complexed with the effector domain of rabphilin-3A. Cell 96: 363-374 
 
Otto IM, Raabe T, Rennefahrt UE, Bork P, Rapp UR, Kerkhoff E (2000) The p150-Spir protein provides 
a link between c-Jun N-terminal kinase function and actin reorganization. Current biology : CB 10: 
345-348 
 
Parent CA (2004) Making all the right moves: chemotaxis in neutrophils and Dictyostelium. Current 
opinion in cell biology 16: 4-13 
 
Peche V, Shekar S, Leichter M, Korte H, Schroder R, Schleicher M, Holak TA, Clemen CS, Ramanath 
YB, Pfitzer G, Karakesisoglou I, Noegel AA (2007) CAP2, cyclase-associated protein 2, is a dual 
compartment protein. Cellular and molecular life sciences : CMLS 64: 2702-2715 
 
Peche VS, Holak TA, Burgute BD, Kosmas K, Kale SP, Wunderlich FT, Elhamine F, Stehle R, Pfitzer G, 
Nohroudi K, Addicks K, Stockigt F, Schrickel JW, Gallinger J, Schleicher M, Noegel AA (2013) Ablation 
of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy. Cellular and molecular life sciences : 
CMLS 70: 527-543 
 
Pfender S, Kuznetsov V, Pleiser S, Kerkhoff E, Schuh M (2011) Spire-type actin nucleators cooperate 
with Formin-2 to drive asymmetric oocyte division. Current biology : CB 21: 955-960 
 
Piper RC, Katzmann DJ (2007) Biogenesis and function of multivesicular bodies. Annual review of cell 
and developmental biology 23: 519-547 
 
Popowicz GM, Muller R, Noegel AA, Schleicher M, Huber R, Holak TA (2004) Molecular structure of the 
rod domain of dictyostelium filamin. Journal of molecular biology 342: 1637-1646 
 
Popowicz GM, Schleicher M, Noegel AA, Holak TA (2006) Filamins: promiscuous organizers of the 
cytoskeleton. Trends in biochemical sciences 31: 411-419 
References 
 
103 
 
 
Quinlan ME, Heuser JE, Kerkhoff E, Mullins RD (2005) Drosophila Spire is an actin nucleation factor. 
Nature 433: 382-388 
 
Quinlan ME, Hilgert S, Bedrossian A, Mullins RD, Kerkhoff E (2007) Regulatory interactions between 
two actin nucleators, Spire and Cappuccino. The Journal of cell biology 179: 117-128 
 
Ralston KS, Petri WA (2011) The ways of a killer: how does Entamoeba histolytica elicit host cell 
death? Essays in biochemistry 51: 193-210 
 
Raper KB (1935) Dictyostelium discoideum, a new species of slime mold from decaying forest leaves. 
Journal of Agricultural Research 50: 135-147 
 
Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends in 
biochemical sciences 21: 267-271 
 
Rivero F, Kuspa A, Brokamp R, Matzner M, Noegel AA (1998) Interaptin, an actin-binding protein of 
the alpha-actinin superfamily in Dictyostelium discoideum, is developmentally and cAMP-regulated and 
associates with intracellular membrane compartments. The Journal of cell biology 142: 735-750 
 
Rogers S, Wells R, Rechsteiner M (1986) Amino acid sequences common to rapidly degraded proteins: 
the PEST hypothesis. Science 234: 364-368 
 
Romans P, Firtel RA, Saxe CL, 3rd (1985) Gene-specific expression of the actin multigene family of 
Dictyostelium discoideum. Journal of molecular biology 186: 337-355 
 
Rosales-Nieves AE, Johndrow JE, Keller LC, Magie CR, Pinto-Santini DM, Parkhurst SM (2006) 
Coordination of microtubule and microfilament dynamics by Drosophila Rho1, Spire and Cappuccino. 
Nature cell biology 8: 367-376 
 
Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, Leonhardt H (2008) A versatile 
nanotrap for biochemical and functional studies with fluorescent fusion proteins. Molecular & cellular 
proteomics : MCP 7: 282-289 
 
Rue SM, Mattei S, Saksena S, Emr SD (2008) Novel Ist1-Did2 complex functions at a late step in 
multivesicular body sorting. Molecular biology of the cell 19: 475-484 
 
Rusten TE, Stenmark H (2009) How do ESCRT proteins control autophagy? Journal of cell science 
122: 2179-2183 
 
Rusten TE, Vaccari T, Lindmo K, Rodahl LM, Nezis IP, Sem-Jacobsen C, Wendler F, Vincent JP, Brech 
A, Bilder D, Stenmark H (2007) ESCRTs and Fab1 regulate distinct steps of autophagy. Current biology 
: CB 17: 1817-1825 
 
Saksena S, Sun J, Chu T, Emr SD (2007) ESCRTing proteins in the endocytic pathway. Trends in 
biochemical sciences 32: 561-573 
 
Saksena S, Wahlman J, Teis D, Johnson AE, Emr SD (2009) Functional reconstitution of ESCRT-III 
assembly and disassembly. Cell 136: 97-109 
 
Sambrook J, Russel DW (2001) Molecular Cloning, 3rd edition edn edn. New York: Cold Spring 
Harbour Laboratory. 
 
Sameshima M, Kishi Y, Osumi M, Mahadeo D, Cotter DA (2000) Novel actin cytoskeleton: actin 
tubules. Cell structure and function 25: 291-295 
 
Schmoller KM, Semmrich C, Bausch AR (2011) Slow down of actin depolymerization by cross-linking 
molecules. Journal of structural biology 173: 350-357 
 
References 
 
104 
 
Schnuchel A, Wiltscheck R, Eichinger L, Schleicher M, Holak TA (1995) Structure of severin domain 2 
in solution. Journal of molecular biology 247: 21-27 
 
Schwalb M, Roth R (1970) Axenic growth and development of the cellular Slime Mould, Dictyostelium 
discoideum. Journal of general microbiology 60: 283-286 
 
Sept D, McCammon JA (2001) Thermodynamics and kinetics of actin filament nucleation. Biophysical 
journal 81: 667-674 
 
Simpson PA, Spudich JA, Parham P (1984) Monoclonal antibodies prepared against Dictyostelium 
actin: characterization and interactions with actin. The Journal of cell biology 99: 287-295 
 
Sitar T, Gallinger J, Ducka AM, Ikonen TP, Wohlhoefler M, Schmoller KM, Bausch AR, Joel P, Trybus 
KM, Noegel AA, Schleicher M, Huber R, Holak TA (2011) Molecular architecture of the Spire-actin 
nucleus and its implication for actin filament assembly. Proceedings of the National Academy of 
Sciences of the United States of America 108: 19575-19580 
 
Skwarek-Maruszewska A, Hotulainen P, Mattila PK, Lappalainen P (2009) Contractility-dependent actin 
dynamics in cardiomyocyte sarcomeres. Journal of cell science 122: 2119-2126 
 
Sparrow JC, Nowak KJ, Durling HJ, Beggs AH, Wallgren-Pettersson C, Romero N, Nonaka I, Laing NG 
(2003) Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1). 
Neuromuscular disorders : NMD 13: 519-531 
 
Spudich JA, Watt S (1971) The regulation of rabbit skeletal muscle contraction. I. Biochemical studies 
of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of 
myosin. The Journal of biological chemistry 246: 4866-4871 
 
Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, Shapiro SS (2001) Filamins as 
integrators of cell mechanics and signalling. Nature reviews Molecular cell biology 2: 138-145 
 
Straub FB (1942) Actin. Studies from the Institute of Medical Chemistry University Szeged 2: 3-15 
 
Sultana H, Rivero F, Blau-Wasser R, Schwager S, Balbo A, Bozzaro S, Schleicher M, Noegel AA (2005) 
Cyclase-associated protein is essential for the functioning of the endo-lysosomal system and provides 
a link to the actin cytoskeleton. Traffic 6: 930-946 
 
Tam VC, Serruto D, Dziejman M, Brieher W, Mekalanos JJ (2007) A type III secretion system in Vibrio 
cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell 
host & microbe 1: 95-107 
 
Urushihara H, Morio T, Saito T, Kohara Y, Koriki E, Ochiai H, Maeda M, Williams JG, Takeuchi I, 
Tanaka Y (2004) Analyses of cDNAs from growth and slug stages of Dictyostelium discoideum. Nucleic 
acids research 32: 1647-1653 
 
Vandebrouck A, Domazetovska A, Mokbel N, Cooper ST, Ilkovski B, North KN (2010) In vitro analysis 
of rod composition and actin dynamics in inherited myopathies. Journal of neuropathology and 
experimental neurology 69: 429-441 
 
Vandekerckhove J, Weber K (1978) At least six different actins are expressed in a higher mammal: an 
analysis based on the amino acid sequence of the amino-terminal tryptic peptide. Journal of molecular 
biology 126: 783-802 
 
Vandekerckhove J, Weber K (1980) Vegetative Dictyostelium cells containing 17 actin genes express a 
single major actin. Nature 284: 475-477 
 
Watts DJ, Ashworth JM (1970) Growth of myxamoebae of the cellular slime mould Dictyostelium 
discoideum in axenic culture. Biochemical  Journal 119: 171-174 
 
References 
 
105 
 
Wegner A (1976) Head to tail polymerization of actin. Journal of molecular biology 108: 139-150 
 
Westphal M, Jungbluth A, Heidecker M, Muhlbauer B, Heizer C, Schwartz JM, Marriott G, Gerisch G 
(1997) Microfilament dynamics during cell movement and chemotaxis monitored using a GFP-actin 
fusion protein. Current biology : CB 7: 176-183 
 
WHO (1997) Amoebiasis. WHO Weekly Epidemiologic Record 72: 97–100. 
 
Williams RL, Urbe S (2007) The emerging shape of the ESCRT machinery. Nature reviews Molecular 
cell biology 8: 355-368 
 
Xia J, Wang W, Li L, Liu Z, Liu M, Yang D (2012) Inhibition of HBV replication by VPS4B and its 
dominant negative mutant VPS4B-K180Q in vivo. Journal of Huazhong University of Science and 
Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong 
keji daxue xuebao Yixue Yingdewen ban 32: 311-316 
 
Xiao J, Chen XW, Davies BA, Saltiel AR, Katzmann DJ, Xu Z (2009) Structural basis of Ist1 function 
and Ist1-Did2 interaction in the multivesicular body pathway and cytokinesis. Molecular biology of the 
cell 20: 3514-3524 
 
Yu Z, Gonciarz MD, Sundquist WI, Hill CP, Jensen GJ (2008) Cryo-EM structure of dodecameric Vps4p 
and its 2:1 complex with Vta1p. Journal of molecular biology 377: 364-377 
 
Zelicof A, Protopopov V, David D, Lin XY, Lustgarten V, Gerst JE (1996) Two separate functions are 
encoded by the carboxyl-terminal domains of the yeast cyclase-associated protein and its mammalian 
homologs. Dimerization and actin binding. The Journal of biological chemistry 271: 18243-18252 
 
Zuchero JB, Coutts AS, Quinlan ME, Thangue NB, Mullins RD (2009) p53-cofactor JMY is a 
multifunctional actin nucleation factor. Nature cell biology 11: 451-459 
 
 
  
List of Figures 
 
106 
 
List of Figures 
Figure 1: The process of spontaneous actin polymerization .............................................................1 
Figure 2: Intranuclear rods as a result of a mutation in the α-skeletal muscle actin protein ...............3 
Figure 3: Domain organization of the WH2 domain containing proteins Spire and CAP2 ....................5 
Figure 4: Life cycle of D. discoideum ..............................................................................................6 
Figure 5: Domain organization of the actin variant filactin ...............................................................8 
Figure 6: Biological roles of the ESCRTs ....................................................................................... 10 
Figure 7: Filactin gene disruption strategy .................................................................................... 27 
Figure 8: Alignment of the WH2 domains of Spire, CAP2 and N-WASP from different organisms ...... 29 
Figure 9: Representation of selected constructs used in this study ................................................. 31 
Figure 10: Purified CAP2-WH2 disrupts preformed actin filaments ................................................. 32 
Figure 11: Disruption of F-actin-fascin bundles by the CAP2-WH2 domain imaged with a confocal 
microscope .................................................................................................................................. 33 
Figure 12: Free SpireWH2 domain constructs nucleate actin polymerization only at sub-stoichiometric 
concentrations ............................................................................................................................. 34 
Figure 13: Preformed SpireWH2-actin complexes act as perfect nuclei for actin polymerization and 
cannot disrupt filaments like free WH2 domains ............................................................................. 36 
Figure 14: SpireWH2 domains in tandem show nucleation only at substoichiometric ratios and 
sequester actin at increasing concentrations .................................................................................. 37 
Figure 15: Decrease of pyrene-fluorescence at steady state after actin nucleation or sequestration by 
SpireWH2 constructs .................................................................................................................... 38 
Figure 16: SpireWH2 constructs disrupt preformed actin filaments extremely fast .......................... 40 
Figure 17: SpireWH2 domains efficiently sequester actin and disrupt filaments as shown by viscosity 
measurements ............................................................................................................................. 41 
Figure 18: SpireWH2 constructs disrupt preformed actin filaments extremely fast as shown by TIRF 
microscopy .................................................................................................................................. 42 
Figure 19: SpireWH2 domains are not associated with actin filaments after effected nucleation as 
shown by a spindown assay with TMR-labeled SpireDDD ................................................................ 44 
Figure 20: SpireWH2 domains only efficiently disrupt F-actin if not phalloidin-stabilized .................. 45 
Figure 21: SpireWH2 constructs bind to G-actin as shown by FRET................................................ 45 
Figure 22: D. discoideum amoebae respond to treatment with SpireWH2 domains ......................... 46 
Figure 23: D. discoideum cells round up and form cytoplasmic cofilin rods upon addition of high 
concentrations of SpireDDD .......................................................................................................... 47 
Figure 24: Alignment of selected D. discoideum actin variants ....................................................... 49 
Figure 25: Amino acid sequence and domain organization of filactin .............................................. 50 
Figure 26: Evolutionary tree for the filactin protein family ............................................................. 51 
Figure 27: Homology of the filactin Ist1-like domain to the N-terminal part of human IST1 ............. 52 
Figure 28: Ribbon model of the N-terminal part of human IST1 used as template and the modeled 
filactin Ist1-like domain ................................................................................................................. 53 
List of Figures 
 
107 
 
Figure 29: Alignment of the filactin Ist1-like domain (aa 1-190) to the N-terminal part of human 
IST1, yeast Ist1 and D. discoideum Ist1-like. ................................................................................. 55 
Figure 30: Filamin-like Ig folds in D. discoideum filactin ................................................................ 56 
Figure 31: Ribbon model of rabbit muscle actin and the modeled filactin actin domain (aa 574-944)57 
Figure 32: Defining the binding epitopes of the monoclonal filactin antibodies 3S-55-4 and 4S-59-4 58 
Figure 33: Localization of filactin in D. discoideum cells ................................................................ 59 
Figure 34: Localization of the GFP-tagged filactin actin domain in D. discoideum cells..................... 60 
Figure 35: Localization of GFP-tagged N-terminal filactin domains in D. discoideum cells. ............... 60 
Figure 36: Filactin is part of the Triton-insoluble cytoskeleton and is present both in soluble and 
membrane fractions...................................................................................................................... 62 
Figure 37: Actin and GFP-cofilin are present in nuclear actin rods .................................................. 63 
Figure 38: Filactin is present in nuclear actin rods ........................................................................ 63 
Figure 39: GFP-filactin is not present in nuclear rods .................................................................... 64 
Figure 40: GFP-tagged filactin domains are not present in the nuclear rods ................................... 64 
Figure 41: FLAG-filactin constructs purified from Sf9 cells ............................................................. 65 
Figure 42: Influence of filactin constructs on actin polymerization as measured by fluorometric 
methods ...................................................................................................................................... 67 
Figure 43: Influence of filactin constructs on actin polymerization as measured by low shear 
viscometry ................................................................................................................................... 68 
Figure 44: The filactin actin domain acts as an actin sequestering protein but can be detected 
together with F-actin as well ......................................................................................................... 69 
Figure 45: Filactin interacts with the ESCRT-related protein vta1 ................................................... 70 
Figure 46: Filactin might interact with the ESCRT-related proteins vps4 and vps46, while vps4 is 
associated with vta1 ..................................................................................................................... 71 
Figure 47: GFP-vta1 and filactin occasionally co-localize in D. discoideum ...................................... 72 
Figure 48: GFP-vps4 and filactin co-localize in D. discoideum ........................................................ 73 
Figure 49: GFP-vps46 and filactin occasionally co-localize in D. discoideum. ................................... 73 
Figure 50: Autophagosomes accumulate in filactin KO cells ........................................................... 75 
Figure 51: Filactin might form a tetramer via its filamin-like Ig repeats .......................................... 77 
Figure 52: Purified FLAG-filactin imaged using a transmission electron microscope ......................... 79 
Figure 53: Purified FLAG-filactin actin domain imaged using a transmission electron microscope ..... 80 
Figure 54: SDS-Page Analysis of GFP-tagged actin variants 24 and 25 ........................................... 81 
Figure 55: The binding epitope of the act-1 actin antibody is conserved in the analyzed actin variants 
but apparently not enough to allow act-1 binding ........................................................................... 82 
Figure 56: The actin antibodies act-1 and 224-236-1 do not recognize GFP-act24 and GFP-act25 .... 82 
Figure 57: Working model of nucleation of actin polymerization by WH2 domains in tandem (at 
substoichiometric concentrations of WH2 domain constructs) .......................................................... 85 
Figure 58: Working model of sequestration of actin by WH2 domains (at high concentrations of WH2 
domain constructs). ...................................................................................................................... 86 
List of Tables 
 
108 
 
Figure 59: Working model for the disruption of actin filaments by WH2 domains ............................ 87 
Figure 60: Working model of filactin conformation and function within the microfilament system in 
the cell ........................................................................................................................................ 91 
Figure 61: The proteins filactin and Hs IST1 / Sc Ist1 and their interaction partners ....................... 94 
Figure 62: Working model of the implication of filactin in the ESCRT-III complex disassembly ......... 95 
 
List of Tables 
Table 1: The different WH2 domain constructs used in this study………………………………………………..30 
Table 2: Actin variants analyzed in this study…………………………………………………………………………….48 
 
  
Acknowledgements 
 
109 
 
Acknowledgements 
 
First of all, I want to thank Prof. Dr. Michael Schleicher for providing an excellent, encouraging 
working environment. He is an outstanding supervisor, very precious colleague and friend. Special 
thanks for ALWAYS taking the time to answer my questions. Thank you for your apparently unlimited 
knowledge of science (and everything else!), your caring support, mentoring and inspiration during 
my work. An immeasurable part both of my professional and personal development is due to you.  
 
Many thanks go to Prof. Dr. Barbara Conradt for assessing this thesis. I learned a lot from you during 
my Diploma thesis under your supervision which provided an excellent basis, mindset and enthusiasm 
to pursue this work. 
 
I thank Prof. Dr. Tad Holak and his lab for inspiring discussions and providing Spire protein constructs. 
Many thanks also go to Prof. Dr. Angelika Noegel, Prof. Dr. Jan Faix, Prof. Dr. Ludwig Eichinger, Prof. 
Dr. Andreas Bausch and Prof. Dr. Wolfgang Baumeister for sharing precious reagents, cell lines and 
lab equipment. 
 
I want to thank all lab members for creating such a great working atmosphere where I found all sorts 
of help, support, motivation and friends. It was a great pleasure to work with you. I am indebted to 
PD Dr. Annette Müller-Taubenberger for sharing advice, valuable reagents and cell lines. Very special 
thanks go to Daniela Rieger, my best bench mate and undisputed Actin-Queen! The past few years 
would not have been as much fun without you. I thank Dr. Hellen Ishikawa-Ankerhold for great 
teamwork, scientific discussions and your friendship. I sincerely thank Dr. Meino Rohlfs, Dr. Matthias 
Samereier, Dr. Nagendran Ramalingam, Dr. Petros Batsios, Dr. Peter Kastner, Linda Sanftenberg, 
Heike Roth, Dr. Marija Vukajlovic, Dr. Dennis Zimmermann, Süleyman Kösem, Thi-Hieu Ho, Maria 
Beer, Gudrun Trommler, Marlis Fürbringer, Stefanie Lindholz and Dr. Stéphane Rolland for their 
scientific and moral support. 
 
Very special thanks go to my brother and colleague Christoph Gallinger. Thanks for your endless 
support, for providing confidence throughout all phases of my thesis and for being my best friend. 
 
I thank the Elite Network Of Bavaria for generous support and providing the possibility to be an active 
part and elected speaker of the innovative graduate program ‘Protein Dynamics in Health and 
Disease’. I especially want to thank all the members of this program for stimulating scientific 
discussions and unforgettable times spent together during the different activities of the program. I 
also express my gratitude to the SFB 863 for financial support during this thesis. 
 
Finally, very special thanks go to my parents, who always supported me in my plans. Thanks for all 
your love, trust and patience throughout all the years of my studies. You are the best! 
